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ABSTRACT 
 
2A/2A-like peptides are short sequences (20-30 amino acids) encoded predominantly within 
open reading frames (ORFs) of RNA viruses. They drive a non-canonical translation, in which 
the nascent chain is released from the ribosome at a sense (proline) codon, followed by 
continued translation to generate a separate downstream protein, initiated from the same proline 
codon. The aim of this study is to investigate the role of ribosomal factors in the 2A reaction in 
Saccharomyces cerevisiae cells. Results obtained showed that reduced activity of eRF1/3 
inhibits the 2A reaction. This inhibition did not strongly correlate with the effect that mutations 
have on termination at stop codons. In particular, several mutations within the NIKS motif, 
which is essential for stop codon recognition, had minimal effect on the 2A reaction. To confirm 
these results, we developed a new reporter to investigate the 2A activity, where the green 
fluorescent protein (GFP) sequence was separated with a 2A sequence, between residues 157 
and 158. This reporter was utilised to confirm the effects of eRF1 mutations, previously 
assessed by immunoprecipitation, and results, observed by flow cytometry, revealed 
consistency in terms of the role of eRFs in the 2A reaction.   In summary, these observations 
provide evidences supporting recruitment of eRFs to the ribosome to drive the non-canonical 
termination event that releases the first part of the 2A reaction. 
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1 INTRODUCTION 
 
1.1 Protein synthesis  
Translation is the mechanism by which proteins are made in the cell, using the 
information stored in a molecule of mRNA. The mRNA sequence is decoded by the ribosome, 
with the help of the translation factors. Regulation of transcription and the consequent 
translation, in addition to the mRNA turnover, define the amount and activity of the synthesized 
protein (Rodnina, 2016). Proteins are also subjected to post-translational modification after 
translation is completed, this ensures the full activity of the protein with proper folding and 
functional groups on the protein structure, and post-translational modification frequently plays 
a key role in regulating protein activity. Eukaryotic canonical translation includes four steps: 
initiation, elongation, termination and ribosomal recycling. Initiation and elongation are the 
steps at which most translation is regulated and which also provide checkpoints for the accuracy 
of translation. A variety of signals on the mRNA sequence may control initiation through the 
selection of the open reading frame (ORF) (Rodnina, 2016). This thesis focusses on translation 
in eukaryotes, and thus most of the information below is specific to eukaryotic protein synthesis. 
 
1.2 Messenger Ribonucleic Acid (mRNA) 
mRNA is a single stranded nucleic acid, carrying genetic codes for proteins to the 
ribosome. mRNA comprises ~5% of the total RNA in the cell. In eukaryotes, mRNA is 
transcribed by RNA polymerase II, and following transcription, the initial precursor mRNA is 
modified by splicing to remove introns, as well as addition of a cap and poly(A) tail. The cap 
is an inverted guanosine, which is methylated on the position 7-nitrogen of the guanosine ring 
(m7G). The cap structure stabilises the mRNA from exonucleolytic digestion and also directs 
binding of the ribosome. The cap is normally followed by a non-coding untranslated region (the 
5’ UTR). The 5’ UTR provides the space for the 40S subunit to bind and initiate translation. 
Eukaryotic mRNAs typically contain one open reading frame (ORF), starting with a start codon 
(AUG for methionine) and ending with a stop codon. The ORF is decoded in the 5’ to 3’ 
direction. Each codon within the ORF consists of three bases, representing a specific amino 
acid. Following the ORF, there is another UTR (3’ UTR). The mRNA ends in a poly(A) tail 
(50-200 nucleotides) (figure 1.1).  This tail is added by poly(A) polymerase and, like the cap 
structure, provides stability to the mRNA. 
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1.3 The ribosome  
Ribosomes, in both eukaryotes and prokaryotes, are responsible for all protein synthesis. 
Ribosomes comprise two subunits, termed small and large, which differ slightly in size 
depending on their source. Thus the small subunit is 30S in bacteria, 40S in eukaryotes, and the 
large subunit 50S in bacteria, 60S in eukaryotes. Both subunits are composed of ribosomal RNA 
(rRNA) and protein, with the eukaryotic ribosome containing more rRNA and ribosomal 
proteins (r-proteins) than their bacterial counterparts.  
About 7000 nucleotides of rRNA are contained in eukaryotic ribosomes. The 40S subunit 
consists of 18S rRNA with 33 proteins, while the 60S subunit consists of 5S, 5.8S, and 25S 
rRNA and 46 proteins. The assembly of the 40S and 60S subunits yields the 80S ribosome, 
which contains three binding sites for transfer RNA (tRNA); A (aminoacyl) site, where each 
codon is recognized and the corresponding aminoacyl tRNA binds, P (peptidyl) site, where the 
peptide-tRNA chain is hosted and E (exit) site where the de-acylated tRNA leaves the ribosome  
(figure 1.2). The two key activities of the ribosome, codon recognition and catalysis of peptide 
bond formation, are found in the 40S and 60S subunits respectively (Yusupova and Yusupov, 
2017).  
The junction between A and P sites within the 60S subunit is called the peptidyl transferase 
centre (PTC), this is the location for the peptide bond formation between the aminoacyl-tRNA 
in the A site and the peptidyl-tRNA in the P site. An aqueous ‘exit’ tunnel, with 15 Å average 
diameter, is extended from the PTC through the P site (figure 1.2) (Schneider-Poetsch et al., 
2010) and the whole 60S subunit. This tunnel hosts the growing nascent peptide chain.  The 
main constituent of the exit tunnel inner walls is rRNA with only 3 r-proteins contributing to 
 
Figure 1.1: Structure of eukaryotic mRNA, see text for details. Adapted 
from: http://molbiol4masters.masters.grkraj.org/html/Ribose_Nucleic_Acid8-
Stability_of_mRNAs_and_its_Regulation.htm 
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the tunnel wall (rpL4, L22, L39), these r-proteins assume the co-translation processing for the 
nascent peptide chain (Marino et al., 2016).  
Cryo-EM examination of the yeast ribosome has revealed that the rRNA is incorporated in the 
core of each subunit, whereas r-proteins are largely located on the surface. The 18S rRNA 
sequences form four secondary domains, which tend to fold into tertiary structures, these 
tertiary structures with r-proteins form the main skeleton for the 40S subunit. The 5.8S and 25S 
rRNAs in the 60S subunit also tend to fold, but into six domains (I–VI), which ensures proper 
base pairing between 5.8S and 25S rRNAs (Woolford et al., 2013).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A schematic structure of the eukaryotic ribosome shows the 40S and 60S ribosomal counterparts with mRNA at 
the interface. A codon of an amino acid is contained in the ribosomal A site, and an appropriate aminoacyl-tRNA, 
carried by elongation factor 1A (eEF1A), binds the codon in the A site. The peptidyl-tRNA is attached to the 
ribosomal P site, whereas the de-acylated tRNA leaves the ribosome from the ribosomal E site. The scheme is an 
outlined example for the canonical elongation. 
 
 
1.4 The steps of translation 
1.4.1 Initiation 
Translation initiation is the first step of translation which undertakes the proper binding 
of the mRNA to the ribosome with the aid of ~20 initiation factors (eIFs) to find the proper start 
codon on the mRNA sequence. The involvement of many eIFs in the initiation rates this step 
as the most complicated step among the translation steps (Schmidt et al., 2016).  Under various 
 
         NNN NNN NNN 
A P   E 
 
60S subunit 
 
 
 
 
 
mRNA 
 
 
40S subunit 
Figure1.2: Structural outlines of the eukaryotic ribosome. 
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stressors, canonical initiation is impeded, which reduces the overall protein synthesis (Piccirillo 
et al., 2014).  
 
 Cap-dependent initiation 
       In general, initiation is the rate-limiting step of translation (Piccirillo et al., 2014), and in 
eukaryotes, translation on most mRNAs occurs through the ‘cap-dependent mechanism’. This 
requires the 5’ m7G cap structure of the mRNA to be recognized by the 40S subunit and eIFs 
(Hinnebusch et al., 2016). A key step in initiation is the formation of the ternary complex, this 
consists of eIF2 bound to tRNAmet (met-tRNA) and GTP, a process which is controlled by the 
guanine nucleotide exchange factor eIF2B (Gomez and Faurobert, 2002). Ternary complex 
binds to the 40S subunit, along with eIF1, eIF1A, eIF3 and eIF5, generating the 43S pre-
initiation complex (PIC), which is competent for binding to the mRNA. At this stage, eIF3 may 
change the conformational status of the 40S subunit to permit access for the Met-tRNA, 
attached to the eIF2 (des Georges et al., 2015). eIF5 serves as an adaptor between 40S subunit-
eIF3 and the ternary complex (des Georges et al., 2015) (figure 1.3). 
In order for a mRNA to bind to the PIC, the 5′ m7G cap must be bound by eIF4F, a complex 
comprising eIF4E, eIF4G and eIF4A (Dhote et al., 2012). Within the eIF4F complex, eIF4E 
binds to the cap structure (a rate-limiting step for initiation). eIF4E also stimulates the activity 
of DEAD-box helicase, eIF4A, the ATPase activity of this factor is utilised for the 5′ UTR 
duplex unwinding (Pause and Sonenberg, 1992). eIF4G acts as a scaffold and has binding sites 
for both  eIF4E and eIF4A, as well as eIF3 via eIF3c, eIF3d and eIF3e subunits, to help the 
recruitment of the PIC (Wagner et al., 2014). A further factor, eIF4B also stimulates eIF4A 
helicase activity. It has been recently demonstrated that there is an eIF4F-independent role for 
eIF4B in this context, which is added to its known function as eIF4A cofactor (Pestova and 
Kolupaeva, 2002; Mancera-Martinez et al., 2017). After the PIC properly assembles on the 
mRNA, a process termed scanning starts. If the 5′ UTR is unstructured, a minimum set of 
factors, 40S plus eIF1, eIF2-Met-tRNA and eIF3, is required to scan the 5′ UTR. This indicates 
that scanning is an intrinsic property of the 40S subunit. However, in most cases, the 5′ UTR is 
structured, and it requires further helicase activity for scanning. Specifically, the DEAD-box 
helicase DHX29 has been identified as a factor that promotes scanning through structured 5’ 
UTRs (Pisarev et al., 2008). In addition, ATP hydrolysis promotes the function of some DEAD-
box family members either through the helicase activity or to stimulate the ribosome 
translocation in a 5′ to 3′ direction (Pisareva and Pisarev, 2016). Once the complex finds the 
appropriate AUG, which is characterized by a favourable context (purine in position 3 with G 
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in +4), scanning stops. The PIC components eIF1 and eIF1A both function to improve scanning 
and are displaced from the ribosomal P site to ensure base-pairing between Met-tRNA and the 
AUG (Lomakin and Steitz, 2013). Within the PIC a basic loop of eIF1 is located in the P site, 
which stabilises the association of the AUG with the tRNA anticodon. This interaction, along 
with GTP hydrolysis, leads to the displacement of the eIF1 basic loop, and this plus other 
structural reorganisation of the complex results in formation of the 48S complex (Lomakin and 
Steitz, 2013). eIF2-GDP is then released from the complex and eIF5B acts to stabilize Met-
tRNA (Pisareva and Pisarev, 2014). At this point, the 60S subunit joins the complex, a reaction 
promoted by the GTPase eIF5B, forming the 80S ribosome which is ready now to decode the 
mRNA and generate peptide chains (basic steps of cap-deprndent initiation are indicated in 
figure 1.3). 
 Cap-independent initiation of viral ORFs 
          While the majority of translation initiation in eukaryotes is driven by the canonical 
pathway outlined above, some mRNAs are efficiently translated while the recognition of the 
m7G cap is impaired. To address this mechanism, studies have focused on this point and an 
alternative cap-independent initiation pathway has been described which requires Internal 
Ribosomal Binding Sites (IRES) (Jackson, 2013).  IRES were first discovered in 1988 when 
Pelletier and Sonenberg (1988) detected an efficient internal initiation of translation on a 
structured 5′ UTR of Polioviruses. This mechanism bypasses the requirement for eIF4E to bind 
the cap structure. The key feature of this mechanism is direct recruitment of 40S subunits to 
internal portions of a mRNA. Subsequent analysis has revealed that IRES-driven translation 
can occur via several different routes, with some using scanning downstream of the initial 40S 
binding-site in search of the AUG, while in other cases the 40S subunit is directly loaded to the 
vicinity of the AUG. IRES also have different requirements for canonical initiation factors. In 
some, such as the Dicistrovirus intergenic IRES, they are entirely independent of any eIFs, 
while others require a subset of initiation factors, such as eIF4G and eIF3 (Lozano and 
Martinez-Salas, 2015; Abaeva et al., 2016). Many viruses have been shown to use IRES 
sequences to direct the translation of the viral protein, typically coupled with the ability to de-
activate host cap-dependent translation initiation through cleaving eIFs, and increasing the 
abundance of the viral mRNA over the eukaryotic mRNA (Pelletier and Sonenberg, 1988).  
The secondary and tertiary structures of IRES are likely to account for an effective, direct or 
indirect, interaction with the 40S ribosomal subunit. Indirect interaction needs assistance of 
some eIFs and IRES trans-acting factors (ITAFs), which helps the binding of the 40S subunit 
to the viral mRNA through their ability to stabilize specific conformations of IRES elements 
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(Komar and Hatzoglou, 2015). An example of this is binding of ITAF45 to the foot-and-mouth 
disease (FMDV) IRES which causes changes in the structure of the IRES that in turn enhances 
binding of both eIF4A and eIF4G (Song et al., 2005). In general, the requirement for eIFs and 
ITAFs is reduced in the more structured IRES. Figure 1.4 illustrates the outlines of cap-
independent initiation. 
While IRES were first characterised as being important in viral gene expression, cellular 
mRNAs also contain IRES. These cellular IRES are different from each other, in terms of both 
sequence and secondary structure (Baird et al., 2006). Mammalian species having this IRES 
are rodents and ruminants, but it is also found in other vertebrates such as birds and frogs 
(Sherrill and Lloyd, 2008). Putative cellular IRES are considered, on the base of eIFs 
requirements, closest to Picorna virus IRES (Jackson, 2013).  
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Figure 1.3: Canonical initiation of translation in eukaryotes. Adapted from: Lacerda et al 
(2016). 
Schematic model for eukaryotic canonical initiation. (A) The formation of ternary complexes, eIF2 associated with 
Met-tRNA and GTP. (B) The ternary complex binds to the 40S subunit with the help of eIF1, eIF1A, eIF3 and 
eIF5, forming the 43S pre-initiation complex. (C) The 43S binds to the cap structure at mRNA 5′ end. (D)  The 
scanning ends when the 43S complex encounters the AUG to bind and form the 48S initiation complex. (E) The 
60S subunit joins to form the 80S ribosome. eIF5B hydrolyses the eIF2–GTP. (F) Releasing the initiation factors, 
eIF5B–GTP then binds to the 40S subunit and accelerates the rate of 60S subunit joining. (G) The ribosome enters 
the elongation phase, eIF2 is recycled to enable a next initiation step. 
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Figure 1.4: Cap-independent initiation. Adapted from: Lacerda et al (2016). 
 
Schematic model of IRES-dependent initiation. mRNA secondary structures recruit the 40S subunit to the AUG 
of the ORF, skipping, or not, the scanning process. eIFs and/or IRES (ITAFs) may or may not assist in this 
context. See text for details. 
 
 
Diverse mechanisms have been employed by viruses to yield efficient translation of their 
mRNA, and to out-compete cellular mRNAs (Lopez-Lastra et al., 2010). The dependence of 
host translation on the m7G cap structure is exploited by viruses. Normally, the cap structure at 
the 5’ end of the mRNA is recognized by eIF4F complex, then, the 40S subunit is recruited to 
form the 43S PIC, which scans the mRNA for the appropriate AUG. Plant and animal viral 
mRNAs are uncapped, i.e. they lack the m7G cap structure at the 5’ of the mRNA, thus eIF4F 
is not recruited. Many mechanisms are used by viruses to inhibit the cap-dependent initiation, 
these mechanisms include de-activation of eIFs (Lloyd, 2006). A common cap-independent 
translation, carried out by viruses, is IRES-mediated initiation. IRES recruit the required eIFs 
and ribosomal subunits to a vicinity of the appropriate AUG on the viral mRNA. This form of 
initiation was first identified in poliovirus, and has since been observed in a variety of viral and 
cellular mRNAs including: Picornaviruses, Hepatitis C virus and Pestvirus etc (Griffiths and 
Coen, 2005). About 84 nts of unstructured sequence has been identified just upstream to the 
Turnip crinkle virus (TCV) ORF of the coat protein. This promotes the expression of the coat 
protein from genomic RNA. The coat protein IRES is universally conserved in viruses of the 
same genus. IRES is eIF4G-dependent, but not eIF4E, in terms of the activity. The translation 
of the coat protein from the viral genomic RNA seems to be essential to stimulate the host 
immune system. It has been suggested that both cellular and viral IRES have same strategies 
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for translation (Bugaud et al., 2017). Infection with RNA viruses produces cell stress, and one 
of the cellular responses is activation of the eIF2α kinase PKR, which recognises double 
stranded RNA. PKR and other eIF2 kinases phosphorylate the α subunit of eIF2 (Garcia et al., 
2007), resulting in repression of translation thereby depleting the ternary complex. Most viral 
initiation steps require a ternary complex. However, viral RNA encodes proteins that counter 
translation of cellular mRNA. An example of this is ICP34.5 (Herpes Simplex Viral Protein), 
that requires phosphatase PI which dephosphorylates eIF2α and reactivates translation, after 
being initially inhibited (Li et al., 2011). As noted above (section 1.4.1.2), the Dicistroviridae 
inter-genic IRES does not require any eIFs. It resembles tRNA, inserts into the ribosomal P site 
and triggers initiation at an Ala codon, which circumvents the requirements for Met-tRNA. A 
number of animal viruses have developed a strategy to cope with the deactivation of eIF2α, by 
using alternative proteins to deliver the initiator tRNA including, eIF2A (Merrick and 
Anderson, 1975), and ligatin (known as eIF2D) (Dmitriev et al., 2010) and eIF5B (Terenin et 
al., 2008). 
 
1.4.2 Elongation 
Elongation is the second step of translation during which the ORF is decoded, and the 
amino acid corresponding to each codon is added to the growing chain. In fungi including 
Saccharomyces cerevisiae, elongating the peptide chain requires three elongation factors, eEF1 
complex in addition to eEF2 and eEF3 (Bourne et al., 1991).  
The eEF1 consists of three subunits: eEF1A (50 kDa), eEF1Bα (23 kDa) and eEF1Bγ (48 kDa). 
It delivers the aminoacylated tRNA to the ribosomal A site. The structure of eEF1A is 
conserved between eukaryotes and prokaryotes (where it is termed EF-Tu). It is composed of 
three domains, termed I, II and III. Domain I binds guanine nucleotides, while domains II and 
III contain the binding site for aminoacyl tRNA (aa-tRNA). A hydrophobic pocket between 
domains I and II is a binding site for eEF1Bα (Andersen et al., 2003).  eEF1A binds 
aminoacylated tRNA in a ternary complex with GTP, and this form binds to the elongating 
ribosome in a codon-anticodon dependent manner in the ribosomal A site.  
A general model for translation elongation starts by binding of an eEF1A-GTP-aa-tRNA ternary 
complex (TC) to the A site, GTP hydrolysis is then triggered by codon recognition, allowing 
the accommodation of the specific aa-tRNA in the ribosomal A site. Once this is achieved, the 
ribosome catalyses peptide bond formation. Nucleophilic attack of the aa-tRNA in the 
ribosomal A site occurs on the ester carbon of the peptidyl-tRNA in the P site. It has been 
proposed that a transient intermediate product is formed to be then broken down into deacylated 
tRNA and elongated peptidyl-tRNA. A76 of the peptidyl-tRNA may play a key role by serving 
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as a proton shuttle which extracts a proton from the amino group to be donated to the de-
acylated 3′ hydroxyl (Kuhlenkoetter et al., 2011). Following peptide bond formation, eEF1 is 
released from the ribosome, the de-acylated P site tRNA and A site peptidyl-tRNA are moved 
into hybrid P/E and A/P positions respectively, with the ends of tRNA in both E and P sites. 
eEF2-GTP binds the ribosome in this stage, the tip of domain IV of this factor is inserted in the 
A site. A structural model suggested that domains I and II move relative to domains III, IV and 
V of this factor during ribosomal translocation, which triggers the translocation of the ribosome, 
by sliding three nucleotides over the mRNA, which promotes the positioning of the de-acylated 
tRNA in the E site to be then released from the ribosome. When eEF2-GTP binds to the 
ribosome, a strong conformation of the 40S subunit is then induced, Domains I and II (the head 
of eEF2) rotate ~18º to the E site, resulting in structural changes, and allowing the movement 
of  the amino acyl tRNA to the post state (Zhou et al., 2013). Steps of elongation are outlined 
in figure 1.5.  
eEF3 is a translation factor unique to fungi, which binds the ribosome close to the E site and 
promotes the release of the de-acylated tRNA from the E site (Pittman et al., 2006). This in turn 
facilitates the delivery of the next aa-tRNA to the A site by eEF1A (Triana-Alonso et al., 1995). 
eEF3 is essential in fungi, and has ATPase activity. The function of the eEF3 is still entirely 
unclear, however its function is likely to be linked to the eEF1A function (Petropoulos and 
Green, 2012).  
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Figure 1.5: Steps of translational elongation. Adapted from: Dever et al (2016). 
 
Eukaryotic translational elongation starts at the top of the figure. The ribosome in this stage contains a peptidyl- 
tRNA and a de-acylated tRNA in P and E sites respectively. (1) eEF1A bound to GTP, shown in green, binds 
aminoacyl-tRNA and delivers it to the cognate codon, contained in the ribosomal A site. The binding of appropriate 
aminoacyl-tRNA to the codon triggers a conformational change in the eEF1A, leading to GTP hydrolysis and 
consequent release of eEF1A-GDP, shown in red. Peptide bond formation is catalysed, followed by ribosomal 
translocation, catalysed by eEF2 (2) Binding to GTP, which stimulates the peptidyl-tRNA from A to P sites, and 
the de-acylated tRNA from P to E sites. The fungal essential factor, eEF3 (3), interacts with the eEF1A and 
possibly helps the release of tRNA from the E site.  
  
 
1.4.3 Termination 
Open Reading Frames (ORFs) usually end with a stop codon (UAA, UAG or UGA). 
When a stop codon occupies the ribosomal A site, this triggers the termination step of 
translation. Release of the nascent peptide chain from the ribosome, which is then followed by 
recycling of ribosomal subunits (Dever and Green, 2012). In eukaryotes, two termination 
(release) factors (eRF1 and eRF3) catalyse termination, with the help of ABCEI. 
 
 Class I release factor 
Class I release factor, eRF1 (or Sup45 in yeast), is a part of the ternary   complex which 
is required for translation termination, along with a class II factor eRF3 (Sup35) and GTP. 
Eukaryotic RF1 (eRF1) was first characterized in the 1990s, following studies on prokaryotic 
RFs. X-ray crystal analysis has revealed that eRF1 is composed of three domains, termed N, M 
and C, and has similar dimensions to a tRNA (Song et al., 2000). Domain N, in S. cerevisiae, 
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contains residues 1-138, while domain M comprises residues 139-271 and domain C residues 
272-431. Domain N is primarily responsible for recognition and binding of the three stop 
codons, mainly via the conserved TASNIKS motif (residues 55-61 yeast numbering), but with 
the help of the GTS (residues 28-30 yeast numbering) and YxCxxxF motifs (residues 125-131 
yeast numbering) (Ito et al., 2002; Kryuchkova et al., 2013; Preis et al., 2014). A further 
conserved surface residue on eRF1 is E55, which has also been suggested to interact with 
mRNA (Kolosov et al., 2005). Unlike prokayotic RFs, eRF1 is omnipotent, able to decipher all 
the three stop codons. Mutations in residues of the GTS and YxCxxxF motifs implied that these 
motifs are essential for stop codon recognition (Cheng et al., 2009). It has recently been shown 
that the GTS motif/loop performs a specific conformational perturbation during termination 
(Pillay et al., 2016).  
A universally conserved motif (GGQ) is contained in the M domain, and is positioned at the tip 
of the protein, in a position corresponding to the CCA-end of a tRNA (Mora et al., 2003). The 
GGQ motif is critical for nascent peptide release and it activates hydrolytic activity at the PTC. 
Mutating the central glycine in GGQ motif to alanine (G181A) results in a loss of the GGQ 
motif function, whereas mutations to Q182 have different effects rated from minor to complete 
loss of activity (Hauryliuk et al., 2006). The M domain carries out a specific interaction with 
the ribosomal 60S subunit whereas no interaction has been detected with the 40S subunit 
(Ivanova et al., 2008). The C domain of eRF1 provides an interface with eRF3. Residues Y410 
and T295 are located on the protein surface thus, it is supposed that they mediate the interaction 
with eRF3 (Merkulova et al., 1999a; Akhmaloka et al., 2008).  
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Figure 1.6: The structure of eRF1. Protein Data Bank Code 1EVV Kisselev (2002). 
 
 The structure of eukaryotic RF1 (Sup45 in yeast) shows the functional regions in each domain. The NIKS motif 
is shown on the epitope of the N domain, the function of this motif is decoding the stop codon in the ribosomal A 
site. The GGQ motif is highlighted in the M domain, this motif functions to catalyse the release of the nascent 
chain from the ribosome as the final action of termination.  
 
The fidelity of translation termination is affected by point mutations in yeast eRF1 (Sup45). 
The effect on termination displays some pleiotropic phenotypes, including osmotic stress 
sensitivity (Singh, 1977), chromosome instability (Borchsenius et al., 2000), respiratory 
deficiency (Ter-Avanesyan et al., 1982) and cytoskeletal and cell cycle defects (Valouev et al., 
2002). Furthermore, the defects in termination, induced by sup45 alleles, are likely to be strain 
specific (Merritt et al., 2010), which means some alleles show significant effects on termination 
in particular strains backgrounds rather than others. Moreover, the effect of some sup45 alleles 
on termination fidelity varies between in vitro and in vivo investigations. Some alleles produce 
effects in an in vitro analysis that mirror the relevant outcomes observed from in vivo analysis. 
These alleles include, N58A and S61A (Merritt et al., 2010). Wheras others such as E52A and 
R62A significantly influence termination in an in vitro analysis but no in vivo effect was 
observed (Merritt et al., 2010).  
The efficiency of termination is usually assessed by the read-through assay, using a dual- 
luciferase reporter. This provides an idea about the ratio of ribosomes reading-through a 
particular stop codon, inserting a cognate aminoacyl-tRNA to decode the stop codon. It was 
reported that one of the most conserved peptides among a variety of organisms in the sequence 
of eRF1 is 54-GTASNIKSR-62 (S. cerevisiae numbering) (Inagaki et al., 2002). However, 
yeast can tolerate amino acid substitution more than other organisms in this particular region. 
Mutations to G54 or K60 yield inviable strains whereas N58A mutant is viable, although it 
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causes severe defects in terms of termination efficiency. In contrast, T55A, S61A and R62A 
mutants cause mild or undetectable termination defects (Merritt et al., 2010). It has been found 
that S30P, I32F and P38L mutations cause suppression of the three stop codons, increasing the 
read-through, whereas mutations to residues in/close to the GGQ motif may result in a minority 
of ribosomes stalling at the stop codon (Bertram et al., 2000). 
 
 Class II release factor 
Class II release factor, eRF3 (Sup35 in yeast) is the second component of the ternary 
complex which stimulates the translational termination. The N terminal region (residues 1-253) 
of eRF3 is non-conserved and not essential for the activity of the protein (Kononenko et al., 
2008). The remainder of the protein is composed of 3 domains: domain 1 (residues 254-488), 
domain 2 (residues 489-576) and domain 3 (residues 577-685). eRF3 is a GTPase and domain 
1 corresponds to the G domain. Domains 2 and 3 of eRF3 are β-barrels, providing an overall 
structure similar to elongation factors, eEF2 and eEF1A (Kononenko et al., 2010).  eRF3 
interacts with eRF1 via domains M and C. The functional role of eRF3 is not conserved between 
eukaryotes and prokaryotes. Prokaryotic RF3 is essential for recycling of class I factors (RF1 
and RF2) after termination, whereas no role in this context has been found in eukaryotic RF3 
(eRF3). eRF3 enters the ribosome in complex with eRF1, and hydrolysis of GTP on eRF3 is 
linked to a necessary conformational change within the pre-termination complex (Alkalaeva et 
al., 2006; Wada and Ito, 2014). Each of eRF1 and eRF3 possess two regions critical for mutual 
binding to each other. In eRF1, residues 281-305 and 411-415, whereas in eRF3, residues 478-
530 and 628-637 are supposed to be the key regions for eRF1-eRF3 binding (Merkulova et al., 
1999a). The availability of eRF1 affects the function of eRF3; there is ~5 times increase in the 
eRF3 capability to stimulate the peptide release, at saturated pool of eRF1 (Salas-Marco and 
Bedwell, 2004; Wada and Ito, 2014). 
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Figure 1.7: Structure of eRF3. Adapted from: Kozlov and Gehring (2010). 
 
During the course of this study, we analysed several mutations in eRF3 (sup35) for their effects 
on the 2A reaction. In addition, we used a strain, limited in eRF3 activity, termed [PSI+], along 
with the relevent wild type, [psi-], for the same purpose. Translation termination is 
epigenetically modified by [PSI+] in S. cerevisiae (Tuite and Cox, 2006). An intrinsic 
disordered prion-determining region is carried on Sup35 at the N terminus, when this region 
turns to the aggregating conformation, also termed prion conformation. There is a limited 
availability of Sup35 for termination, which increases the read-through across stop codons 
(Bidou et al., 2000). It was reported that different phenotypes can result from [PSI+] in different 
genetic backgrounds, the majority of the effects induced by these phenotypes are recapitulated 
by different degrees of loss of Sup35 function (True et al., 2004). It has been suggested that 
some phenotypic effects shown by [PSI+] is a result of ribosomal frame-shifting (Namy et al., 
2008). In addition, it has also been shown that the variation in read-through among different 
yeast strains might be a result of ribosomal bypass and reading into the 3’ UTR (Shorter and 
Lindquist, 2005).   
 
  ATP-Binding Cassette E1 (ABCEI) 
The third key factor for termination is ABCEI (also known as RNAase L inhibitor/Rli1 
in yeast). This protein is found in all eukaryotes and archaea. It belongs to the ATP-binding 
cassette transporter protein family, which carries out a variety of functions such as translocating 
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substrates across membranes, DNA repair, DNA replication, histone biosynthesis, chromosome 
maintenance as well as translation (Toompuu et al., 2016). Typically, ABC proteins possess 
double nucleotide-binding domains (NBDs), and these couple ATP hydrolysis to 
conformational changes in their substrate-binding sites. ABCEI is a 68 kDa protein which 
contains the typical two NBDs, arranged in a head-to-tail direction (Karcher et al., 2008). 
Among the members of the ABC protein family, ABCE1 contains an N-terminal domain 
comprising two iron-sulphur (FeS) clusters (Barthelme et al., 2007). Each NBD contains a bi-
lobed fold of ATPase domains, as well as ATP-binding sites. The specific arrangement of the 
two NBDs forms two binding sites. Among ABC proteins family, the cysteine-rich N-terminus 
is conserved among species and unique among ABC proteins. The FeS cluster is composed of 
non-heme iron molecule with organic sulphide; the function of this kind of cluster is mostly the 
mediation of electron transport in redox reactions, however, they can stabilize protein folding, 
substrate binding and activation (Lill et al., 2006). The FeS clusters of the S. cerevisiae ABCE1 
homologue Rli1 are essential, mutation of most of the conserved Cys that co-ordinates iron in 
the FeS cluster lead to a loss of activity (Barthelme et al., 2007). Thus the framework for this 
domain, in addition to its functional interactions with the NBD domains, are the keys for ABCEI 
function. 
Loss or reduced activity of ABCEI is lethal, or causes severe defects (Winzeler et al., 1999). In 
addition to its function in translational termination and recycling, ABCEI is involved in 
ribosomal biogenesis via the FeS clusters on its N domain (Kispal et al., 2005). The 
involvement of ABCEI in several steps of translation has recently been established. It associates 
with the 40S subunit as well as initiation factors eIF2, eIF3 and eIF5 suggesting a distinct role 
in the formation of pre-initiation complex (Andersen and Leevers, 2007). ABCE1 has also been 
identified as a quality control factor to dissociate stalled ribosomes (Stec et al., 2015). ABCEI 
directly associates with Hcr1 (eIF3j), which is a subunit of eIF3 involved in several steps of 
translation and in rRNA processing (Beznoskova et al., 2013). Beyond translation, ABCE1 has 
roles in other processes including HIV capsid assembly (Karblane et al., 2015). 
 
 Mechanism of translational termination 
When the elongating ribosome encounters one of the three stop codons in the A site, the 
termination ternary complex (TTC) which consists of eRF1:eRF3-GTP recognizes the stop 
codon. Motifs of eRF1 which function in stop codon recognition are TASNIKS, GTS and 
YxCxxxF. Then, eRF3 triggers GTP hydrolysis, which allows the eRF1 to fully accommodate 
in the A site, positioning the M domain in the PTC, and orienting the GGQ motif at the ester 
bond between the tRNA and the nascent peptide chain. The GTS motif is located close to the 
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pentose of the +3 base of the stop codon  (Wong et al., 2012) therefore, when UAG stop codon 
is contained in the ribosomal A site, the threonine (T29 of S. cerevisiae numbering) in the GTS 
motif faces the +3 base of the stop codon sequence, forming a hydrogen bond with the nitrogen 
atom of the guanosine of the stop codon (Cheng et al., 2009). This mechanism of stop codon 
recognition is structurally and functionally different from that in bacteria.  eRF1 N and M 
domains contact the tRNA in the P site and a structural helix (α2 helix), located in the N domain, 
interacts with the anticodon loop of the tRNA in the P site (Brown et al., 2015). The TASNIKS 
motif, located at the end of α2 helix, interacts directly with the uridine in the first position of 
the stop codon with hydrogen bonds between side chains of both asparagine and lysine in the 
TASNIKS motif and the uracil carbonyl groups. This lysine is hydroxylated, and in the absence 
of this modification termination efficiency is reduced (Feng et al., 2014). Therefore, uridine is 
universal as the first nucleotide in stop codons, due to its ability to form hydrogen bonds with 
eRF1, and other nucleotides are not able to make productive interactions with the TASNIKS 
motif, explaining the universality of uridine in the first position of the stop codon.  
The discrimination of stop codons from sense codons is carried out via interaction of the 
YxCxxxF motif with the +2 and +3 purines, through forming hydrogen bonding between 
purines in the stop codon and residues in the YxCxxxF motif (Brown et al., 2015).  
The pre-termination complex binds the ribosome, via the eRF1 N domain, which binds the 40S 
subunit. The recognition of the first two nucleotides in the stop codon is followed by a 
conformation of the N domain of eRF1, allowing decoding of the stop codon (Kryuchkova et 
al., 2013). Helices α8 and α11 of eRF1 contact the C domain of eRF3 whereas the M domain 
of eRF1 anchors it to the 40S subunit. The C domain of eRF1 is then packed against the three 
domains of eRF3, forming a large interface which extends to the switch regions of the G domain 
of eRF3 (Preis et al., 2014). In this stage, GTP hydrolysis is triggered, which acts as a key point 
to induce an appropriate conformation of eRF1. It has been found that eRF1 enhances the 
GTPase activity of eRF3, via acting as a guanine nucleotide exchange factor (Frolova et al., 
1996). It has been proposed that eRF3 may have a role here, by simulating the eRF1, through 
maintaining recycling of eRF1 (Zavialov et al., 2001). However, others suggested that the 
eRF3’s GTPase activity might be a result of stop codon recognition, maintained by eRF1 (Salas-
Marco and Bedwell, 2004). 
 As a result of these events, a locked conformation sandwiches the GGQ motif between both 
40S subunit and the G domain of eRF3, but with an incompatible position to trigger the peptide 
release in this stage, a dramatic conformation is then undergone for proper positioning of the 
GGQ loop in the PTC (Preis et al., 2014). 
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Figure 1.8: Structure of eukaryotic translation termination complex. Adapted from: Brown et 
al (2015). 
 
(a) Structure of an eRF1-eukaryotic ribosome-nascent chain complex with UAG, E-(yellow) and P-site (green) 
tRNAs, eRF1 (purple) in the A site, and ABCE1 (blue) in the GTPase centre. (b) Zoom of eRF1 coloured by 
domain (N, M, C) with the GGQ, NIKS and YxCxxxF motifs highlighted (pink). The P-site tRNA (green), nascent 
polypeptide (teal), the mRNA containing the UAG stop codon (slate), and ABCE1 (blue) with its FeS 
(orange/yellow) and nucleotide binding sites (grey). 
 
eRF3 with GDP are then released from the ribosome, to allow recruitment of the ABCEI which 
has an overlapping binding site on the ribosome to eRF3. ABCEI stimulates an additional 
conformational change of eRF1 to trigger the release of the nascent peptide chain from the 
ribosome (Dever and Green, 2012). Indeed, peptide release is accelerated in a GTP-hydrolysis- 
dependant manner (Eyler et al., 2013). The FeS domain of ABCE1 contacts the C domain of 
eRF1, and causes a drastic conformation in the M domain of eRF1 resulting  rearrangements in 
helix 95 (H95) of the 60S subunit, these events lead to multiple contacts of ABCE1 to rRNA, 
which results in an extension of the eRF1 M domain toward the P site-tRNA. All together, these 
events locate the GGQ motif at the PTC in close vicinity to the CCA of the peptidyl-tRNA, in 
this active conformation; ABCE1 exerts stabilization of eRF1 via the active contact of eRF1. 
This confirms the role of ATPase in eRF1-dependent peptide release (Shoemaker and Green, 
2011). 
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1.4.4 Ribosome recycling 
Once the nascent peptide chain is released from the ribosome, recycling of the ribosomal 
subunits takes place so that they are available for subsequent cycles of translation. In some 
cases, only partial dissociation of the complex takes place to allow re-initiation, when the 
ribosome translates more than one ORF however, most ribosomes undergo full dissociation 
after releasing the nascent peptide. In bacteria, a specific ribosome recycling factor (RRF) 
dissociates ribosomal subunits from mRNA, this factor interacts with the post-termination 
complex following the dissociation of the RF1/RF2. Eukaryotes have no homologues of RRF, 
and current evidence indicates that eRF1 remains associated with the ribosome following 
termination (Pisarev et al., 2007). Thus, eRF1-bound post-termination complex, in addition to 
the deacylated tRNA, must be targeted by the recycling process in eukaryotes. Initially, it was 
considered that eIF3 plays a role in recycling of eukaryotic ribosomes (Pisarev et al., 2007), 
stabilizing separated subunits through its capacity to bind 40S in a region overlapping with the 
subunit interface. However, the current model is that the multifunctional ABCE1 is a key factor 
for eukaryotic ribosomal recycling factor (Pisarev et al., 2010; Barthelme et al., 2011; 
Shoemaker and Green, 2011).  Since eRF1 remains associated with the ribosome after 
termination (Pisareva et al., 2011), eRFs may slowly trigger subunit dissociation (Pisarev et al., 
2007). However, ABCE1 stimulates subunit dissociation in an ATP-dependent manner (Pisarev 
2011; Shoemaker and Green 2011). In this context, energy from ATP hydrolysis is proposed to 
be converted to a mechanical motion, used to separate ribosomal subunits: ATP hydrolysis is 
essential to promote fully closed ABCE1 conformational state which is required for efficient 
dissociation of the ribosomal subunits (Becker et al., 2012). 
Two further factors are involved in ribosomal recycling in eukaryotes. These include Dom34 
and Hbs1 which function in cases of stalled ribosomes on aberrant mRNAs. Dom34 and Hbs1  
are related to eRF1 and eRF3 respectively, they bind to the ribosomal A site and promote 
subunit dissociation in codon-independent manner (Pisareva et al., 2011). 
 
1.5 Translational Recoding 
While translation mostly follows the standard rules of decoding, ribosomes, in particular 
cases do not follow the mRNA-protein co-linearity and participate in alternative decoding of 
the codons (Baranov et al., 2006). This is termed recoding, a translational event when the 
outcome of translation is not what would be expected by standard reading of the mRNA, and is 
driven by signals in the mRNA sequence or occasionally the nascent peptide chain. 
Furthermore, in some mRNAs in competition with standard decoding, stop codons are 
occasionally redefined to amino acids such as glutamine, tryptophan or the 21st amino acid 
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selenocysteine (Gesteland and Atkins, 1996). Recoding is particularly prevalent in RNA 
viruses, providing them with control over gene expression that might be governed by 
transcription in DNA viruses/cellular genes. Examples of translational recoding are outlined 
below. 
 
1.5.1 mRNA-mediated recoding 
  Frameshifting 
Frameshifting is a common recoding event which occurs in either + or – direction on 
the mRNA. The ribosome shifts by one or two nucleotides, thereby changing the reading frame 
(Caliskan et al., 2015; Dunkle and Dunham, 2015). Typically, only a small percentage of 
ribosomes undergo frame-shifting, and this is therefore a means by which a protein needed in 
relatively small amounts can be generated at an appropriate level. The vast majority of 
frameshifting sequences have been identified in viruses, and it is typically used for expression 
of replicase proteins (Liao et al., 2011). For example, in HIV, frameshifting is essential to 
produce the DNA polymerase, in addition, it defines the ratio of Gag to Pol proteins, as it should 
not exceed a certain limit in order to maintain assembly of this virus, as well as genome 
maturation (Brakier-Gingras et al., 2012). It has been recently suggested that frameshifting 
regulates mRNA and DNA stability in addition to its established role in controlling protein 
production. Thus frameshifting signals in four mRNAs encoding proteins essential for yeast 
telomerase maintenance limit the amount of protein made from these mRNAs and contribute 
towards the proteins being made in the correct stoichiometry  (Advani et al., 2013).   
Several elements, embedded in the mRNA, promote -1 frame shifting. An essential element is 
the so-called slippery sequence. This is a heptametrical sequence with a X XXYYYZ or 
ZYYYXX X pattern which ensures proper base pairing between codons in the mRNA and the 
tRNA anticodons during the slippage. 0 frame and +/-1 can be decoded by the same tRNA 
according to the wobble interaction at the third position (Caliskan et al., 2015). In addition to 
the slippery sequence, many frame-shift signals contain secondary structures such as 
pseudoknots and stem-loops downstream to the slippery sequence in the mRNA, which 
stimulate frame-shifting (Howard et al., 2004). 
Mechanistically, the structures in the mRNA are considered to pause the ribosome with tRNAs 
at the slippery site. This sequence aids to re-pair the non-wobble bases of the amino acid-tRNA 
and the peptidyl-tRNA, together with the -1 frame codons (Jacks and Varmus, 1985). Other 
mRNA structures are also capable of filling the role of the pseudoknots, by providing an 
energetic barrier to elongating ribosomes, as well as positioning them right over the slippery 
sequence (Yu et al., 2011).  
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In contrast to the -1 frameshifting, in +1 frameshifting, the elongating ribosome bypasses a 
nucleotide while moving in the 3’ direction. The signals for +1 frameshifting seem to be more 
specific with different mechanisms. In eukaryotes, a strong secondary mRNA structure located 
3’ of the slippery site is implicated in this context (Ivanov et al., 2004). Many +1 frame-shift 
sites contain the stop codon UGA in the A site (in the 0 frame), which stimulates the frame-
shift, they also depend on the tRNA:mRNA interaction in the P site. The yeast Ty 
retrotransposable elements are good examples of +1 frameshifting, which controls the synthesis 
of gag-pol protein (Farabaugh, 1995). Here, the ribosome slips on the sequence CUU AGG C. 
Frameshifting is primarily driven when the P site tRNA slips from CUU to UUA. The Ty frame-
shift site does not contain the UGA stop codon, rather, AGG in the A site. This is decoded by 
a low abundance tRNA (Arg-tRNACCU). Overexpression of this tRNA results in a 50-fold 
decrease in frameshifting, whereas deletion of the gene encoding it increases the efficiency 
(Kawakami et al., 1993). 
 
 Ribosome shunting 
Ribosome shunting occurs when the 40S subunit bypasses an RNA structure, after 
translating a short ORF, to reinitiate translation of the downstream main ORF (Ogawa, 2013). 
Ribosomal shunting is well-studied in Caulimoviridae. Some members of this family have 3’ 
ORFs on their mRNAs. A long 5’ UTR has been identified in these mRNAs, comprising a short 
ORF downstream of the cap structure, which is then followed by a long stem loop of ~480 
nucleotides (Pooggin et al., 2012). The ability of the ribosome to carry out the shunt depends 
on retaining initiation factors, particularly eIF2, while translating the short ORF. The position 
and probably the length of the short ORF are essential for shunting, but not the sequence, ie. 
more efficient shunting is expected with shorter ORFs (Pooggin et al., 2012).  
      
 Stop codon read-through 
Although translational termination is an efficient process, the nature of the stop codon 
and/or the sequence context may significantly influence termination. Noticeably, some stop 
codons contexts are leaky, allowing the ribosome to read-through the stop codon at a frequency 
of 0.3-5% (Bertram et al., 2001). In this case, a near-cognate tRNA decodes the stop codon to 
carry on translation toward the next stop codon, extending the protein. In the case of viruses, as 
with frame-shifting, this frequently allows expression of specific functions such as polymerases 
(Nam and Rousset, 2010). In Luteovirus, while the mRNA is translated, the ribosome reads-
through at the end of the coat protein gene, generating a protein necessary for aphid 
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transmission (Brault et al., 1995). Elements located either on the 5’ or 3’ of the suppressed stop 
codon can affect the efficiency of read-through. The presence of A in the two positions 
preceding the stop codon can increase the read-through efficiency in yeast, and this feature is 
also commonly seen in viruses such as tobamoviruses, poleroviruses and luteoviruses (Tork et 
al., 2004). Two kinds of downstream stimuli have been recognized: the nucleotides directly 
adjacent to the suppressed stop codon and more distal elements which form secondary 
structures. The 3’ sequences are thought to involve the identification of the stop codon (Bonetti 
et al., 1995) thereby a competition between eRFs and potential near cognate tRNA to bind to 
the stop codon is expected. A mechanism has suggested that stop codon read-through might be 
a result of either mRNA-protein or mRNA-rRNA interactions. This interaction may modulate 
ribosome activity, and also alter eRFs function, although some stimulatory structures on mRNA 
do not significantly pause the ribosome (Napthine et al., 2012).  
 
  Translational coupling 
Many mRNAs contain short, cap-proximal ORFs (<~30 amino acids). Following 
translation and termination on these ORFs, the 40S ribosomal subunit is frequently able to 
resume scanning and re-initiate at a downstream AUG (Jackson et al., 2012). For this to occur, 
certain eIFs must remain associated with the 40S subunit, and during scanning towards the 
downstream AUG, the complex must also reacquire ternary complex (eIF2-Met-tRNA-GTP). 
In a number of cases, cap-proximal ORFs have been shown to play key roles in regulating 
expression of the main ORF (Kojima et al., 2005). In contrast to re-initiation following a short 
upstream ORF, re-initiation is extremely rare after translation of a long coding ORF. However, 
this has been shown to occur in a few cases, termed translational coupling, and produces key 
proteins in a number of viruses (Jackson et al., 2012). An example of translational coupling is 
seen in Calicivirus. Caliciviral RNA contains three protein-coding ORFs: ORF1 encodes the 
non-structural proteins, whereas ORF2 and ORF3 encode the major capsid protein and a protein 
which is a component of the virion respectively (Herbert et al., 1996). In some genera, ORF2 
is continuous with ORF1 thus, some capsid proteins are generated as fusion proteins with the 
non-structural counterparts. The initiation codon of ORF3 is located close to the termination 
codon of ORF2 (either AUGnnUGA or overlapping as UAAUG or AUGA), and ORF3 is 
usually translated via translational coupling (Napthine et al., 2009). Re-initiation of translation 
in this case, depends on RNA motifs, ranging from 40 to 90 nt, located upstream to the ORF2 
stop codon. Using yeast cells as an experimental system in which to examine the coupling 
mechanism. An interaction between this motif and the 18S rRNA was determined to be required 
to increase the efficiency of re-initiation (Luttermann and Meyers, 2009). It has also been 
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suggested that eIF3 binds to a proportion of 40S subunits of ribosomes terminating the 
translation of the ORF2, this seems to be followed by recruitment of the ternary complex to the 
ribosome. eIF3-bound subunits then undergo subsequent initiation at ORF3 start codon (Poyry 
et al., 2007). When mutations are induced at the normal ORF3 start site, initiation codons 
downstream to it can be utilised, but less efficiently and, in addition, initiation may occur on 
non-AUG initiation, though it is less preferred (Poyry et al., 2007; Luttermann and Meyers, 
2009; Powell et al., 2011). A second example of translational coupling is seen in Caulimovirus 
and Soymovirus. In contrast to coupling in calicivirus, where only a fraction of ribosomes 
undergo re-initiation, these events are highly efficient and are driven by a specific viral protein 
termed transactivator viroplasmin (Schepetilnikov et al., 2011). 
 
1.5.2 Nascent peptide-mediated recoding  
 Stop-carry on/Stop Go 
           This recoding event is mediated by amino acid motifs rather than mRNA sequence. This 
is driven by the 2A peptide, the focus of this thesis, and will be described in more detail in 
section 1.7. Briefly, 2A peptides, encoded within the body of an ORF, interact with the 
ribosomal PTC and exit tunnel to prevent the formation of a peptide bond at the end of the 2A 
sequence, specifically to a proline. This results in release of the nascent chain in a stop-codon 
independent manner. Translation is then resumed with proline as the first amino acid of a 
separate downstream product. The 2A reaction is a primary processing step in the resolution of 
polyproteins encoded by a number of viruses, and 2A peptides are found in a number of RNA 
viruses including aphthoviruses, cardiviruses, boviruses and teschoviruses (Luke et al., 2008).  
 
  Secretion monitor (SecM) 
In particular cases, ribosomes are affected by some peptides, while being translated, 
but with no recoding observed. A few examples of this are mentioned below. 
SecM is a regulatory sequence located upstream to SecA, which encodes an ATPase required 
for protein secretion in bacteria. After translation, the SecM peptide chain pauses the ribosome. 
This pause is released if the signal sequence of SecM is engaged in the protein conducting 
channel. However, if translocation is inefficient the pause is prolonged. Stalled ribosomes on 
SecM disrupt secondary structures in mRNA which otherwise impair recognition of the Shine-
Dalgarno sequence of SecA. Prolonged ribosomal pausing on SecM thus increases the synthesis 
of SecA. SecM carries out the stalling effect on the ribosome via a conserved motif (amino 
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acids 150-166) (Nakatogawa and Ito, 2001). Although prolyl-tRNA binds to the ribosomal A 
site, proline is not included in the nascent chain (Garza-Sanchez et al., 2006). 
 
  CrbcmIA peptide 
The N-terminus of CrbcmIA nascent chain starts with eight amino acids (MSTSKNAD), 
encoded by an uORF to the gene Tn1696 which is responsible for the development of 
chloramphenicol resistance, thereby, inhibiting the peptidyl transferase activity. Tn1696 was 
initially isolated with a plasmid from Pseudomonas aeruginosa  (Partridge et al., 2001). The 
regulatory mechanism is pausing the ribosome via CrbcmIA in response to chloramphenicol, the 
inhibitory upstream nascent chain regulates the activity of the PTC through altering the 
conformation of certain domains of 23S rRNA. Therefore, the paused ribosome modulates the 
translation of the downstream gene (Harrod and Lovett, 1995).  
 
  TnaC 
TnaC is a peptide composed of 24 residues, encoded by a short ORF upstream to the E. 
coli tryptophanase (tnaA) gene. Similar to the mechanisms described above, the interaction of 
nascent chain with the ribosome structure regulates the expression of the tryptophanase operon 
in E. coli. At high concentration of tryptophan ribosomes pause at the end of TnaC, and 
termination is impeded. The particular conformation of the stalled ribosome occludes binding 
sites for the rho terminator, allowing transcription of the downstream tnaA and tnaB within the 
operon. The peptide chain of TnaC interacts with the exit tunnel, resulting in stalling of the 
ribosome at the Pro24 of TnaC thus termination is impaired. It has been found that both Pro24 
and Trp12 in addition to rRNA nucleotides U2609, A749-753 and L22 protein are the key 
elements for ribosomal pausing on TnaC (Konan and Yanofsky, 2000). 
 
  Arginine attenuator peptide 
           The yeast carbamoylphosphate synthase (Cpa1) is encoded by the CPA1 gene. Cpa1 is 
a key enzyme in the pathway of arginine biosynthesis. The concentration of arginine in the cell 
modulates translation of CPA1 mRNA. CPA1 mRNA contains a leader sequence composed of 
250 nucleotides which contains a 25 codon uORF. The sequence of amino acids in this uORF, 
but not the mRNA sequence, is the essential feature for the repression of the CPA1 by arginine 
level (Hood et al., 2007). 
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1.6 Translational quality control 
Translation is a highly accurate process which ensures that the codons in mRNA are 
faithfully interpreted. Despite the high accuracy level, up to one in ten of synthetized proteins 
have been found to contain at least one miscoded amino acid (Wolff et al., 2014). Moreover, 
failure to maintain proteostasis are potential consequences of mRNA processing and 
modification (Simms et al., 2014; Simms et al., 2017). A number of quality control mechanisms 
have evolved to detect errors and subject mRNA/protein to degradation (van Hoof and Wagner, 
2011).  
 
1.6.1 Non-stop decay (NSD) 
The lack of a stop codon (non-stop mRNA) leads the ribosome to stall at the 3’ end of 
the RNA due to the inability of the subunits to dissemble through recycling. Non-stop mRNA 
is rapidly degraded by actions of both cytoplasmic endonucleases and exonucleases (Barthelme 
et al., 2011). NSD was first discovered in yeast, in which constructs lacking stop codons turn 
over rapidly. The GTPase Ski7 is essential for initial recognition of the defective mRNA (van 
Hoof et al., 2002). Ski7 is an eRF3-related protein, and a component of the yeast exosome. 
Also, Ski7 is the paralog of NGD protein, Hbs1, they both arise from the same origin (van Hoof, 
2005). In other organisms, Hbs1 tends to simulate the function of Ski7, interestingly, deletion 
of Ski7 is complemented by overexpression of Hbs1 however, the molecular mechanism of 
Ski7/Hbs1 role in the recognition of defective mRNA is not fully understood. Most non-stop 
cellular mRNAs originate from premature polyadenylation, in contrast to truncated mRNA, and 
the ribosome stalls while decoding the polyA tail into Lys (Kervestin and Jacobson, 2012). 
Here, the endonucleolytic cleavage of mRNA is driven by Dom34:Hbs1 complex (homologs 
of eRF1 and eRF3 respectively). This process is performed through the Dom34:Hbs1 activity 
to dissociate stalled ribosomes at the 3’ end of non-stop mRNA, and then stimulates the 
degradation by exosomes (Kobayashi et al., 2010). However, an endonucleolytic cleavage of 
mRNA can be observed in the absence of Dom34:Hbs1 complex (Kuroha et al., 2010). It has 
recently been revealed that the Dom34:Hbs1 complex also promotes peptidyl-tRNA drop-off 
in addition to direct the elongation complex into the subunits dissociation and release the 
mRNA with the help of ABCE1/Rli1 (Pisareva et al., 2011). During elongation, the 
Dom34:Hbs1 is supposed to compete with the eEF1α for binding the ribosomal A site, and 
therefore the number of nucleotides downstream of the P site should be critical for the 
Dom34:Hbs1 to recognise the ribosome (Pisareva et al., 2011). The binding of Dom34 to the 
ribosomal A site destabilizes the mRNA, and probably disrupts codon-anticodon binding in the 
P site (Shoemaker and Green, 2011). The degradation of non-stop mRNA is carried out by the 
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exosome, along with the Ski2-Ski3-Ski8 helicase complex (van Hoof et al., 2000; Araki et al., 
2001). Ski7 interacts with Ski2-Ski3-Ski8 complex via its N terminus, this kind of interaction 
is essential for the 3’ to 5’ direction decay pathway of normal mRNAs. Whereas the C-terminus 
of the Ski7 simulates the GTP-binding domain of eEF1α, the C-terminus has a role in the non-
stop mRNA decay in a poly A-dependent manner (Tsuboi et al., 2012). The N domain of 
Dom34 contains loops which are essential for the recognition of the stalled ribosome in the A 
site (Kobayashi et al., 2010). Although Ski7 might not be required for the dissociation of stalled 
ribosomes at the 3’ end of non-stop mRNA, the C terminus of Ski7 may play a role in 
recognizing stalled ribosomes at the 3’ end of a polyA tail, independently of Dom34:Hbs1   
(Tsuboi et al., 2012).  
 
1.6.2 No-Go-Decay (NGD) 
NGD is triggered by structures that block ribosome progress on the mRNA template. 
Dom34:Hbs1 is involved in this pathway (Doma and Parker, 2006). The Dom34:Hbs1-GTP 
ternary complex splits the 80S ribosome into 40S and 60S subunits, a process which is carried 
out with an independency of the codon in the A site (Shoemaker et al., 2010). Rli1 has a 
significant role in this process by increasing the Dom34-mediated ribosome dissociation, 
presumably functioning analogously to how it functions in recycling of ribosomal subunits 
post-termination (Shoemaker and Green, 2011). The recognition of the defective ribosome is-
in part-driven by the interaction between Hbs1 and the 40S subunit (Becker et al., 2011). The 
N domain of Hbs1 binds the mRNA entry tunnel, while ribosomes are in elongation and the 
entry tunnel is dwelt by the mRNA, thus, Hbs1 is not effective (Shoemaker and Green, 2011). 
The defective mRNA is then cleaved by the endonucleolytic activity in the vicinity of the stall 
site (Tsuboi et al., 2012). The cleavage yields an uncapped mRNA, which is degraded by the 
5-3’ exonuclease termed, Xrn1.  
 
1.6.3 Nonsense-Mediated Decay (NMD)  
NMD is the mechanism through which cells degrade mRNAs that contain a premature 
stop codon. Premature stop codons may arise from several causes such as mutations and 
inaccurate transcription. NMD was first discovered in yeast, in which some mutations in ura3 
were noted to reduce the transcript level with no effect on the rate of synthesis (Losson and 
Lacroute, 1979). However, after about four decades of studying the mechanism of NMD, it is 
still not fully understood. Genetic studies in yeast and nematodes identified a group of 
conserved factors to be involved in the NMD, acting as bridges to connect the mRNA sequence 
with eRFs (Chakrabarti et al., 2011). The binding between mRNA and eRFs induces post-
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translational modification to Upf1 which results in a stimulatory signal for NMD via the 
recruitment of mRNA-degrading factors (Okada-Katsuhata et al., 2012). Also, this connection 
seems to inhibit interactions between poly A-binding protein (PABP) and eRF3 which might 
be a key step for normal termination (Kashima et al., 2006). Two models have been put forward 
to uncover the mechanism of target recognition during NMD, the efficiency of both is related 
to the length of the UTR. The first model suggests that the proximity between both the 
premature stop codon and the poly A-tail is a proposed reason for the inhibition of interaction 
between PABP and eRF3 (Singh et al., 2008). The Upf proteins are then recruited to bind the 
mRNA, marking it as an NMD target. The second model has suggested that Upf1 binds and 
coats the 3’ UTR (Hogg and Goff, 2010). For this reason, longer UTRs recruit a higher 
concentration of Upf1.  
 
1.7 The 2A peptide  
It has been briefly described earlier that 2A peptides are short peptides that act to co-
translationally separate the nascent chain into two molecules, driving a skip in the formation of 
a specific peptide bond, between Gly18 and Pro19, the last two amino acids in the 2A sequence 
(Ryan et al., 1991; de Felipe et al., 1999; Donnelly et al., 2001b; Doronina et al., 2008).  2A is 
found in many RNA viruses and, in addition, it has been identified in non LTR- 
retrotransposons of Trypanosoma spp. as well as cellular genes in sea urchin and a number of 
other species. The first identified and most studied 2A peptide is encoded within the foot-and-
mouth disease Virus (FMDV) RNA (figure 1.9).  
      A key feature of 2A is that it can be transposed into other contexts (polyprotein systems/ 
reporters) and retains its activity (Ryan and Flint, 1997). Thus 2A is autonomous and there are 
no other requirements for other parts of the virus. This trait enabled the usage of 2A as a tool 
for co-translational processing of proteins (Ryan et al., 1991; Ryan and Drew, 1994; de Felipe 
et al., 2006). The activity of 2A is driven by the amino acid sequence rather than the mRNA 
sequence. Thus, synonymous substitution of codons in the sequence does not change activity, 
whereas changing the reading frame over the 2A sequence or introducing non-synonymous 
changes affects activity (Ryan and Flint, 1997; Donnelly et al., 2001a; Donnelly et al., 2001b; 
Sharma et al., 2012). 
A conserved motif has been identified in all 2A and 2A-like sequences, D(V/I)EXNPG-P, 
which lies at the C-terminus and this is preceded by a non-conserved N-terminus (Donnelly et 
al., 2001a). 2A peptides have been subjected to extensive mutational analysis. This has revealed 
that most of the C-terminal conserved amino acids, including G18-P19, are critical for activity of 
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the peptide. In addition, mutations to the non-conserved sequences at the N-terminus can also 
affect the 2A activity. Further, efficiency of the 2A reaction is enhanced by addition of residues 
(5-14) from the C-terminus of the upstream FMDV 1D protein. On the other hand, addition of 
viral (2B) sequences downstream of 2A has no effect on activity (Donnelly et al., 2001a; Odon 
et al., 2013). Table 1.1 shows 2A sequences from different viruses. 
 
Figure 1.9: Structure of FMDV ORF and 2A sequence. 
 
The ORF of FMDV is shown on the top with sites of primary and secondary cleavage for different segments to 
produce mature viral proteins. The amino acid sequence is shown with the conserved C-terminus motif highlighted. 
In the bottom, the outcomes of translation of 2A-containing ORF are shown, which separate the products into an 
upstream, containing 2A and a downstream, starting with P19.  
 
 
 
 
 
 
…2TTP
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Family Type Amino acid sequence 
Cypoviruses BmCPV 1  
LdCPV 1  
DoCPV 1  
OpbuCPV 18  
Totiviridae IMNV 2A1  
IMNV 2A2  
Rotaviruses PoRV C  
BoRV C  
HuRV C  
ADRV N  
Dicistroviridae CrPV  
DCV  
ABPV  
KPV  
IAPV  
Tetraviridae TaV  
EeV  
PrV 2A1  
PrV 2A2  
PrV 2A3  
Iflaviruses IFV  
EoPV 2A1  
PnPV 2A1  
EoPV 2A2  
PnPV 2A2  
Picornaviridae EMCV  
TMEV  
T-LV  
SAF-V  
FMDV  
ERAV  
ERBV1  
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PTV  
BRV2  
LV  
SVV  
DHV1  
 
Table 1.1: Sequence analysis of various 2A peptides (Luke et al., 2008). 
 
1.7.1 The 2A reaction 
The 2A reaction is not proteolytic, but is instead a co-translational event. The use of 
artificial polyprotein reporters such as CAT-2A-GUS, GUS-2A-GFP, GFP-2A-GUS revealed 
that the ratios resulting from the reaction are not consistent with the 1:1 ratio expected from a 
proteolytic event (Donnelly et al., 1997; Donnelly et al., 2001a; Donnelly et al., 2001b): three 
different translation products are observed from such reporters, the full length protein and 
separated upstream and downstream proteins, frequently with a molar excess of the upstream 
product over the downstream. Furthermore, prolonged incubation of the reaction does not alter 
the outcomes (Donnelly et al., 2001a; de Felipe et al., 2010).  
Mutational analysis targeting nucleophilic residues in the conserved motif did not affect the 2A 
activity, however, mutagenesis targeting several conserved positions abolished the reaction, 
confirming that they are essential for the normal activity of the 2A. These residues are P17, G18 
and P19. Proline and glycine have the least nucleophilic properties, thus, the 2A reaction is not 
expected to be a self-proteolytic reaction (Donnelly et al., 2001a) which suggests that 2A 
reaction is unique in terms of the mode of action (de Felipe et al., 2003). To further investigate, 
an inactive version of 2A (P17A), termed 2A*, was developed and constructed into a reporter 
consisting of α Factor-2A/2A*-GFP. Through testing the localization of the translation 
products, it was concluded that the 2A reaction occurs before the emergence of the nascent 
chain from the ribosome (de Felipe et al., 2003). The 2A reporter, CAT-2A-GUS was expressed 
in prokaryotic cell model, using E. coli. As a result of translation, only a full-length product 
was obtained, indicating that the 2A peptide is non-functional in prokaryotes (Donnelly et al., 
1997). 
 
1.7.2 Proposed 2A mechanism 
It has been demonstrated by ribosomal toe-printing that the ribosome at 2A peptide 
pauses with codons encoding Gly18 and Pro19 in P and A sites respectively (Doronina et al., 
2008). Given the dependence of the reaction on the peptide sequence, this suggests that the 
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nascent chain makes specific interactions with the ribosomal exit tunnel to facilitate ribosomal 
pausing and to drive the 2A reaction. It has been suggested that the majority of the 2A peptide 
may take alpha helical conformation in the exit tunnel, and the conserved C-terminus forms a 
tight loop (de Felipe et al., 1999; Ryan et al., 1999; Donnelly et al., 2001). The specific 
interaction between both conserved and non-conserved regions of 2A on one side and, the 
ribosome on the other side, prevents the formation of the peptide bond between glycine and 
proline in the PTC however, Doronina and her collaborators suggested a substitution in this 
context; they further investigated the C terminus of the upstream 2A product. Using N. crassa 
extracts, they confirmed that translating ribosomes pause at the 3’ end of the 2A-coding 
sequence. Furthermore, the upstream fragment from peptidyl 2A-tRNA is rapidly released from 
the ribosome. They also suggested that termination factors might be involved in the 2A reaction, 
through detecting reduction in the 2A reaction in S. cerevisiae strains with defective eRFs 
(Doronina et al., 2008). Further, high level expression of mRNA encoding 2A peptides in such 
strains led to growth inhibition and enhanced stop codon read-through, suggesting that the 
mRNA encoding 2A was able to exert a titration effect on the available eRFs (Doronina et al., 
2008). On the other hand, more recently, Machida et al (2014) aimed to define translation 
factors involved in the 2A reaction, and recruited to the ribosome. They reconstituted an HCV 
IRES-dependent translation system, with eEF1, eEF2, eRF1, eRF3, aminoacyl tRNA 
synthetases and tRNA, being added to a human-derived ribosome. Using this they found that 
while translating 2A with this system, 2A and subsequent 2B processing does not recruit eRFs, 
but instead, they suggested that the process is entirely an elongation event (Machida et al., 
2014). The current study provides further evidence that the process is a termination-elongation 
event. 
 
1.7.3 Biological activity of the 2A reaction 
As described above in section 1.7.2, 2A activity can be found in several organisms. As 
the main example of 2A peptide used in this study was derived from the FMDV, it would be 
logical to briefly discuss the previous knowledge and related work on this version of 2A peptide. 
FMDV is a member of Picornaviridae which also includes Cardiovirus, Enterovirus, 
Hepatovirus, Parechovirus and Rhinovirus. More than 200 serotypes of Picornaviridae have 
been isolated, with the most ancient type (1400 BC) from Egypt. A variety of organisms, 
including humans are potentially the hosts of Picorna viruses. For example in humans these 
viruses cause Polio, Hepatitis A and common colds. FMDV was first discovered in 1898 in 
cattle (Rott and Siddell, 1998). It causes Foot and Mouth Disease (FMD) which is infective 
among the species (Barrionuevo et al., 2018). Although FMD mainly infects animals, a few 
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cases of infection in human have been diagnosed world wide. Outbreaks in animals usually 
result in huge economical loss. Although FMD normally is not fatal, especially for adult 
animals, the economic loss comes from the acute reduction of animal production such as milk 
production and weight gain in livestock. Unfortunately no successful treatment has been 
introduced to control FMD. FMDV exists in seven serotypes but also with sub-serotypes thus 
vaccines have limited ability to control the disease due to their high specificity against a 
particular serotype (Lyons et al., 2016).  
The genetic information of all Picornaviridae is encoded on sense single stranded RNA, which 
includes a single ORF, translated by the host ribosome. Despite the presence of only one ORF, 
the translation end result is co-and post-translationally processed into polyprotein, carried out 
by viral proteases. The 5’ UTR of Picornaviridae varies in length (624-1199 bp), and contains 
an IRES structure, whereas the 3’ UTR is relatively short (47-125 bp) and it is followed by the 
poly A tail (Curry et al., 2007; King et al., 2016). 
During the translation of the FMDV ORF, it is not expected to obtain the full length protein. 
This is due to the 2A cleavage activity, which functions to separate the product into two parts. 
The first part consists of peptides, 1A, 1B, 1C and 1D, termed VPs which represents the capsid 
protein. The other counterpart of the translation (2B, 2C, 3A, 3B and 3D) is the viral replicative 
protein. Additional processing of the products results in up to 12 different products. The 2A, 
and similar activity shown by 3C, are for polyprotein processing (Donnelly et al., 1997).  
 
1.7.4 Employment of 2A peptides in biotechnology 
Classically, selection of traits in different microorganisms was achieved by selection 
of parents carrying the desired trait to be then identified in offspring however, the generation 
time in some cases places major obstacles on the process. Many studies have made a significant 
progress in terms of gene therapy although limits in technologies still exist, one of the major 
limits is the non-sufficient coding capacity of viral vectors (Tahara and Lotze, 1995; Walther 
and Stein, 2000). Only small inserts can be accommodated in commonly used delivery systems, 
which limits the size of the target protein to be expressed, in addition to difficulties 
accompanying the co-expression of two or more proteins. A revolution in protein co-expression 
was made after introducing 2A to biotechnology (Qian et al., 2001). The small size of 2A and 
2A-like sequences, in addition to their ability for efficient co-expression, when placed between 
genes, made 2A as the best tool to be utilised in this field, which overcomes disadvantages 
observed when IRES were used for the same purpose (Donnelly et al., 2001a; Donnelly et al., 
2001b). 2A peptide was first reported to be used in biotechnology by Percy and colleagues who 
generated a neuraminidase and chloramphenicol acetyl transferase genes linked together by 2A 
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sequence (Furler et al., 2001). This success led to a revolution in terms of genes co-expression, 
such as the expression of IL-12 subunits (Kessels et al., 2001). Many examples have been 
published on how 2A and 2A-like sequences are successfully employed in different fields of 
biology including, genetic engineering, plant biotechnology, recombinant protein production, 
metabolism engineering, gene therapy and many other applications. Some of these utilisations 
are briefly discussed below:  
 
  Generation of transgenic organisms 
2A activity has been invested to generate a wide variety of transgenic mice (Szymczak 
et al., 2004; Alli et al., 2008; Chaparro et al., 2008; O'Connell-Rodwell et al., 2008; Trichas et 
al., 2008; Rothwell et al., 2010; Bettini et al., 2012; Rawlins and Perl, 2012; Tittel et al., 2012; 
van der Velden et al., 2016), fish (Provost et al., 2007; Dempsey et al., 2012), rats (Herold et 
al., 2008), pigs (Yang et al., 2010; Deng et al., 2011), birds (Bower et al., 2011), amphibians 
(Lin et al., 2012), insects (Diao and White, 2012) and sheep (Tian et al., 2013).  
 
  Co-expression of multiple genes  
Multiple gene co-expression at a desired amount is an attractive aspect in 
biomedicine. The expression includes cellular reprogramming (Takahashi and Yamanaka, 
2006; Vierbuchen et al., 2010). Reprogramming of multiple subunits of complex multimeric 
proteins is one application of gene therapy (Zitvogel et al., 1994; Szymczak et al., 2004). 
Tagging of a particular protein for isolation or estimation (Huh et al., 2003; Park et al., 2014). 
The strategy which was used for multiple gene co-expression includes utilisation of multiple 
vectors or multiple promoters within a single vector. However, introducing the self-cleaving 
2A peptides into these strategies represented a huge step to improve genes co-expression (Liu 
et al., 2017). 2A peptide was adopted to Trichoderma reesei fungus in order to obtain an easily 
screenable marker protein which can be co-translated with a target protein (Subramanian et al., 
2017). In plants, such as tobacco cells, 2A has been utilised for coordinated expression of 
multiple proteins. Experiments were undertaken  using an Ssp DnaE mini-intein variant, 
engineered for N-terminal auto-cleavage of intein. Ssp DnaE mini-intein is covalently linked to 
a 2A peptide, which yields an Int-2A self-cleaving fusion protein domain, that acts, in cis, to 
effectively release the flanking protein (POIs), which is the protein of interest. The efficiency 
of polyprotein processing, mediated by Int-2A domain, has also been employed in lettuce and 
Nicotina benthamina (Zhang et al., 2017). Another study described a novel strategy for co-
expression of adeno-viral vascular endothelial growth factor (VEGF) and fibroblast growth 
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factor 2 (FGF2), connected together through 2A peptide in umbilical cord monocytes. After 
injection into transgenic mice, co-expression of both factors was observed in spinal cord after 
1 month (Garanina et al., 2016). 2A cleavage properties have also been used to produce multi-
transgenic pigs. 2A sequence was constructed in a double promoter expression vector, by which 
the expression of four fluorescent proteins is mediated. This vector was transfected into porcine 
fetal fibroblasts, and the four fluorescent proteins were found to be evenly expressed in the 
reconstructured embryos (Deng et al., 2011). 2A has been used to co-express the a and b chains 
of T lymphocyte cell receptors, which can be successfully assembled into the active form. This 
made a substantial advance in the field of cancer therapy (Szymczak et al., 2004). This strategy 
has shown success in treatment of various types of cancers such as, metastatic melanoma, 
synovial cell sarcomas, renal cell carcinomas, colorectal cancer and renal cell carcinomas 
(Chhabra et al., 2008; Johnson et al., 2009; Parkhurst et al., 2009; Govers et al., 2010; Hudecek 
et al., 2010; Leisegang et al., 2010; Robbins et al., 2011; Wang et al., 2011).  
 
  Stable co-expression of transgenes 
The co-expression of multiple genes opens the door for therapeutic attempts to treat multi-
gene deficiency. However, problems, such as the inability to ensure efficient co-expression, 
halted these attempts. The usage of IRES to achieve this met success to some extent, thereby 
upto 4 genes were able to be co-expressed from a polycistronic vector (Fussenegger, 2001). 
However, two major problems were identified in this context, the imbalance and the large size 
of IRES which interferes with the accurate detection of the downstream products (Mizuguchi 
et al., 2000).    
Vectors containing 2A sequences have been used to drive equimolar expression of multiple 
transgenes from one promoter. Co-expression of antibody fragment and enhanced yellow 
fluorescent protein was established from lentiviral shuttle plasmids through inserting 2A 
sequence between the two cDNAs. The order of the transgenes relative to the 2A influences the 
level of expression i.e. reduced expression of transgenes located downstream of 2A compared 
to the upstream is expected (Appleby et al., 2013).  
  
  Enhancement of productivity in plants 
In plants, the early findings, which proved that 2A is fully active in wheat germ extracts, 
made 2A as a strong candidate to be used in co-expression of genes. Consequently, 2A was 
successfully used to co-express multiple proteins in transgenic tobacco cells in addition to its 
efficiency in terms of plant virus genome manipulation. In this context, recombinant plant 
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viruses encoding 2A have been used to co-express high quality proteins. Accordingly, 2A has 
been used to produce a broad range of novel traits in plants such as drought resistance, high 
nutritional value crops, breeds with high productivity in addition to crops with modified 
metabolic pathways (Halpin et al., 1999; Francois et al., 2002; Abbadi et al., 2004; Yasuda et 
al., 2005; Obro et al., 2009; Ha et al., 2010; Petrie et al., 2012; Ruiz-Lopez et al., 2015). 
Furthermore, employment of 2A came with a solution for resistance against the herbicide, 
glyphosate and Bacillus thuringiensis toxins (Sun et al., 2012).  
2A-based polyprotein constructs have been introduced in plants to generate novel products. An 
example is potato strains which show resistance against drought, generated by co-expression of 
both trehalose-6-phosphate synthase and trehalose-6-phosphate phosphatase genes from the 
yeast, Zygosaccharomyces rouxii (Yeo et al., 2000). 
 
   Recombinant virus vectors 
Using strong promoters is a critical step in recombinant expression. Cytomegalovirus 
(CMV) promoter is commonly used for monoclonal antibody expression in Chinese Hamster 
Ovary cells. This is performed by using four bicistronic vectors encoding 2A sequences, which 
is an efficient tool to produce viable antibodies, used for therapeutic and diagnostic aspects 
(Ebadat et al., 2017). Moreover, the non-oxygen-dependent fluorescent protein (iLOV) is a 
promising alternative to the green fluorescent protein (GFP). The sequence of iLOV was fused 
to the C terminus of Tobacco mosaic virus coat protein, which carries a 2A sequence. A 
systemic transfection with this recombinant vector was achieved in the plant, Nicotiana 
benthamiana, and by testing the presence of iLOV, detected by electron microscopy, it was 
indicated that this vector is efficient for production of proteins when combined with 2A 
sequence, which allows the production of proteins in different cells (Roder et al., 2017). 
Another study combined 2A with recombinant adeno associated virus to perform long term 
overexpression of nerve growth factor (VGF) gene together with a fluorescent marker gene to 
track it in the transfected neurons. The relatively short sequence of the 2A allowed successful 
overexpression on VGF gene combined with the ability to follow the protein (Lewis et al., 
2015).  
 
   Gene therapy 
Adenovirus-associated vectors encoding 2A sequence have been used to generate 
therapeutic proteins. Examples for these proteins are human-synclein which is expressed in 
Parkinson disease (Furler et al., 2001). Also, this system was successfully used in homeobox 
36 
 
protein of target genes (Klump et al., 2001). Furthermore, 2A sequence was successfully 
constructed in a vector bearing three genes and 2A between them to separate human iduronidase 
gene as well as the firefly luciferase and DsRed2. This allowed an expression of active forms 
of the three individual proteins which enabled a supratherapuetic iduronidase in addition to 
efficient protein tracking (Osborn et al., 2005).     
 
   Cancer diagnosis and treatment or monoclonal antibody production 
The challenge of cancer treatment and diagnosis has benefited from 2A properties. The 
utilisation of 2A enhanced the employment of monoclonal antibodies in this approach by 
overcoming the difficulties of antibodies limited production in addition to reduce the high cost. 
Due to the ability to co-express multiple proteins, stable production of a full-length antibodies 
was established by using 2A properties to express both heavy and light chains from a single 
ORF (Fang et al., 2005).  
  
  Stem cells applications 
One application of 2A in biomedicine is that related to the treatment with stem cells. 
Utilisation of 2A overcame problems associated with isolation of stem cells for therapeutic 
purposes. Four genes were defined in this context, Oct-3/4, SOX2, c-Myc and Klf4, which when 
co-expressed together result in production of induced stem cells. These genes were linked to 
each other using 2A sequences (Okita et al., 2008), which ensures the co-expression of the 
desired proteins in the same cells.  
  
1.8 Aims of the study 
Despite the fact that 2A reaction has been subjected to investigations and/or employment 
for around two decades, many aspects of the reaction, including the molecular mechanism, are 
still vague. As discussed above, the presence of 2A-encoding sequence in eukaryotic cellular 
system dictates an efficient production of separated proteins during translation. There is, 
however, a contradiction on the mechanism of the 2A reaction. In 2008, Doronina and co-
workers suggested that eRFs are involved, at least partially, in the reaction (Doronina et al., 
2008), whereas in 2014, Machida and his team argued against this idea, and through in vitro 
experiments, suggested that eRFs are not required, and that 2A is an elongation rather than a 
termination event (Machida et al., 2014).  
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In the work carried out in this thesis, I have biochemically tested the involvement of cellular 
factors in the 2A reaction, using Saccharomyces cerevisiae strains lacking/limited in these 
factors. In addition, I examined a wide variety of mutations in eRF1/eRF3, to further investigate 
the involvement of these factors in the reaction and to identify features of the protein that are 
important to drive a normal 2A reaction.  
A further part of this study was to develop new reporters to study 2A activity. Reporters that 
have been used thus far for this purpose are either based on polyprotein systems (de Felipe et 
al., 2006) or rely on metabolic pathways such as adenine biosynthesis to report on 2A activity 
(Sharma et al., 2012). For in vivo investigations, metabolic conditions may interfere with cell 
growth and the consequent result. Thus, the aim here was to develop a novel reporter which 
works efficiently and independently of cellular pathways, and which could be used to estimate 
the activity of the 2A reaction under different conditions.    
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2 MATERIALS AND METHODS 
2.1 Materials 
All chemicals/reagents and enzymes, except where indicated, were purchased from 
Sigma-Aldrich Chemical Co, Fisher, New England Biolabs or Promega. Ingredients for media 
were from Melford or Formedium. 
 
2.2 Strains and growth conditions 
S. cerevisiae 
  
Strain Genotype Source 
JDY2 MATa, trp1-289, lys2-801, his3-352, ura3-52, 
ade2-101 
Derived from TR1 
(Parker et al., 1988)   
JDY4 MATa, trp1-Δ99, his3-Δ200, ura3-Δ99, leu2-Δ1, 
ade2-101, ciro  
(Sharma et al., 2012) 
JDY778 
(MT557/1d) 
MATa, sup45-2, ade2-1, leu2-3,-112 ura3-1 (Doronina et al., 2008) 
JDY795 
(IS37/7b) 
MATa, sup45::hisG, leu2-3,-112, ura3-52, met8-
1, SUQ5, ade2-1, [pGB1-702]  
(Bertram et al., 2000) 
JDY808 MATa, sup45::kanMX4-tetO7-SUP45, ura3-52, 
leu2-Δ1, his3-Δ200, GAL2, CMVp(tetR'-
SSN6)::LEU2, trp1::tTA 
(Doronina et al., 2008) 
JDY809 MATa, sup35::kanMX4-tetO7-SUP35, ura3-52, 
leu2-1, his3-200, GAL2, CMVp(tetR'-
SSN6)::LEU2, trp1::tTA 
Laboratory strain 
JDY832 MAT, ade1-14, his3, leu2, trp1, ura3, 
[PSI+]STRONG 
(Doronina et al., 2008) 
JDY833 MAT, ade1-14, his3, leu2, trp1, ura3, 
[PSI+]WEAK 
(Doronina et al., 2008) 
JDY834 MAT, ade1-14, his3, leu2, trp1, ura3, [psi-] (Doronina et al., 2008) 
JDY837 MATa, leu2-3,-112, his3-11,-15, trp1-1, ura3-1, 
ade1-14, sup35::HIS3, pCEN-TRP1-SUP35, 
[psi-] 
Laboratory strain 
derived from YDB498 
(Salas-Marco and 
Bedwell, 2004) by 
plasmid shuffling 
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JDY838 MATa, leu2-3,-112, his3-11,-15, trp1-1, ura3-1, 
ade1-14, sup35::HIS3, pCEN-TRP1-
sup35R419G, [psi-] 
Laboratory strain 
derived from YDB498 
(Salas-Marco and 
Bedwell, 2004) by 
plasmid shuffling 
JDY839 MATa, leu2-3,-112, his3-11,-15, trp1-1, ura3-1, 
ade1-14, sup35::HIS3, pCEN-TRP1-
sup35H348Q, [psi-] 
Laboratory strain 
derived from YDB498 
(Salas-Marco and 
Bedwell, 2004) by 
plasmid shuffling 
JDY876 
(W303) 
MATa, ade2-1, his3-11,-15, leu2-3,-112, ura3-2, 
trp1-1 
(Thomas and Rothstein, 
1989) 
JDY879 MATa, ura3-52, leu2- 1, his3-Δ200, GAL2, 
CMVp(tetR'-SSN6)::LEU2, trp1::tTA, 
sup35::kanMX6, [CEN-TRP1 tet-SUP35] 
Laboratory strain 
JDY895 
(BY4741) 
MATa, ura3-Δ0, leu2-Δ0, met15-Δ0, his3-Δ1  (Brachmann et al., 
1998) 
JDY1253 MATa, ura3-Δ0, leu2-Δ0, his3-Δ0, met15-Δ0, 
dom34Δ::kanMX4 
(Giaever et al., 2002) 
JDY1254 MATa, ura3-Δ0, leu2-Δ0, his3- Δ0, met15-Δ0, 
hbs1Δ::kanMX4 
(Giaever et al., 2002) 
JDY1255 MATa, ura3-Δ0, leu2-Δ0, his3- Δ0, met15-Δ0, 
hcr1Δ::kanMX4 
(Giaever et al., 2002) 
JDY1256 MATa, ura3-Δ0, leu2-Δ0, his3-Δ0, met15-Δ0, 
ski7Δ::kanMX4 
(Giaever et al., 2002) 
JDY1257 MATa, ura3-Δ0, leu2-Δ0, his3-Δ0, met15-Δ0, 
CYH2+, DAmP-RLI1 
(Breslow et al., 2008) 
JDY1296 MATa, ura3-Δ0, leu2-Δ0, his3-Δ0, met15-Δ0, 
CYH2+, DAmP-SUP45 
(Breslow et al., 2008) 
JDY1297 MATa, ura3-Δ0, leu2-Δ0, his3-Δ0, met15-Δ0, 
tef1Δ::kanMX4 
(Giaever et al., 2002) 
JDY1298 MATa, ura3-Δ0, leu2-Δ0, his3-Δ0, met15-Δ0, 
CYH2+, DAmP-TEF4 
(Breslow et al., 2008) 
JDY1299 MATa, ura3-Δ0, leu2-Δ0, his3-Δ0, met15-Δ0, 
SOD1-DHFR [F1,2]::natMX 
Laboratory strain 
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JDY1300 MATa, ura3-Δ0, leu2-Δ0, his3-Δ0, lys2-Δ0, 
SOD1-DHFR [F3]::hohMX 
Laboratory strain 
YTH89 MAT, ade1-14, trp1-2889, his3-Δ200, ura3-52, 
leu2-3,-112, sup45::kanMX4 
Tobias von der Haar 
lab 
YTH91 MATa/α, his3-Δ1/his3-Δ1, leu2-Δ0/leu2-Δ0, 
LYS2/lys2-Δ0, met15-Δ0/MET15, ura3-Δ0/ura3-
Δ0, sup45::kanMX4 
Tobias von der Haar 
lab 
 
Table 2.1: Strains of S. cerevisiae used in the study with the genotype. 
 
 
Table 2.1 shows strains of S. cerevisiae, used in this study. Yeast were grown in non-selective 
rich medium, YPD (1% w/v yeast extract, 2% w/v peptone, 2% w/v glucose, with 2% w/v agar 
for plates), or selective media (0.67% w/v yeast nitrogen base, 2% w/v glucose, with 2% w/v 
agar for plates, supplemented with required amino acids and/or nucleobases, according to 
growth requirements. Selective media containing 0.1% w/v 5-fluoroorotic acid (5FOA) was 
used for selection against URA+ cells (Boeke et al., 1984). Expression of 2A reporters from the 
galactose-dependent GAL1 promoter was performed for immunoprecipitation experiments, by 
growing cells in selective media with 2% w/v raffinose, rather than glucose, then galactose was 
added to concentration of 2% w/v for ~5 hours. Yeast cells were incubated at 30 ºC, unless they 
were thermosensitive. 
 
E. coli 
E. coli strain, DH10b BF- endA1 recA1 galK6 nupG rpsL ΔlacX74 Φ80lacZΔM15 
araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC)λ- (Grant et al., 1990) was used in this 
study to produce plasmid  
DNA and to transform ligation reactions. Cells were grown in lysogeny broth (LB) 
media (2% w/v tryptone, 1% w/v yeast extract, 1% w/v NaCl, with 2% w/v agar for plates), 
with 100 µg/ml ampicillin added when necessary for plasmid selection, and incubated at 37 ºC. 
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2.2.1 Plasmids 
Plasmids, and their details, which were used in this study are stated in table 2.2. 
 
Name Vector Insert Source/Reference 
pJNY11 pMW20 GAL 
(CEN, URA3) 
- (de Felipe et al., 
1999) 
pJNY59 pMW20 αFactor-2A-GFP (de Felipe et al., 
1999) 
pJNY161 YCplac22 Wild type SUP35 (Salas-Marco and 
Bedwell, 2004) pJNY162 YCplac23 H438Q SUP35 
pJNY163 YCplac24 G419A SUP35 
pJNY175 pMW20 αF-2A TAV-GFP Lab collection 
pJNY176 pMW21 αF-2A* TAV-
GFP 
pJNY250 pDB0688 read-through 
cassette CAAA s 
(Du et al., 2009) 
Gifted by Bedwell 
pJNY251 pDB0688 Renilla-read-
through cassette 
UAAA-Fire fly 
pJNY253 pDB0688 Renilla-read-
through cassette 
UAGC-Fire fly 
pJNY252 pDB0688 Renilla-read-
through cassette 
CGAC-Fire fly 
pJNY254 pDB0688 Renilla-read-
through cassette 
UAGu-Fire fly 
pJNY278 pJNY11 3HA-αF-2A*-
GFP 
Lab collection 
pJNY279 pJNY12 3HA-αF-2A-GFP Lab collection 
pET17b _ Protein induction 
plasmid 
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pJN132 pET17b SUP45-STREP 
tagged 
Lab collection 
pJN134 pET17b SUP35 Lab collection 
pJN141 pET17b αF-2A-PPL SP6 Lab collection 
pJN142 pET17b αF-2A*-PPL SP6 Lab collection 
pJN177 pSP65 aF-2A-pL poly A Lab collection 
pJN178 pSP66 aF-2A*-pL poly 
A 
Lab collection 
pJN197 pET3-a Wild type SUP35 Lab collection 
pJN198 pET3-a H438Q sup35 Lab collection 
pJN199 pET3-a G419A sup35 Lab collection 
pJN239 pDB1083 HIS-SUP45 Gifted by David 
Bedwell 
pTH353 pRS315 WT SUP45 (Merritt et al., 
2010) 
 
pTH399 pRS316 S30P SUP45 
pTH313 pRS317 I32F SUP45 
pTH314 pRS318 P38L SUP45 
pTH438 pRS319 L49A SUP45 
pTH439 pRS320 E52A SUP45 
pTH355 pRS321 T55A SUP45 
pTH371 pRS322 S61A SUP45 
pTH373 pRS323 R62A SUP45 
pTH374 pRS324 V68A SUP45 
pTH316 pRS325 V107D SUP45 
pTH443 pRS326 P174Q SUP45 
pTH444 pRS327 G180A SUP45 
pTH376 pRS328 G181A SUP45 
pTH397 pRS329 Q182E SUP45 
pTH445 pRS330 I222S SUP45 
pTH357 pRS331 T295A SUP45 
pTH363 pRS332 T388A SUP45 
pTH366 pRS333 F401Y SUP45 
pTH365 pRS334 Y410F SUP45 
pTH769 pRS313 WT SUP45 
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pTH770 pRS314 R320I SUP45 
pTH773 pRS315 G357D SUP45 
pTH774 pRS316 S416F SUP45 
pDHFR pRS317 WT DHFR This study 
pDH pRS318 F3 fragment of 
DHFR 
This study 
pFR pRS319 F1,2 fragment of 
DHFR 
This study 
pDHFR/A pRS320 FMDV 2A in the 
middle of DHFR 
This study 
pDHFR/* pRS321 2A in the middle 
of DHFR 
This study 
pGFP pRS316 WT GFP This study 
pTAV 19 pRS317 Short TAV 2A in 
GFP 
This study 
pTAV* 19 pRS318 Short TAV 2A* 
in GFP 
This study 
pTAV 31 pRS319 Long TAV 2A in 
GFP 
This study 
pTAV* 31 pRS320 Long 2A* in 
GFP 
This study 
pFM pRS321 FMDV 2A in 
GFP 
This study 
 
Table 2.2: Plasmids used in this study. 
 
A collection of plasmids was constructed during the course of this study, which encodes the 
GFP-2A reporter (see Chapter 5). We used different sequences of 2A peptides and cloned them, 
into a pRS316 vector, which carries a URA3 marker. 2A sequence was cloned between bases 
encoding the amino acid residues 157 and 158 of the GFP sequence, with few extra sequences 
on both sides to allow folding flexibility. The whole construct was cloned in the plasmid poly-
linker which is flanked by T7 initiator and T3 terminator. The initial strategy of cloning 
included amplification of PCR DNA encoding the required 2A sequence using the forward 
specific oligonucleotide and T3 universal oligonucleotide as a reverse. This produces a DNA 
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fragment with a 2A sequence at the 5’, starts with BglII site, and ends with T3 terminator at the 
3’ end, flanked with EcoRI site. BglII and EcoRI sites, which are unique in the vector backbone, 
were successfully used to clone PCR fragments encoding different 2A/2A* sequences-extra 
amino acid codons to allow folding flexibility-GFP sequence starts with sequence encoding 
residue 158 -T3 terminator sequence, into a pRS316 vector.  
 
2.2.2 Oligonucleotides 
Oligonucleotides used in this study were supplied by Sigma Aldrich. Sequences of 
oligonucleotides are stated in table 2.3. 
 
Name Sequence 5’-3’ Usage  
2A Fwd CCGTCTAGAGCATGCGCACCG 19 amino acids 
2A inserted in 
DHFR 
2A Rvs CCTCCATGGCATGACTGCCCGGGGCCC 
DHFR 
Fwd 
AGGGGATCCACGGTTCGACCATTGAACTG DHFR F1,2  
DHFR 
Intrvs 
GGCCCATGGGAATCTAGAGCCACTGCCCAATTCCGGT
TGTTCAATAAGTC 
DHFR 
intfwd 
CGGACCGGTCCATGGGGGAGCGGCGCAAGTAAGTAG
ACATGGTTTGG 
DHFR F3 
DHFR 
intrvs 
ACGCTGCAGTTAGTCTTTCTTCTCGTAGAC 
RLI1FE
D 
CCGGAGCTCCCGCCGACGTGTCATTTTCG RLI1 
amplification 
RLI1RV
S 
CCGTTACCCGGGAATACCGGTGTTATCCAAGAAAAAG 
eif3jfwd
xba1 
GCATCTAGAATTGGTCGCG CACTAAATTTG HCR1 (eIF3j) 
amplification 
eif3jrvsB
amHI 
GCTGGATCCAACGGCAATATTGGCTACATTC 
Sup45fw
d 
GCCCATATGGATAACGAGGTTGAAAAAAATATTG SUP45  
amplification 
Sup45rvs GCCTCTAGATTAATGATGATGATGATGATGATGATG 
AATGAAATCATAGTCGGATCC 
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IFV 2A CCGAGATCTCCCTCAATTGGTAATGTCGCGCGGACTCT
GACGAGGGCGGAGATTGAGGATGAATTGATTCGTGCA
GGAATTGAATCAAATCCAGGTCCATCCATCCGGA 
Various 
sequences of 
2A peptides 
from different 
viruses 
PrV2A CCGAGATCTTTGGAGATGAAGGAGTCTAATAGTGGTT
ACGTAGTCGGTGGTCGGGGGTCTCTTCTCACTTGTGGG
GACGTTGAATCCAATCCAGGTCCATCCGGA 
DCV 2A CCGAGATCTCAAGGCATCGGTAAGAAGAATCCGAAAC
AGGAAGCTGCACGTCAGATGTTGCTCTTGTTATCAGG
AGATGTTGAGACTAATCCGGTCCATCCGGA 
PTV CCGAGATCTGCTATGACTGTGATGACATTCCAGGGAG
GAGGTGCAACAAACTTCTCCCTCTTGAAACAAGCAGG
AGATGTTGAGGAAAATCCAGGTCCATCCGGA 
IMNV CCGAGGTCTTGGGACCCAACCTACATTGAAATTTCTG
ATTGTATGCTGCCACCTCCAGACCTTACATCGTGCGGG
ACGTTGAGAGTAATCCAGGTCCATCCGGA 
IFV 2A CCGAGATCTCCCTCAATTGGTAATGTCACGCGGACTCT
GACGAGGGCGGAGATTGAGGATGAATTGATTCGTGCA
GGAATTGAATCAAATCCAGGTCCATCCGGA 
PrV2A1 CCGAGATCTTTGGAGATGAAGGAGTCTAATAGTGGTT
ACGTAGTCGGTGGTCGGGGGTCTCTTCTCACTTGTGGG
GACGTTGAATCCAATCCAGGTCCATCCGGA 
DCV 2A CCGAGATCTCAAGGCATCGGTAAGAAGAATCCGAAAC
AGGAAGCTGCACGTCAGATGTTGCTCTTGTTATCAGG
AGATGTTGAGACTAATCCAGGTCCATCCAGGA 
PTV CCGAGATCTGCTATGACTGTGATGACTTCCAAGGGAC
CAGGTGCAACAAACTTCTCCCTCTTGAAACAAGCAGG
AGATGTTGAGGAAAATCCAGGTCCATCCGGA 
IMNV CCGAGATCTTGGGACCCAACCTACATTGAAATTTCTG
ATTGTATGCTGCCACCTCCAGACCTTACATCGTGCGGG
GACGTTGAGAGTAATCCAGGTCCATCCGGA 
IFV 2A CCGAGATCTCCCTCAATTGGTAATGTCGCGCGGACTCT
GACGAGGGCGGAGATTGAGGATGAATTGATTCGTGCA
GGAATTGAATCAAATCCAGGTCCATCCGGA 
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TaV 2A GGTAGATCTAGGGGCCCCAGACCGCAGAACCTCGGAG
TCAGAGCTGAAGGTAGAGGTTC 
T3 AATTAACCCTCACTAAAGGG For 
amplification 
of 2A using 
pRS316 
template 
OPT* CCAAGATCTAGACATAAACAAAAAATTGTTGCTCCAG
TTAAACAAACTTTGAATTTTGATTTGTTGAAATTGGCT
GGTGATGTTGAATCTAATGCTGGTCCATCCGGAGG 
Optimised 2A 
sequence 
S15I CCAAGATCTAGACATAAACAAAAAATTGTTGCTCCAG
TTAAACAAACTTTGAATTTTGATTTGTTGAAATTGGCT
GGTGATGTTGAAATTAATCCAGGTCCATCCGGAGG 
De-optimised 
2A sequence 
N16H CCAAGATCTAGACATAAACAAAAAATTGTTGCTCCAG
TTAAACAAACTTTGAATTTTGATTTGTTGAAATTGGCT
GGTGATGTTGAATCTCATCCAGGTCCATCCGGAGG 
Mutations in 
the FMDV2A 
sequence 
E14Q CCAAGATCTAGACATAAACAAAAAATTGTTGCTCCAG
TTAAACAAACTTTGAATTTTGATTTGTTGAAATTGGCT
GGTGATGTTCAATCTAATCCAGGTCCATCCGGAGG 
TaV2A 
GGTAGATCTAGGGGCCCCAGACCGCAGAACCTCGGAG
TCAGAGCTGAAGGTAGAGGTTC 
19 amino acids 
Tav2A 
sequence 
FMDV 
2A* 
CCAAGATCTAGACATAAACAAAAAATTGTTGCTCCAG
TTAAACAAACTTTGAATTTTGATTTGTTGAAATTGGCT
GGTGATGTTGAATCTAATGCTGGTCCATCCGGAGG 
Inactive 
FMDV2A 
 
Table 2.3: Oligonucleotides used in this study. 
 
2.3 Molecular biology techniques  
Standard techniques including plasmid preparation, PCR amplification, DNA ligation, 
digestion were achieved according to Sambrook and Gething (1989), or following 
manufacturer’s instructions when kits were used. Sequencing was carried out by Source 
Bioscience. 
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2.3.1 Separation and visualization of DNA fragments 
Separation of DNA was performed using gel electrophoresis, with 1% w/v agarose in 
1X TAE (40 mM Tris-HCl, 20 mM acetic acid, 1 mM EDTA) with 1 µg/ml ethidium bromide. 
Gels were run at 140 V until suitable resolution of fragments was achieved. DNA was visualised 
under UV light, and images captured using gel documentation system (BIO RAD Gel DocTM 
XR). 
 
2.3.2 Separation of proteins 
Proteins were resolved by polyacrylamide gel electrophoresis (SDS-PAGE) (Table 2.4), 
using tris-glycine gels (Zhang et al., 2016). Protein samples were run on a vertical 
electrophoresis system, using 1X protein running buffer (25 mM Tris-HCl, 192 mM Glycine, 
0.1% w/v SDS). Gels were run at 150 V until the dye-front reached the bottom of the gel. When 
necessary, visualization of protein fractions was carried out using Coomassie blue staining 
(0.25% w/v Coomassie brilliant blue, 50% v/v methanol, 7% v/v acetic acid) for 15 minutes, 
then de-stained for ~2 hours, using destain solutions (45% v/v methanol, 7% v/v acetic acid). 
 
Ingredient 
(ml)  
Gel (%) 
10 12 15 Stacking  
Separating 
buffer 2.5 2.5 2.5 1.25 
40% 
Acrylamide 2.5 3 3.75 1.25 
2% Bis 
acrylamide 1.5 1.6 2 0.66 
10% SDS 0.1 0.1 0.1 0.1 
H2O 3.23 2.6 1.4 6.4 
TEMED 0.004 0.004 0.004 0.005 
10% APS 0.167 0.167 0.167 120 
 
Table 2.4: Ingredients used in different concentrations of SDS-PAGE. 
2.3.3 Polymerase chain reaction (PCR) 
PCR was performed using Velocity DNA polymerase (BIOLINE), or homemade 
polymerase for general diagnostic procedures. A standard PCR reaction (total volume 100 µl) 
consists of 10 µl of 10X polymerase buffer (provided by manufacturer or 10 mM Tris-HCl pH 
8.3, 50 mM KCl,  2 mM MgCl2, 0.01% w/v gelatin diluted from a 10X stock), 1 mM dNTPs, 
1-2 units of DNA polymerase, 1 pM of each oligonucleotide and 1 ng/µl of DNA template. A 
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standard 3 step programme was used and reactions were run in PTC-100 (MJ Research), as 
follows (table 2.5): 
 
Step Temperature 
(ºC) 
Time 
Initial denaturation 96 5 min. 
Denaturation 96 30 sec. 
Annealing* 55 30 sec. 
Extension 72 1 min. 
Extension in total 72 10 min. 
                           
Table 2.5: The three step program used to amplify PCR fragments. 
 
*Annealing temperature was optimized according to the oligonucleotides used in the reaction. 25-35 cycles for 
the denaturation, annealing and extension were used to obtain considerable concentration of PCR products, while 
a final extension step was set on 10 minutes. 
 
 
2.3.4 Preparation of competent E. coli cells 
Competent E. coli cells of DH10b strain were prepared according to Sambrook and 
Gething (1989), using the CaCl2 method. A culture was grown in LB at 37 ᵒC overnight, the 
culture was then diluted 200 times into 100 ml of LB medium and incubated again until it 
reached OD600 ~ 0.5. Cells were incubated on ice for 10 minutes, then centrifuged at 5000 rpm 
for 5 minutes using Avanti J20-XP (Beckman Coulter). Cell pellets were re-suspended in 40 ml 
TFBI (30 mM KOAc, 100 mM RuCl2, 10 mM CaCl2, 50 mM MnCl2, 15% v/v glycerol, pH 5.8 
adjusted with acetic acid) at 4 ᵒC. Cells were then incubated on ice for 5 minutes, pelleted at 
3000 rpm for 10 minutes and suspended in 4 ml TFBII (10 mM MOPS, 75 mM CaCl2, 10 mM 
RuCl2, 15% v/v glycerol, pH 6.5 adjusted with KOH). Cells were incubated on ice for 15 
minutes, then dispensed as 200 µl aliquots into Eppendorf tubes and stored at -80 ᵒC. 
 
2.3.5 Transformation of E. coli 
Transformation of competent E. coli cells was carried out as follows. Appropriate 
number of competent cell aliquots (60 µl per sample) prepared as in section 2.3.4 were thawed 
on ice, 1-100 ng of plasmid DNA or 10 µl of a ligation reaction were added, mixed and the tube 
incubated on ice for 15-30 minutes. Cells were exposed to heat shock at 42 ºC for two minutes 
and then placed back on ice for another minute. 1 ml of LB media was added to each reaction, 
and cells were then incubated at 37 ºC for 45 minutes. Cells were harvested; 8000 rpm for 5 
minutes, and most of the liquid was discarded. Pellets were re-suspended in the remaining 
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liquid, and either plated onto LB plates or inoculated into LB liquid supplemented with 100 
µg/ml ampicillin as appropriate. Plates/flasks were then incubated at 37 ºC overnight. 
 
2.3.6 Plasmid preparation from E. coli 
Plasmid preparation from E. coli was performed in small and large scales namely mini 
and midi preparations. Both rely on alkaline lysis of cells (Birnboim and Doly, 1979). 
 
  Midi preparation 
Cells were harvested from 50 ml of overnight culture by centrifugation at 3000 rpm for 
15 minutes in a 50 ml Falcon tube using a Beckman J6 centrifuge. The culture media was 
discarded and the pellet re-suspended in 2 ml of TEG buffer (1% w/v glucose, 2 mM EDTA, 
2.5 mM Tris-HCl pH 8.0). 4 ml of SDS/NaOH reagent were added (0.2 M NaOH, 1% w/v SDS) 
and the tubes mixed by inversion. Then, 2.5 ml of 3 M sodium acetate (pH 5.2) were added and 
the tubes, mixed by vortexing. Samples were centrifuged as above, supernatants transferred to 
fresh Falcon tubes, mixed with an equal volume of isopropanol, and centrifuged again as above. 
Pellets were washed with 70% v/v ethanol, allowed to air dry and re-suspended in 0.5 ml Tris 
EDTA (TE) (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). Solutions were transferred to Eppendorf 
tubes and 5 µl of 10 mg/ml RNAase A were added. Tubes were then incubated at 37 ºC for 30 
minutes. PCI (25:24:1 phenol:chloroform:isoamylalcohol) extraction was applied, by adding 
an equal volume to each tube, vortexing, and centrifuging at full speed for 5 minutes in a 
microcentrifuge. The top aqueous layers were separated into fresh tubes, and PCI extraction 
was repeated 3-5 times until the interface between the layers was clear. DNA was then 
precipitated by addition of an equal volume of isopropanol and 1/10 volume of 3 M sodium 
acetate (pH 5.2), and centrifuged at full speed for 15 minutes in a microcentrifuge. DNA pellets 
were washed in 70% v/v ethanol and allowed to air dry. Finally, DNA was dissolved into 250 
µl TE and frozen at -20 ºC. 
 
  Mini preparation 
3 ml of overnight culture of E. coli were harvested in Eppendorf tubes (by filling the 
same tube twice) in a microcentrifuge at full speed for 3 minutes. The pellet was re-suspended 
in 100 µl TEG buffer and 200 µl of SDS-NaOH were added and mixed by inversion, and 150 
µl of 3 M sodium acetate were also added and mixed. 10 µl RNAase A were added, and samples 
were incubated at 37 ºC for 30 minutes. Samples were centrifuged, and supernatants were 
transferred to fresh tubes. One PCI extraction cycle was applied, and upper layers were 
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transferred to fresh tubes. DNA was precipitated by addition of an equal volume of isopropanol, 
and centrifugation at full speed in a microcentrifuge for 15 minutes. Supernatants were removed 
and pellets were washed with 70% v/v ethanol, allowed to air dry, and dissolved in 25 µl TE.   
 
2.3.7 Restriction enzyme digestion of DNA  
  Standard DNA digestion reactions were performed as follows in table 2.6: 
 
Componenets Volume (µl) 
DNA 2-5 (1 µg) 
Restriction 
enzyme 1 
Optimum 
manufacturer’s 
buffer (10X) 2 
dH2O To 20 
 
Table 2.6: Basic components of DNA digestion reaction. 
 
Reactions were incubated at recommended temperatures for maximum enzyme activity for 1 
hour and then run on a 1% w/v agarose gel (section 2.2.1). 
 
2.3.8 DNA ligation 
Ligation reactions were assembled as follows in table 2.7: 
 
Components Volume (µl) 
Vector DNA 50 -200 ng 
Insert 
Equal molar ratio (3-5 
times of the vector) 
T4 DNA 
ligase 1 
10X T4 ligase 
buffer 
2 
dH2O To 20 
                                      
Table 2.7: Basic components of ligation reaction. 
Reactions were incubated at room temperature for 1-3 hours and then transformed into E. coli (section 2.3.5). 
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2.3.9 DNA transformation into yeast  
  S. cerevisiae transformation 
DNA including plasmids and fragments were introduced into S. cerevisiae cells using 
the lithium acetate method (Ito et al., 1983). Overnight cultures of yeast cells were grown at 30 
ºC, diluted 10-times the next morning and incubated again to an OD600 of ~0.5. Cells were 
harvested at 3000 rpm for 5 minutes in 50 ml Falcon tubes in a Beckman J6 centrifuge and 
pellets washed with lithium acetate mix (0.1 M LiOAc pH 7.3) and re-suspended in 1 ml of the 
same reagent. 0.1-1 µg of transforming DNA was added to 100 µl of cell suspension, 10 µl of 
carrier DNA (10 mg/ml) (freshly denatured and chilled salmon sperm DNA) and 700 µl 
polyethylene glycole (PEG) mix (46% w/v polyethylene glycol-2000, 0.1 M LiOAc pH 7.3, 1X 
TE) were added and mixed gently with the cell suspension, and then samples were incubated at 
room temperature (RT) for 30 minutes. Heat shock was applied at 42 ºC for 20 minutes, and 
cells were then pelleted at 5000 rpm for 1 minute in a microcentrifuge. Most of the liquid was 
discarded; cells were re-suspended in the remaining volume and plated on appropriate selective 
plates.  
 
2.3.10 Plasmid recovery from S. cerevisiae 
To isolate plasmid DNA from S. cerevisiae, 2 ml cultures were grown in selective media 
overnight. Cells were harvested in a 15 ml Falcon tube at 3000 rpm for 5 minutes. Pellets were 
washed with TE, and then re-suspended in 100 µl of STET buffer (8% w/v sucrose, 50 mM 
Tris-HCl pH 8.0, 50 mM EDTA and 5% v/v Triton X-100). Suspensions were transferred to 
Eppendorf tubes and Zirconium beads (Biospec Products) were added to just below the liquid 
surface. Cells were lysed using a bead-beater (Mini-Beadbeater-16, Biospec products) twice for 
20 seconds, with 2-3 minutes incubation on ice in between to cool down the lysate. A further 
volume (100 µl) of STET were added, and samples were boiled for 10 minutes and centrifuged 
for 10 minutes at 14,000 rpm, in a cooled microcentrifuged. 100 µl of liquid were taken to a 
fresh Eppendorf tube containing 50 µl of 7.5 M ammonium acetate. Tubes were then incubated 
at -20 ºC for 2 hours, and then centrifuged at 14,000 rpm for 10 minutes in a cooled 
microcentrifuge. 100 µl of the resulting supernatant were transferred to a fresh tube with 200 
µl ethanol. Samples were incubated on ice for 15 minutes before repeating the centrifugation 
step to pellet DNA. The resulting pellets were washed with 70% v/v ethanol, allowed to air dry 
and then re-suspended in 10-20 µl of TE. 10 µl of the final volume was used for transformation 
into E. coli.  
 
52 
 
2.3.11 Extraction of genomic DNA from S. cerevisiae 
To isolate the genomic DNA from S. cerevisiae, cultures (5 ml) of relevant strains were 
grown overnight in YPD at 30 ºC. Cells were harvested by centrifugation at 3000 rpm for 5 
minutes, using a bench-top centrifuge, washed twice with sterile water, and re-suspended in 
200 µl of lysis buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 100 mM NaCl, 1% w/v SDS, 
2% v/v Triton X-100). Cell suspensions were transferred to Eppendorf tubes, 200 µl of phenol: 
chloroform: isoamylalcohol (25:24:1) were added, and zirconium beads were then added to just 
below the liquid surface. Cell lysis was achieved using a bead-beater, twice for 20 seconds, 
with 2-3 minutes incubation on ice in between. Samples were then centrifuged, and 200 µl of 
supernatants transferred to fresh tubes. To precipitate the DNA, 20 µl of 3 M sodium acetate 
(pH 5.2) in addition to 400 µl of ethanol were added, and samples were centrifuged at 14,000 
rpm for 15 minutes in a microcentrifuge. Pellets were washed in 70% v/v ethanol, allowed to 
air dry, and then re-suspended in 100 µl of dH2O.  
 
2.4 Biochemical techniques 
2.4.1 Protein expression 
50 ml of S. cerevisiae culture were incubated overnight at 30 ºC in appropriate selective 
media. For induction from a GAL1 promoter, overnight cultures contained 2% w/v raffinose 
(instead of glucose) to remove repression on the promoter. Cultures were diluted on the next 
day to OD600 0.2 and re-incubated with addition of 2% w/v galactose. Cells were harvested 
when cultures reached OD600 ~0.5 by centrifugation at 3000 for 5 minutes, and washed twice 
with dH2O at 4 
oC. Cell suspensions were transferred to Eppendorf tubes and centrifuged at 
5000 rpm for 1 minute and processed as required for downstream experiments. 
 
2.4.2 Western blotting 
  Cell lysis and protein extraction for western blotting 
Pellets of S. cerevisiae cells were re-suspended in 0.5 ml of native buffer (150 mM 
NaCl, 20 mM Tris-HCl pH 7.5, 2 mM MgCl2, 1 mM EDTA pH 8, 5 mM DTT, 1 mM PMSF), 
Zirconium beads were added and cells were lysed using the bead-beater, twice for 20 seconds 
with 2-3 minutes incubation on ice in between. The lysate was removed from the beads to fresh 
tubes and centrifuged at 13000 for 20 minutes at 4 ºC in a microcentrifuge. Clarified lysates 
were then transferred to fresh tubes. Protein concentration was measured using Bradford assay 
(Biorad), and a standard curve generated using Bovine Serum Albumin (BSA).  
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  Blotting technique 
Samples were adjusted for equal concentration of protein, mixed with equal volume of 
SDS-PAGE sample loading buffer (50 mM Tris-HCl pH 6.8, 100 mM DTT, 10% v/v glycerol, 
2% w/v SDS, 0.1% w/v bromophenol blue), heated at 65 ºC for 5 minutes and a volume 
corresponding to 10-20 µg lysate run on an SDS-PAGE gel (see section 2.2.2). Proteins were 
transferred from the gel onto nitrocellulose membrane (Schleicher & Schuell) using a semi-dry 
blotter (Bio-Rad Trans-Blot) according to manufacturer’s instructions. Transferred proteins 
were visualised by applying Ponceau stain for 1 minute and then rinsing the membrane in water. 
Blocking of the membrane was performed through incubation in block solution (5 % w/v 
skimmed milk, 0.5% v/v Tween, 1X TBS, for 1X TBS, 50mM Tris-HCl, 120 mM NaCl pH 
7.6) for 30-60 minutes. The membrane was then exposed to the primary antibody (1:1000 
dilution in block solution) and incubated 1 hour at room temperature or overnight at 4 oC. The 
membrane was then washed 3 times for 5 minutes with block solution, and then exposed to the 
secondary antibody for 1 hour at room temperature (1:2000 in block solution) and washed as 
previously. A final wash was carried out with 1X TBS. The membrane was then incubated with 
developing solution (1.25 mM luminal, 0.2 mM p-coumaric acid in 1M Tris-HCl pH 8.5 to 
which 0.03% v/v H2O2 was added just before use). The signal was detected on photographic 
film (Kodak BIOMAX light).      
 
2.4.3 Pulse labelling and immunoprecipitation 
  Protein expression 
Culture growth and protein induction was performed as stated in section 2.4.1. Cells 
were harvested from a volume of culture corresponding to 2-5 OD600, by centrifugation at 3000 
rpm for 5 minutes in a bench-top centrifuge. Cells were washed once in dH2O, transferred to 
screw top Eppendorf tubes and centrifuged at 5000 rpm for 1 minute. Cells were then washed 
once in -Met -Cys selective media, containing 2% w/v each of raffinose and galactose, re-
suspended in 1 ml of the same media and incubated at 30 ºC for 15 minutes. 50 µCi  [35S]- 
labelled Met/ Cys (EXPRES protein labelling mix, Perkin Elmer, 11 mCi/ml) were added per 
OD, and incubation continued for a further 10 minutes. Cells were harvested at 5000 rpm for 1 
minute in a microcentrifuge, media removed and tubes placed into liquid nitrogen. 
 
  Cell lysis and protein extraction for immunoprecipitation 
Pellets of yeast were re-suspended in 0.5 ml TCA buffer (20 mM Tris-HCl pH 8.0, 50 
mM ammonium acetate, 2 mM EDTA), and 0.5 ml 30% w/v TCA. ~0.5 ml Zirconium beads 
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was added and cells were lysed in a mini bead-beater (Biospec products) twice for 30 seconds, 
with a 2-3 minute incubation on ice in between. Lysate was transferred to fresh tubes, and beads 
were washed with 400 µl of 1:1 (TCA buffer:30% w/v TCA), and this liquid was added to the 
initial lysates. Precipitated proteins were collected by centrifugation at 14000 rpm for 10 
minutes in a microcentrifuge, supernatants were discarded, and pellets re-suspended in 40 µl/ 
OD of resuspension buffer (3% w/v SDS, 100 mM Tris-HCl pH 10.8, 3 mM DTT). The samples 
were heated at 65 ºC for 5 minutes and at 100 ºC for another 5 minutes prior to centrifugation 
at 14000 rpm for 5 minutes in a microcentrifuge. Protein solutions were transferred to fresh 
tubes in 40 µl aliquots and frozen in liquid nitrogen. 
       
  Immunoprecipitation 
Aliquots of labelled proteins were thawed and the following were added to each: 560 
µl of IPSII (13.3 mM Tris-HCl pH 7.5, 50 mM NaCl, 1% v/v Triton X100, 0.02% w/v NaN3), 
6 µl of 100 mM PMSF and 30 µl of protein G resin (Amintra), pre-equilibrated in IPSI (0.2% 
w/v SDS, 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% v/v Triton X, 0.02% w/v NaN3). Samples 
were incubated at 4 ºC for 1 hour on a rotating wheel, and centrifuged at 2000 rpm for 1 minute 
in a microcentrifuge. The liquid was transferred to fresh tubes and 1-2 µl of antibody were 
added to each sample and incubated for 1 hour on the rotating wheel. 30 µl of protein G resin 
in IPSI were added and incubation continued for 1 more hour. Samples were centrifuged, 
supernatants discarded and resin washed 5X with TBS. Resin was transferred to fresh tubes 
before the last washing steps. After removal of the final wash, 30 µl of protein loading dye were 
added to samples, which were then heated at 65 ºC for 5 minutes and loaded onto SDS-PAGE 
gels. After electrophoresis, gels were stained with Coomassie brilliant blue for 15 minutes and 
de-stained for 2 hours. Gels were dried on a vacuum drier and [35S] Met/Cys detected using 
phosphor storage screens and a Typhoon Trio Scanner (GE Healthcare). Quantification of bands 
was carried out using ImageQuant. Relative amounts of protein were normalized according to 
the number of methionine and cysteine residues contained in the detected different proteins. 
  
2.4.4 Dual reporter assay 
Dual luciferase assay was carried out in the presence of 2A over-expression. The activity 
of luciferases generated from Renilla and Firefly were determined using home-made reagents 
and values read using a fluorimeter (POLARstar Omega plate reader). 
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  Protein expression 
Cultures of S. cerevisiae expressing dual luciferase reporters were grown at 30 ºC 
overnight in selective media, diluted the next day and re-grown  to OD600 ~0.5. Cells were 
harvested in 50 ml Falcon tubes at 3000 rpm for 5 minutes in a bench-top centrifuge. Cell pellets 
were re-suspended in 1 ml dH2O, transferred to Eppendorf tubes and cells re-pelleted by 
centrifugation at 5000 rpm for 1 minute in a microcentrifuge. The resulting pellets were re-
suspended in 500 µl of passive lysis buffer (Promega). Zirconium beads were added to just 
below the top of the liquid and cells lysed using the mini bead beater, 2X for 20 seconds, with 
2-3 minutes incubation on ice in between. Lysates were transferred to fresh tubes and 
centrifuged at 13000 rpm for 20 minutes at 4 ºC in a microcentrifuge. Supernatants were taken 
to fresh tubes, and protein concentrations determined as in section 2.4.2.1.  
 
  Measurement of luciferase activity 
Lysate corresponding to 10-20 µg protein was used to measure Renilla and Firefly 
luciferase activity. Two reagents were used; reagent A (200 mM Tris-HCl pH 7.4, 15 mM 
MgSO4, 0.1 mM EDTA, 25 mM DTT, 1 mM ATP (Calbiochem), 0.2 mM Co-enzyme A 
(Calbiochem), 200 μM D-luciferin substrate (Sigma Aldrich)), and reagent B (25 mM NaPPi, 
10 mM NaAc, 500 mM Na2SO4, 500 mM NaCl, 50 μM Luciferase Inhibitor (Calbiochem), 4 
μM colentrazine-h (Melford)). Reagent A measures Firefly luciferase activity, whereas reagent 
B inhibits Firefly luciferase and allows the measurement of Renilla luciferase activity. 
Measurement was performed in 96-well microplates, with lysate being added to each well, then 
the plate inserted into the fluorometer. Reagents A and B were prepared separately in 15 ml 
Falcon tubes, and connected to injectors on the fluorimeter. The reagents were then added and 
Renilla (first ORF) and Firefly (second ORF) activities measured automatically and background 
(i.e. measurements from lysates not containing any luciferase) subtracted from the measured 
values. Average values for each enzyme were calculated from 26 interval measurements and 
the ratio of the Firefly (downstream)/Renilla (upstream) was then established. 
 
2.5 In vitro translation 
2.5.1 Yeast translation competent extracts 
Lysates were made essentially as described (Ng et al., 1994). Cultures of S. cerevisiae 
strains were grown in 2.8 L flasks in YPD at 30 ºC overnight, diluted on the next day using the 
same media, and re-grown again to OD600 0.5. Cells from 10-12 L culture were harvested at 
3000 rpm for 5 minutes at 4 ºC in 1 L centrifuge bottles in a Beckman Coulter J-20 XP 
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centrifuge. Pellets were collected, snap frozen by squirting from a syringe into liquid nitrogen, 
and stored at -80 ᵒC. Cells were lysed while frozen by homogenization in a Waring blender 
equipped with a stainless steel vessel in the presence of a small volume of liquid nitrogen. 
Blending was for 15 seconds and the resulting frozen lysate was thawed into 3 ml of buffer A 
(0.1 M KOAc pH 7.5, 2 mM MgOAc, 4 mM HEPES KOH pH 7.4, 0.5 mM PMSF, 3 mM 
DTT). Lysates were centrifuged at 6000 rpm for 15 minutes at 4 ºC in JA20 Beckman tubes. 
The clear supernatant was collected and centrifuged again at 29000 rpm for 35 minutes at 4 ºC 
in  a Beckman Ti80 ultracentrifuge rotor. Following this step, the clear middle layer of the 
resulting supernatant was recovered from the tubes and loaded into a 100 ml  sephadex G25 
column equilibrated in 1X buffer A containing 14 % v/v glycerol. Fractions were collected 
every 2 minutes, and samples with highest OD260 were pooled, aliquoted and snap frozen at -
80 ᵒC. Alternatively, the clear fraction from the ultracentrifugation step was loaded onto Zeba 
spin desalting columns (Thermofisher Scientific), according to the manufacturer’s instructions. 
Protein fractions were collected and frozen as above. 
 
2.5.2 In vitro transcription 
  Capped mRNA templates used for in vitro translation were generated from DNA 
templates, using a commercial kit (RiboMAX™ Large Scale SP6, Promega). Plasmid DNA, 
encoding the desired 2A reporter, was linearized using an appropriate restriction enzyme to be 
used as a template, purified by PCI, precipitated with ethanol and re-suspended in an 
appropriate volume of RNAase-free water. Transcription reactions were assembled according 
to the manufacturer recommendations as follows in table 2.8: 
 
 
Component Qty (µl) 
5X SP6 transcription buffer 4 
rNTPs (25 mM ATP, CTP, UTP and 
3 mM GTP) 
4 
DNA template 2 (5-10 µg) 
40 mM Ribo cap analog (Promega) 1.5 
enzyme mix  2 
RNAase-free water 
To final 
volume 20  
                 
Table 2.8: The components of RNA transcription reactions. 
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Reactions were incubated at 37 ºC for 4-5 hours. RNA was then extracted with PCI, precipitated 
with ethanol and re-suspended in RNAase-free water. RNA concentration was estimated using 
a Nanodrop spectrophotometer (ThermoFisher), and integrity checked by mixing 2-4 µg with 
RNA-loading dye (90% v/v formamide, 0.5% w/v EDTA, 0.1% v/v xylene cyanol, 0.1% w/v 
bromphenol blue), heating at 65 ºC for 5 minutes and resolving on pre-warmed 20X20 cm 6% 
w/v acrylamide 8 M urea 1X TBE gels. Gels were run at 20 W for 2-3 hours. RNA was 
visualized by staining with ethidium bromide (1 µg/ml). 
2.5.3  Translation reactions 
Yeast translation competent extracts and in vitro transcripts (sections 2.5.1 & 2.5.2) 
were used for in vitro translation. Endogenous mRNAs in yeast extracts were degraded by 
treatment with micrococcal nuclease: 4.2 μl micrococcal nuclease (20000 U/ml), 5.6 μl of 0.1 
M CaCl2 were added to 1 ml of yeast extract which was then incubated at room temperature for 
20 minutes. 14 μl of 0.1 M EGTA were then added and the extract mixed and aliquoted (50 
μl/tube), and the aliquots snap frozen and kept at -80 ºC. A 6X buffer was used for in vitro 
translation prepared as follows in table 2.9: 
 
Component Qty. 
(μl) 
1M HEPES. KOH pH 
7.4 
66 
1M MgOAc 6 
800 mM Creatine 
Phosphate 
93.8 
100 mM ATP 2.25 
100 mM GTP 3 
1 mM amino acid 
mixture without Met 
120 
1M DTT 5.1 
dH2O 183.6 
 
Table 2.9: The ingredients used to prepare 6X in vitro translation buffer. 
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7 μl [35S] labelled Met EasyTag, Perkin Elmer, 10.25 mCi/ml) and 3 μl CPK (10 mg/ml in 50% 
v/v glycerol, Sigma Aldrich) were added to 25 µl of 6X buffer and the translation reaction was 
assembled as follows in table 2.10: 
Component Qty. (µl) 
1M KOAc  1.2 
yeast extract  3.3 
mRNA 3.2 (1 µg) 
6X buffer plus CPK and 35S labelled 
Met 2.3 
 
Table 2.10: The reaction components of an in vitro translation reaction. 
Reactions were incubated for 30 minutes at room temperature. 10 µl of protein loading dye (80 
mM Tris-HCl, 10% v/v glycerol, 0.0006% w/v bromophenol blue, 0.1 M DTT) were added to 
the samples which were heated at 65 ºC for 5 minutes and loaded onto SDS-PAGE gels. 
Following electrophoresis, gels were fixed and stained with Coomassie brilliant blue (0.1% w/v 
Coomassie brilliant blue R-250, 50% v/v methanol, 10% v/v glacial acetic acid) for 15 minutes 
and de-stained for 2 hours using de-staining solution (50% v/v methanol, 10% v/v glacial acetic 
acid). Gels were dried using a vacuum drier, exposed to phosphor storage screens, which were 
scanned in a phosphorimager (Typhoon Trio, GE Healthcare). 
2.6 Flow cytometry 
Yeast cells were exposed to cell sorting and flow cytometry to measure the GFP 
fluorescence in different constructs. Strains expressing GFP reporters were grown overnight in 
selective media, diluted in the morning, and allowed to grow again to OD600 ~0.5. A volume 
corresponding to 5X OD600 was harvested at 3000 rpm for 5 minutes in a Beckman J-6 
centrifuge. Pellets were washed in sterile PBS, and re-suspended in 1 ml PBS. Suspensions of 
cells were sonicated (MESONIX SONICATOR 3000), on 0.5 mA for 10 seconds per sample. 
Cells then were exposed to the cell sorting using a Fortessa X20 cell analyzer. The equipment 
was set up according to the GFP standard parameters. This was performed with the excitation 
set at 488 nm and the emission at 520 nm to detect GFP fluorescence. Fluorescein channel was 
used for sorting target cells in the total number of cells (40,000 events per second) and GFP 
gating to calculate the GFP-positive cells numbers, keeping the sample flow constant. 
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3 CHAPTER 3: INVESTIGATING THE ROLES OF 
RIBOSOME-ASSOCIATED FACTORS IN 2A REACTION. 
3.1 Introduction 
As discussed (introduction section 1.9), It had suggested that eRF1 and 3 might be 
required for the 2A reaction (Doronina et al., 2008), whereas a more recent paper (Machida et 
al., 2014) found that eRFs are not required for the 2A reaction, but instead suggested that the 
2A reaction is an elongation event. The premise of work carried out in this thesis was that eRF1 
and 3 are essential for the 2A reaction. Thus, as a first step in this project, the effect of reducing 
levels of eRFs on the 2A reaction was investigated. Furthermore, experiments were carried out 
to investigate prospective roles of eEFs. Alongside translation factors, other proteins have been 
shown to influence termination efficiency. These include ABCE1/Rli1 and eIF3j/Hcr1. These 
are also examined in this chapter for involvement in the 2A reaction. eIF3j is loosely associated 
with the core initiation factor eIF3, facilitating the formation of the 43S pre-initiation complex 
and hence scanning for the appropriate AUG. However, hcr1 yeast strains have increased stop 
codon read-through, and this can be suppressed by over-expression of Rli1, which 
concomitantly suppresses the cold-sensitive phenotype of these cells. This led to the conclusion 
that a key role of this protein is in promoting dissociation of eRF3 from the termination complex 
thereby, promoting binding of ABCE1 (Beznoskova et al., 2013). 
Further factors examined in this chapter are Dom34, Hbs1 and Ski7, all of which are required 
in mechanisms that rescue ribosomes during abnormal translation such as NSD and NGD. Since 
ribosomes pause at 2A, we reasoned that factors which could influence the 2A reaction are 
those that resolve stalled ribosomes. Dom34 and Hbs1 are key factors in this context. These are 
eRF1- and eRF3-related proteins that are important for resolving stalled ribosome-mRNA 
complexes in the NSD and NGD pathways. As mentioned earlier in the literature review, 
section 1.7, Dom34 and Hbs1 share structural similarities with eRF1 and eRF3, respectively, 
though Dom34 lacks the motifs specific for stop codon recognition and nascent peptide chain 
release (Shoemaker and Green, 2011). The Dom34:Hbs1 complex can recognise stalled 
ribosomes and, concomitantly, it recruits endonucleases to degrade the aberrant mRNA (Passos 
et al., 2009). It has been shown that the Dom34:Hbs1 complex triggers the dissociation of 
stalled ribosomes in cases of NGD (Shoemaker and Green, 2011). Rli1 is also involved in these 
pathways, particularly in dissociation of ribosomal subunits along with the Dom34-Hbs1 
complex (Kashima et al., 2014). Ski7 (Super killer protein 7) is, like Hbs1, similar to eRF3. It 
interacts via its N-terminus with the exosome on one side and the SKI complex on the other 
side, and is required for the general 3’-5’ RNA decay pathway (Jamar et al., 2017). In addition, 
it has a role in NSD, mutations to the C-terminal GTP binding domain of the protein specifically 
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affect its ability to function in this pathway where it is proposed to act competitively to 
Dom34/Hsb1 (Horikawa et al., 2016). Furthermore, Ski7 mutant cells are sensitive to 
hygromycin B, suggesting a role in translation (Kowalinski et al., 2015). 
 
3.2 Reporter of the 2A reaction 
Experiments reported in this chapter used an artificial polyprotein reporter of the 2A 
reaction. This reporter derived from a previous reporter,  αF-2A-GFP (de Felipe et al., 2003), 
has the signal sequence of the alpha factor replaced by three copies of the haemagglutinin (HA) 
epitope-tag (YPYDVPDYA). Expression of the fusion protein is driven by the inducible GAL1 
promoter in the plasmid pMW20 (Zieler et al., 1995). A control containing the non-functional 
P17A (2A*) mutation was included in all experiments to confirm the size of the full-length 
translation product. When 2A is active, the expression of this reporter in S. cerevisiae generates 
3HAαF-2A and GFP separately. In contrast, the absence of 2A activity yields the intact fusion 
protein. 2A activity is assessed through pulse-labelling and immunoprecipitation of proteins 
from cell extracts with either anti-HA or anti-GFP antibodies, followed by quantification of the 
amount of full-length translation product and separated upstream and downstream fragments 
by phosphorimaging. The pMW20 vector has a URA3 selectable marker, and to provide further 
flexibility, a second set of reporters were generated in which HIS3 was inserted into the middle 
of the URA3 gene on the pMW20 vector. A schematic figure of the reporters and the expected 
protein bands outcomes are presented in figure 3.1. 
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                            Figure 3.1: 2A reporters used in the immunoprecipitation experiments. 
 
 The 2A-containing reporter and the expected translation products are expressed from a GAL1 promoter. [PSI+] 
and [psi-] strains expressing the 3HAαF-2A-GFP reporter were pulse-labelled with [35S] methionine and cysteine, 
and translation products retrieved from cell lysates by immunoprecipitation with either anti-HA (A and B) or anti-
GFP (C and D) antibodies. Images of gels (A and C) and quantification of them (B and D) are presented. Quantified 
data are expressed as the ratio of upstream (B) or downstream (D) to total translation events. The ratio for wild 
type [psi-] (control) cells was set to 100%, and the ratio for [PSI+] cells expressed relative to this.   
 
 
3.3  Decreased eRF1 and eRF3 levels inhibit the 2A reaction 
3.3.1 Limited availability of eRF1 increases the read-through over the 2A peptide 
Three strains of S. cerevisiae were tested to address whether reducing Sup45 activity 
affects the 2A reaction. Two contained point mutations to the gene, the sup45-42 and sup45-2 
mutations (Stansfield et al., 1997), while the third contained a DAmP (Decreased Abundance 
by mRNA Perturbation) allele of sup45 (Breslow et al., 2008). The sup45-2 allele is a missense 
mutation, which imposes thermosensitivity due to loss of activity of the protein at higher 
temperatures, whereas sup45-42 is a nonsense mutation leading to expression of a C-terminally 
truncated protein lacking 27 amino acids (Stansfield et al., 1996). The truncated protein is non-
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functional and the allele is lethal in an otherwise wild type yeast strain. The strain used here 
contains a suppressor tRNA that leads to sufficient full-length Sup45 being produced to 
maintain viability.  
Initially, the Sup45 availability was tested in the DAmP-sup45 strain, through western blotting. 
This was to confirm that there is a reduction in the Sup45p expressed in this strain. DAmP-
sup45 strain, along with wild type were grown at 30 ºC and diluted on the next day for protein 
extraction (see section 2.3.2.1) and western blotting was undertaken as described in Materials 
and Methods, section 2.3.2.2. Results of protein blottings showed that there is a considerable 
reduction in Sup45 in the DAmP-sup45 strain, compared to the isogenic wild type which 
expresses the normal level of Sup45p (figure 3.2). This confirms that the DAmP-sup45 strain is 
suitable to be used to examine the effect of eRF1 on 2A reaction, due to the significant lower 
SUP45 expression. 
 
Figure 3.2: DAmP-sup45 strain produces less Rli1 protein compared to the wild type. 
Western blotting analysis was performed to examine the level of Sup45 in the DAmP-sup45 strain, against the wild 
type (JDY895). Cultures were incubated at 30 ºC and diluted on the next day, and allowed to grow again to OD600 
~0.5. Cells were harvested in 50 ml Falcon tubes at 3000 rpm for 5 minutes, using bench-top centrifuge, washed 
and lysed in native buffer using zirconium beads in a bead beater (2X, for 30 seconds each). Proteins were observed 
from lysates by centrifugation (12.000 rpm for 20 minutes at 4 ºC), and clear lysates were collected into fresh 
tubes. Protein concentration was estimated (Bradford assay), and 10-15 µg of protein was denatured by heating 
with protein loading dye at 65 ºC for 5 minutes. Protein samples were resolved onto 10% SDS-PAGE, and then 
blotted on nitrocellulose membrane. The membrane was blocked using blocking solution and exposed to the 
primary antibody (1:1000 of mouse monoclonal, Abcam), washed (3X) with TBS and exposed to the secondary 
antibody (1:2000 of mouse polyclonal, Abcam). The membrane was then washed (3X) with TBS and the protein 
signal was detected on light films through exposing the membrane to ECL. Developing the films was performed 
using auto-developer. Phosphoglycerate kinase (PGK) was used as a reference protein to ensure equal sample 
loading. Primary mouse monoclonal anti PGK antibody (1:1000) and secondary mouse polyclonal anti PGK 
antibody (1:2000) were used to detect the signal for the reference protein. 
 
      
The three strains and isogenic wild types were transformed with plasmids from which the 3HA-
αF-2A-GFP polyprotein reporter is expressed, pulse-labelled and proteins containing 2A 
peptides then immunoprecipitated from cell extracts using either anti-HA antibody to detect the 
upstream product, or anti-GFP to detect the downstream product. Immunoprecipitated proteins 
were quantified and data presented as ratios of up/downstream fragments to the whole 
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translation products (figures 3.3 & 3.4). In all cases, at least 3 independent experiments were 
carried out and the results are expressed as an average of these repeats. All assays were carried 
out with cells grown at 30 ºC. This is a permissive temperature for sup45-42. 
Initial results revealed that, excluding the sup45-42 strain which shows a reduction only in the 
upstream products, the expression of 2A-containing polyproteins in the other two strains 
revealed a highly significant reduction (P≤0.01) in the ratios of both upstream and downstream 
products of the 2A reaction to full-length extended proteins (figure 3.4).  
Reduction in the ratio of upstream fragment in the three strains tested varied, with the sup45-
42 mutation having the least effect, reducing the amount of upstream fragment to ~50%, while 
the sup45-2 and DAmP-sup45 strains reducing it to ~30% of that seen in the equivalent wild 
type strains. This effect is most readily attributed to the reduced activity of Sup45 in these 
strains, with more ribosomes then reading through the 2A peptide and elongating into the 
downstream sequences. 
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Figure 3.3: Immunoprecipitation of proteins from strains with defective eRF1. 
 
Plasmids carrying 2A signal were transformed into the indicated strains and grown in selective media with 2% w/v 
galactose before pulse labelling and immunoprecipitation. Negative controls include the empty vector in wild-type 
strain. In addition, inactive 2A (P17A), namely 2A*, was used. Pulse labelling and immunoprecipitation were 
carried out using anti-HA and anti-GFP antibodies. Samples were loaded onto SDS-PAGE, gels fixed, dried and 
exposed to phosphor exchange screen, and scanned using Typhoon scanner. (A) proteins from sup45-42 and 
sup45-2 strains with isogenic wild types, detected by anti-HA antibody. (B) proteins from sup45-42 and sup45-2 
strains with isogenic wild types, detected by anti-GFP antibody. (C) proteins from the DAmP-sup45 strain, detected 
by anti-HA antibody. (D) proteins from the DAmP-sup45 strain, detected by anti-GFP antibody. 
 
A direct consequence of ribosomes failing to undergo the first step in the 2A reaction, i.e. 
terminate translation at the Pro 19 of the 2A sequence, would be that less of the downstream 
fraction should be generated. This was the case in all three strains. For both sup45-2 and DAmP-
sup45 strains, the reduction of downstream product was similar to the reduction of upstream 
fragment. In the case of the sup45-42 strain, the upstream product was decreased significantly 
more than the downstream (figure 3.4). Putting these results together with those above 
regarding the upstream product, it can be concluded that when ribosomes are translating 2A 
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peptides, lowered eRF1 activity leads to reduce upstream and downstream proteins, suggesting 
that an increased number of ribosomes are reading-through the 2A peptide.  
 
 
Figure 3.4: Defects in eRF1 inhibit both steps of the 2A reaction. 
 
Gels from 3 experiments for each of the strains (as shown in figure 3.3) were quantified, values normalized 
according to the number of methionine and cysteine contained in each product, and the fractions of either upstream 
(A) or downstream (B) translation product out of the total translation events were calculated and expressed as a 
percentage. The average for each mutant strain is shown relative to the wild type, which is set to 100%.  * refers 
to significance (p≤0.01).
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3.3.2 eRF3 is also required for the 2A reaction 
As described in the introduction (section 1.4.3.2), termination requires a complex of 
both eRF1 and eRF3. To this point, data have confirmed that eRF1 is important for the 2A 
reaction. Here, the involvement of the second component of this complex, eRF3, was 
investigated. Levels of eRF3 in yeast are conveniently affected by the [PSI+] state. In [PSI+] 
strains, eRF3/Sup35 is present in an aggregating prion-like conformation (Derkatch et al., 
1996). This leads to reduced availability and hence activity of this essential protein. Here, a 
[PSI+] and control [psi-] strain with the same genetic background were used. In addition to the 
[PSI+]/[psi-] cells, strains expressing mutations in the GTPase domain of eRF3 previously used 
to examine the importance of eRF3 for the 2A reaction were also examined (Doronina et al., 
2008). As described above, strains were transformed with 2A reporters, pulse labelled, proteins 
immunoprecipitated and the amount of upstream, downstream and elongation product 
quantified. 
 
 Effects of limiting eRF3 on the 2A reaction 
As with strains with reduced eRF1 activity, lower abundance of eRF3 ([PSI+] strain) 
negatively affected the generation of both the upstream and downstream fragments of the 2A 
polyprotein reporter, compared to the isogenic wild type ([psi- ] strain) (figure 3.5). In the [PSI+] 
strain, both the upstream and downstream products of the reaction were reduced to ~40% of 
that seen in the [psi-] cells. This is similar to what was found with the eRF1 experiments, which 
confirms the role of both eRF1 and eRF3 in 2A reaction. 
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Figure 3.5: 2A reaction is inhibited by limited activity of eRF3. 
 
 Scans of gels were quantified, values normalized according to the number of methionine and cysteine contained 
in each product, and the fraction of free upstream (A) or downstream (B) translation product out of the total 
translation events expressed as a percentage. Values are obtained from 3 independent experiments. *refers to 
significance (p≤0.01). 
 
 Mutations within the GTPase domain of eRF3 have no effect on 2A reaction 
To further extend analysis of the involvement of eRF3, the effect of mutations in the 
GTPase domain of this protein was tested. eRF3 functions as a part of the ternary complex, 
which includes eRF1, eRF3 and GTP. This complex binds the ribosomal A site, and GTP is 
then hydrolysed by eRF3, and promotes a specific conformation of the eRF1 to contact the PTC 
and trigger the peptide release from the exit tunnel. Two specific mutations, H348Q and R419G, 
which reduce the activity of the GTPase domain of eRF3 were used here (Salas-Marco and 
Bedwell, 2004). These were generated by plasmid shuffling (materials and methods section 
2.1.1.1), transformed with the 2A reporter and analysed as described above.  
In previous analysis (Doronina et al., 2008), cells expressing these mutant eRF3 as the only 
version of the protein revealed an increase in the level of upstream product compared to the 
wild type. However, here, analysis of the strains expressing H348Q and R419G did not show 
significant effect on the production of either the upstream or downstream product. Indeed, 
values of the two sup35 alleles tested were in the same range as the isogenic wild type (figure 
3.6). This suggests that GTP hydrolysis accompanying termination at 2A peptide is catalysed 
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by eRF3, but in a slightly different scenario than that seen in the canonical termination, due to 
the special conformation undergoen mainly by eRF1 at a sense (Pro) codon. 
 
 
Figure 3.6: Mutations in the GTPase motif of eRF3 do not affect the 2A reaction. 
 
Gels of relevant protein samples were quantified, values normalized according to the number of methionine and 
cysteine contained in each product, and the fraction of free upstream (A) or downstream (B) translation product 
out of the total translation events was calculated. Values are obtained from 3 independent experiments and 
expressed as means±SE. 
 
To this point, we have confirmed that both eRF1 and eRF3 are required for the 2A reaction, 
although these results may suggest different features for proteins, particularly eRF3, from that 
involved in the canonical translation, in the presence of a stop codon in the ribosomal A site. 
Thus, how do release factors mediate the 2A reaction? Further investigations will be performed 
to address the roles of translational termination factors in the 2A reaction. 
 
3.4 Investigating the involvement of further termination factors and ribosome-rescue 
factors in the 2A reaction  
Beyond eRF proteins, several other factors that influence termination (ABCE1/Rli1, 
eIF3j/Hcr1) are required for the rescue of stalled ribosomes (Dom34, Hbs1,  and Ski7) (see 
introduction sections 1.7). None of these had previously been tested to investigate whether they 
are required for or influence the efficiency of the 2A reaction. For this analysis, strains lacking 
these factors, through deletion of the respective gene, were used. An exception was Rli1, which 
is an essential factor, and a strain from the DAmP strain collection (Breslow et al., 2008; Finkel 
et al., 2011) expressing reduced levels of the protein was used. Rli1 level was investigated in 
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the DAmP-rli1 strain using western blotting, and results revealed that this strain produces less 
amount of Rli1 in comparison with the wild type strain, which expresses the normal level of 
protein, that is essential to undergo the biological functions in the ribosome (figure 3.7). 
 
 
Figure 3.7: DAmP-rli1 strain produces less Rli1 protein compared to the wild type 
strain. 
Western blotting analysis was performed to examine the level of Rli1 in the DAmP-rli1 strain , against the wild 
type strain (JDY895). Cultures were incubated at 30 ºC and diluted on the next day, and allowed to grow again to 
OD600 ~0.5. Cells were harvested in 50 ml Falcon tubes at 3000 rpm for 5 minutes, using bench-top centrifuge, 
washed and lysed in native buffer using zirconium beads in bead beater (2X, for 30 seconds each). Proteins were 
observed from lysates by centrifugation (12.000 rpm for 20 minutes at 4 ºC), and clear lysates were collected into 
fresh tubes. Protein concentration was estimated (Bradford assay), and 10-15 µg of protein was denatured by 
heating with protein loading dye at 65 ºC for 5 minutes. Protein samples were resolved onto 10% SDS-PAGE, and 
then blotted on nitrocellulose membrane. The membrane was blocked using blocking solution and exposed to the 
primary antibody (1:1000 of mouse monoclonal, Abcam), washed (3X) with TBS and exposed to the secondary 
antibody (1:2000 mouse polyclonal. Abcam). The membrane then was washed (3X) with TBS and the protein 
signal was detected on light films through exposing the membrane to ECL, and developing the films was performed 
using auto-developer. Phosphoglycerate kinase (PGK) was used as a reference protein to ensure equal loading. 
Primary mouse monoclonal anti PGK antibody (1:1000) and secondary mouse polyclonal anti PGK antibody 
(1:2000) were used to detect the signal for the reference protein. 
 
 
To investigate whether these factors play a role in the 2A reaction, mutant strains and isogenic 
wild types were transformed with a plasmid from which the HA-αF-2A-GFP reporter was 
expressed, and analysed similarly to the strains limited for eRF activity. Example images of 
SDS-PAGE gels on which immunoprecipitated proteins were run and bar graphs representing 
ratios of upstream/downstream to the full-length averaged for 3 independent experiments are 
shown in figures 3.8 & 3.9.  
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Figure 3.8: Immunoprecipitation of proteins from cells lacking/ limited in termination 
and ribosomal rescue factors. 
 
Plasmids expressing HA-αF-2A-GFP or the non-active 2A* were transformed into the indicated strains which 
were grown in selective media with 2% w/v galactose to induce the GAL1 promoter before pulse labelling and 
immunoprecipitation with either anti-HA (A) or anti-GFP (B) antibodies. Samples were loaded onto SDS-PAGE, 
gels fixed, dried and exposed to phosphor exchange screen, and scanned using Typhoon scanner.  Note that the 
contrast of the DAmP-rli1 strain immunoprecipitations was altered compared to the other lanes as the signal was 
relatively weak in this experiment.  
 
 
 
 
 
 
 
A                                                            
B                                                           
HA-F-2A-GFP 
GFP 
2A* 
WT 
2A 
HA-F-2A-GFP 
HA-F-2A 
2A* 
WT 
2A 
71 
 
 
 
Figure 3.9: Quantification of protein bands observed from strains lacking/ limited in  
termination and ribosomal rescue factors. 
  
Gels from 3 experiments for each of the strains (as shown in figure 3.8) were quantified, values normalized 
according to the number of methionine and cysteine contained in each product, and the fractions of either upstream 
(A) or downstream (B) translation product out of the total translation events were expressed as a percentage. The 
average for each mutant strain is shown relative to the wild type, which is set to 100%.    * refers to significance 
(p≤0.01). 
 
 
From the data presented in figure 3.9, no evidence for the majority of factors analysed being 
involved in the 2A reaction was found. The fraction of ribosomes undergoing the 2A reaction 
is statistically similar in all strains analysed, which has been observed with the anti-HA, and/ 
or anti-GFP antibodies. Strains with DAmP-rli1, or lacking dom34, hcr1 or hbs1 have revealed 
an insignificant increase in the downstream product compared to the wild type strain. An 
exception has been observed here, which is the ski7Δ strain. Specifically, in this strain, the 
relative amount of downstream product is doubled. In general, it is unlikely that the ribosome 
generates more downstream fragments than the upstream. However, if there is less downstream 
product, it would indicate ribosomal drop off, then an increase of outcomes of the second part 
of the 2A reaction could be explained as a result of re-initiation, which may become more 
efficient in the absence of Ski7. This would then imply that normally Ski7 interferes with the 
completion of the 2A reaction.   
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To briefly sum up the above results, deletion of ribosomal factors including Hbs1, Dom34 and 
Hcr1 in yeast does not alter 2A activity. Moreover, limiting the availability of Rli1 also had no 
significant effect on the 2A reaction, suggesting that these factors are not required for the 
translational recoding event driven by the 2A peptide. On the other hand, deletion of Ski7 
increased both upstream and downstream products ratios, which may reflect a certain effect on 
the ribosome, possibly the absence of this factor during translation of 2A promotes the re-
initiation of ribosomes stalled at the C terminus of the 2A peptide. These effects will be 
followed with more investigations for deeper insight. 
 
3.5 Investigating growth rates of strains overexpressing 2A-encoding   mRNA 
  It has been shown that overexpression of a 2A-containing polyprotein (from a GAL1 
promoter) inhibits the growth of strains with limited release factor activity (Doronina et al., 
2008). The reason for this is not clearly understood, though it has been suggested that the 
presence of multiple copies of the 2A-containing mRNA may somehow titrate the remaining 
available release factors. This is perhaps through affecting the conformation of release factors 
when they are released from the ribosome such that they take longer to be recycled.  To 
complement the labelling and immunoprecipitation experiments, growth profiles of the same 
strains used in immunoprecipitations when the same 2A-containing reporter was expressed 
were generated and compared with the growth of the same strain in the presence of the 2A*-
containing control reporter. 
 
3.5.1 The overexpression of 2A-containing proteins inhibits the growth of cells with 
defective eRF1 
Strains containing the sup45-42, sup45-2 and DAmP-sup45 alleles, used for 
immunoprecipitation experiments in section 3.3.1, were used here. Strains were transformed 
with plasmids from which the HA-αF-2A/A*-GFP reporters is expressed from the inducible 
GAL1 promoter. Growth curves were generated from the strains on expression of the reporters 
and this revealed that while the overexpression of reporters did not perturb growth of the wild 
type strain, the 2A-, but not 2A*-containing reporter resulted in a reduction in growth of the 
sup45-42, sup45-2 and DAmP-sup45 strains (table 3.1). This is charactarised by a significant 
increase in doubling time in strains expressing 2A peptide, compared to the same strain 
expressing 2A* (inactive 2A). Interestingly, the DAmP-sup45 strain grew significantly slower 
than other strains (doubling time~300% of the wild type). Doubling time was also increased 
significantly in the sup45-2 strain expressing 2A compared to the wild type, whereas the 
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elevation observed in the sup45-42 strain was not significant, probably due to the high 
significance level used in our study (p≤0.01).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: Growth doubling time in strains with defective eRF1 while expressing 2A 
peptide 
 
Strains with defects in eRF1 (Sup45) which includes, DAmP-sup45, sup45-42 and sup45-2, were transformed with 
2A and 2A*-containing reporters (pJNY278 and 279), and grown overnight at 30 ºC in selective media. Cultures 
were diluted on the next day with the same media plus 2% w/v galactose to induce the GAL1 promoter of the 2A 
reporter. OD600 was recorded every one hour for eight hours, and data were processed to find the doubling time 
for each strain expressing active 2A, and normalised to the doubling time of the strain expressing 2A*. Averages 
of 3-4 independent experiments are presented above ± standard error. (A) Table of doubling time values. (B) Chart 
of values corresponding to A. * refers to significance p≤0.01. 
 
 
3.5.2  Growth rates of strains lacking/limited in ribosome-rescue factors  
Strains investigated for their prospective effect on 2A reaction, by means of 
immunoprecipitation, were subjected here to measurement of growth rate when the HA-αF-
2A/A*-GFP mRNAs were expressed in them. Comparison of each strain was achieved through 
comparing data of each active and inactive 2A of the same strain. 
 
 
 
 
 
 
 
 
 
 
Strain 
Expressing 
2A 
Growth Doubling 
Time (%) 
(mean±SE) 
WT 107.287± 4.90 
DAmP-sup45 295.034± 13.48* 
sup45-42 143.914± 6.57 
sup45-2 175.403± 8.01* 
A                                                          B 
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Figure 3.11: Growth doubling time of strains with defects in some ribosomal factors while    
expressing 2A peptide. 
 
Strains with defects in several ribosomal factors (JDY1253-1257)  which includes, DAmP-rli1, dom34Δ, hbs1Δ, 
eif3jΔ and ski7Δ, were transformed with 2A and 2A*-containing reporters and grown overnight at 30 ºC in selective 
media. Cultures were diluted on the next day with the same media plus 2% w/v galactose to induce the GAL1 
promoter of the 2A reporter. OD600 was recorded every one hour for eight hours, and data were processed to find 
the doubling time for each strain expressing active 2A, and normalised to the doubling time of the strain expressing 
2A*. Averages of 3-4 independent experiments are presented above ± standard error. (A) Table of doubling time 
values. (B) Chart of values corresponding to A. 
 
Growth profiles of the strains reveal no effect of the 2A peptide overexpression on doubling 
time: each strain grew at a similar rate with the active and inactive 2A peptides (table 3.2, figure 
3.11). Thus the presence of mRNA encoding 2A in strains lacking Dom34, Hbs1, eIF3j/Hcr1, 
Ski7 or limited for ABCE1/Rli1 does not compromise growth in the way seen with cells limited 
for eRFs. From these and the immunoprecipitation data, it has been confirmed that the ribosome 
can maintain normal 2A reaction in S. cerevisiae, even when cells lack one of these factors. 
Thus, Dom34, Hbs1, Rli1, Hcr1 or Ski7 are not required to promote a normal 2A reaction in 
yeast cells. 
 
3.5.3       Limited activity, but not GTPase mutations, of eRF3 inhibits the growth of    
cells overexpressing 2A peptide 
Growth profiles of both [PSI+] and [psi-] strains, along with strains with mutations in the 
GTPase domain of eRF3, were measured while expressing HA-αF-2A/A*-GFP (table 3.3. 
figure 3.12). The [PSI+] strain grew slower when HA -αF-2A-GFP was expressed. On the other 
hand, the overexpression of active 2A peptide in strains carrying H438Q or R419G mutations 
in sup35 did not alter the growth profile of cells compared to the strain expressing the inactive 
2A peptide (2A*).  
Strain 
Expressing 
2A 
 Growth Doubling 
Time (%) 
(mean±SE) 
WT 111.239± 5.08 
dom34Δ 112.514± 5.14 
DAmP-rli1 143.322± 6.54 
hbs1Δ 132.509± 6.05 
eif3jΔ 113.075± 5.16 
ski7Δ 111.860± 5.11 
A                                                           B 
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Figure 3.12: Growth doubling time of strains with defective eRF3 (Sup35) while                                                              
expressing 2A peptide.                                                         . 
 
Strains with defects in eRF3 (Sup35) namely, [PSI+] (JDY832) in addition to two mutations in GTPase domain of 
sup35 which are, H438Q and R419G (JDY838 and 839), along with the wild type, [psi-] (JDY832) were 
transformed with 2A and 2A*-containing reporters (pJNY278 and 279) and grown overnight at 30 ºC in selective 
media. Cultures were diluted on the next day with the same media plus 2% w/v galactose to induce the GAL1 
promoter of the 2A reporter. OD600 was recorded every one hour for eight hours, and data were processed to find 
the doubling time for each strain expressing active 2A, and normalised to the doubling time of the strain expressing 
2A*. Averages of 3-4 independent experiments are presented above ± standard error. (A) Table of doubling time 
values. (B) Chart of values corresponding to A. * refers to significance (p≤0.01). 
 
 
Data shown in table 3.3 and figure 3.12 are consistent with the outcomes of 
immunoprecipitation experiments using the same strains. The overexpression of a functional 
2A peptide in the [PSI+] strain, within which much of the eRF3 in the cell is inactive, strongly 
inhibited the growth of this strain, compared to the expression of a non-functional 2A peptide 
(2A*), which is detected by the significant increase in the doubling time of [PSI+] strain 
expressing 2A. On the other hand, no influence of 2A peptide expression, in terms of growth, 
was detected in strains expressing mutations in the eRF3 GTPase domain. To this point, it has 
been confirmed that the limited availability of eRF3, which has been examined in the strong 
[PSI+] strain, inhibits the 2A reaction, and one consequence of this effect is an inhibition of the 
growth rate of this strain, compared to the equivalent [psi-] strain. 
 
3.6 Elongation factors are also involved in the 2A reaction 
In this section, the prospective roles of eEF1α and eEF1β in the 2A reaction were 
analysed. The second step of the 2A reaction requires the ribosome to proceed, with the Pro 19 
codon encoding the first amino acid of the downstream protein. Following the termination 
reaction that releases the upstream product, this is in the A site, and presumably prolyl-tRNAPro 
must bind to it and then be translocated to the P site. Prolyl-tRNAPro will associate with the 
ribosome in complex with eEF1-GTP and translocation requires eEF2 (see introduction section 
1.4.2). In previous work (J Brown, F Yan and E Leung unpublished), a number of mutations in 
Strain 
Expressing 
2A 
 Growth Doubling 
Time (%) 
(mean±SE) 
R419G 118.537± 5.41 
H438Q 105.340± 4.81 
[PSI+] 193.367± 14.51* 
[psi-] 112.248± 5.12 
A                                                           B 
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eEF2 were found not to affect the 2A reaction. Therefore here the focus was on eEF1.  Strains 
of S. cerevisiae with reduced levels of eEF1For eEF1eEF1Bγ) (the G-nucleotide 
exchange factor for eEF1) were used to investigate the effects of these factors on the 2A 
reaction. In the case of eEF1 a DAmP allele was used, whereas for eEF1 a strain lacking 
one copy (tef1) of this duplicated gene was used. These two strains, along with the isogenic 
wild types, were transformed with plasmids from which the HA-αF-2A/A*-GFP reporters were 
expressed from the GAL1 promoter.  Cells were grown and pulse labelled, proteins were 
extracted and immunoprecipitated with anti-HA and anti-GFP antibodies (figure 3.13).  
 
 
Figure 3.13: Reduction of eEF1 activity inhibits the second step of the 2A reaction. 
Gels from 3-5 independent experiments for each of the strains indicated were quantified and compared to the WT 
strain (JDY895). Values normalised according to the number of methionine and cysteine contained in each product, 
and the fractions of either upstream (A) or downstream (B) translation product out of the total translation events 
were expressed as a percentage ± standard error. The average for each mutant strain is shown relative to the wild 
type strain, which is set to 100%.    * refers to significance (p≤0.01). 
 
 
The reduction in levels of either eEF1α or its exchange factor eEF1β had no effect on the 
generation of the upstream fragments of the 2A reporter during the first step of the reaction, but 
in both strains the amount of downstream product produced was significantly reduced (figure 
3.13). These data are consistent with the first part of the reaction being a termination step (and 
hence not requiring elongation factors) but that the restart to translation after release of the 
upstream product is particularly sensitive to abundance of the ternary complex prolyl-tRNAPro-
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eEF1-GTP. Limiting the availability of this complex through either of the routes used reduced 
the amount of downstream fragment by ~30%, leaving the ribosome stalled at the C-terminus 
of the 2A peptide.   
 
3.7 Overexpression of SUP45 and RLI1 enhances the 2A reaction in S. cerevisiae 
It has been found that the overexpression of Rli1 improves the efficiency of canonical 
termination, even when cells are mutants or deficient in one or more factor (Khoshnevis et al., 
2010). Here, the effect of overexpressing Rli1 or eRF1 on the 2A reaction has been investigated 
using a centromeric plasmid expressing Rli1 or Sup45 from GAL1 promoter (kind gift of Prof. 
D. Lydall, Newcastle). The SUP45/RLI1 genes in the plasmids mentioned above are His-tagged, 
which enabled testing the efficiency of the overexpression of such gene through western 
blotting. Both strains (DAmP-sup45 and DAmP-rli1) were transformed with plasmids encoding 
SUP45/RLI1 genes, and proteins were extracted to undergo western blotting. RLI1 was 
overexpressed in both DAmP-sup45 and DAmP-rli1 strains, whereas sup45 was only 
overexpressed in the DAmP-sup45 strain, as the previous examination of the DAmP-rli1 strain, 
undergone by immunoprecipitation, did not show effects on the 2A reaction (figure 3.9). 
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Figure 3.14: Western blotting of SUP45 and RLI1 overexpression. 
Plasmids encoding SUP45 and RLI1 genes (Professor D. Lydal lab), under a GAL1 promoter and with a His tag, 
were transformed into strains limited in these genes (JDY1296 and 1257). Cultures of these strains, along with the 
appropriate wild type (JDY895) were incubated in selective media with 2% w/v raffinose as a source of carbon at 
30 ºC, and diluted on the next day using the same media but with 2% w/v galactose, and allowed to grow again to 
OD600 ~0.5. Cells were harvested in 50 ml Falcon tubes at 3000 rpm for 5 minutes, using bench-top centrifuge, 
washed and lysed in native buffer using zirconium beads in bead beater (2X, for 30 seconds each). Proteins were 
observed from lysates by centrifugation (12.000 rpm for 20 minutes at 4 ºC), and clear lysates were collected into 
fresh tubes. Protein concentration was estimated (Bradford assay), and 10-15 µg of protein was denatured by 
heating with protein loading dye at 65 ºC for 5 minutes. Protein samples were resolved onto 10% SDS-PAGE, and 
then blotted on nitrocellulose membrane. The membrane was blocked using blocking solution and exposed to the 
primary antibody (1:1000 of mouse monoclonal anti His antibody, Abcam), washed (3X) with TBS and exposed 
to the secondary antibody (1:2000 of mouse polyclonal anti His antibody, Abcam). The membrane then was 
washed (3X) with TBS and the protein signal was detected on light films through exposing the membrane to ECL, 
and developing the films using auto-developer. Phosphoglycerate kinase (PGK) was used as a reference protein to 
ensure equal loading. Primary mouse monoclonal anti PGK antibody (1:1000) and secondary mouse polyclonal 
anti PGK antibody (1:2000) were used to detect the signal for the reference protein. 
 
As seen in figure 3.14, the overexpression of both SUP45 and RLI1 genes in strains limited in 
these genes, induced by DAmP feature, increased the amount of protein detected by western 
blotting compared to the appropriate wild type strain, which expresses the normal level of the 
protein with no overexpression. Obviously, the expression of these genes from an inducible 
(GAL1) promoter has an efficient effect to increase the protein abundance over that seen in the 
wild type, which can overcome the effects observed by limiting the studied factors in the DAmP 
strains.  
 Now, to examine the effects of gene overexpression in DAmP strains stated above, the same 
strains used in western blotting (figure 3.14) were then transformed with the 2A reporters with 
HIS3 as a selective marker. Pulse labelling and immunoprecipitation were performed as 
described in earlier sections.  
 
3.7.1 Overexpression of SUP45 in S. cerevisiae 
The overexpression of eRF1 from an inducible promoter restored the efficiency the 2A 
reaction caused by reduced expression in a strain containing the DAmP-erf1 allele to a similar 
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amount to that seen in a wild type strain (figure 3.15). A significant increase in both upstream 
and downstream products was observed, compared to the control strain, where no eRF1 
overexpression was induced. In contrast, overexpressing eRF1 did not increase the efficiency 
of the reaction in a wild type strain. A previous study has shown that overexpression of eRF1 
does not reduce stop codon read-through (Salas-Marco and Bedwell, 2004), and this suggests 
that for both canonical termination and the 2A reaction eRF1 is not limiting. In yeast, eRF1 
overexpression did not alter the 2A reaction in strains lacking eef1α, or ski7 or limited in eef1β 
(figure 3.15). This may indicate an independence of these factors to drive a 2A reaction far from 
termination factors, and for eEF1 with this factor affecting a different step (restart to 
translation).  
 
 
 
Figure 3.15: Overexpression of eRF1(SUP45) enhances the 2A reaction in strains with limited 
Sup45p. 
  A plasmid encoding the SUP45 gene, expressed from the GAL1 promoter, was transformed in the above strains, 
which are limited/lacking one factor, and expressing 2A reporter from a plasmid. Cultures were grown in selective 
media with 2% w/v galactose. Pulse labelling,  immunoprecipitation and quantification of protein bands were 
performed as described above. (A) Quantification of the upstream product. (B) Quantification of the downstream 
product. * refers to significance (p≤0.01). 
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3.7.2 Overexpression of RLI1 in S. cerevisiae 
Here, the overexpression of Rli1 was tested in several strains including, DAmP-sup45, 
rli1 DAmP, ski7Δ, eef1αΔ, DAmP-eef1β as well as isogenic wild type cells. Reduction of Rli1 
levels does not reduce the efficiency of the 2A reaction (figure 3.9) and this was also seen here. 
Overexpression of RLI1 from the GAL1 promoter in wild type cells and the DAmP-rli1 strain 
did not alter the efficiency of the 2A reaction. Thus Rli1 is not limiting for the efficiency of the 
reaction. However, overexpression of RLI1 (ABCE1) led to an increase in 2A activity in cells 
with reduced eRF1 (DAmP-sup45) activity. This increased activity was detected by increased 
upstream and downstream products generated from the ribosome. In cells with reduced eEF1 
activity, in which generation of the downstream fragment of the 2A reaction is reduced, 
overexpression of RLI1 compensated for this defect, especially in cells with reduced levels of 
eEF1. This suggests that while Rli1 may not be a limiting factor for the first step of the 2A 
reaction, when the ternary prolyl-tRNAPro-eEF1-GTP complex is limiting, efficient completion 
of the first step of the 2A reaction/release of termination factors from the ribosome by the action 
of Rli1 promotes completion of the whole reaction (figure 3.16). Finally, the overexpression of 
RLI1 had no effect on cells lacking Ski7, which has already been found to increase the ratios of 
the smaller fragments of the 2A reporter. The above results confirm that Rli1 plays an essential 
role in ribosomes translating ORFs with 2A peptides although limiting the abundance of Rli1 
in cells overexpressing 2A reporter did not affect the 2A activity. 
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Figure 3.16: Overexpression of RLI1 enhances the 2A reaction in strains limited in Sup45p 
and eEF1. 
A plasmid encoding RLI1 gene, expressed from the GAL1 promoter, was transformed in the above strains, which 
are limited/lacking one factor, and expressing 2A reporter from a plasmid. Cultures were grown in selective media 
with 2% w/v galactose. Pulse labelling,  immunoprecipitation and quantification of protein bands were performed 
as described above. (A) Quantification of the upstream product. (B) Quantification of the downstream product. * 
refers to significance (p≤0.01). 
 
3.7.3 The overexpression of SUP45 and RLI1 improves the growth of the strain with 
defective eRF1 
              In this section, the growth rate of the strain limited in erf1 (DAmP strain) is measured  
against the overexpression of eRF1 and RLI1 in this strain. It was shown that the 2A activity is 
significantly diminished in S. cerevisiae cells limited in the availability of eRF1. Furthermore, 
in sections 3.7.1 and 3.7.2, data confirm the role of RLI1 and SUP45 overexpression in 
enhancing the activity of 2A peptide in those cells, achieved by immunoprecipitation.  To 
perform this part, the same strains used in experiments stated in sections 3.7.1 and 3.7.2 have 
been subjected to the growth rate measurement, as described earlier. 
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Figure 3.17: The overexpression of SUP45 and RLI1 improves the growth of cells limited for 
eRF1 cells while expressing 2A peptide. 
 
The indicated strains were grown in selective media, containing 2% w/v raffinose and diluted in the morning using 
the same media in addition to 2% w/v galactose to induce the GAL1 promoter. Growth rate was measured in the 
DAmP-erf1 strain, with and without overexpression of SUP45 and RLI1, through measuring the OD600 every 1 
hour. Data are plotted on a semi logarithmic chart. 
 
As shown in figure 3.17, overexpression of eRF1 improved the slow growth rate of the DAmP-
sup45 strain. This is consistent with the GAL1-SUP45 allele restoring levels of the eRF1 
protein. Intriguingly, overexpression of RLI1 in these cells had a similar effect which confirms 
the recruitment of Rli1 to the ribosome along with eRF1 and 3 to maintain a normal 2A reaction. 
Although the limited availability of this factor did not influence the reaction, it seems that a 
significant ratio of ribosomes fail to undergo termination at Pro19 unless Rli1 is recruited to the 
ribosome. This suggests that over-expression of eRF1 suppressed the ‘titration’ effect of the 
2A-encoding mRNA on eRF1 availability in these cells.  
 
3.8 Discussion 
3.8.1 Ribosome rescue factors, Rli1 and eIF3j, are not required for the 2A reaction 
One aspect of this study was to investigate whether several factors associated with 
termination and ribosome rescue are involved in the 2A reaction. The factors tested were 
Dom34, Hbs1, Rli1, eIF3j (Hcr1) and Ski7. Experiments carried out were both pulse-labelling 
and immunoprecipitation to examine the 2A reaction itself and growth curves to assess whether 
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it is affected by the expression of a 2A-containing mRNA. Data presented in section 3.4 
regarding immunoprecipitation of 2A-containing polyprotein reporters and growth curves 
respectively, showed that no effects on the 2A reaction have been found in cells lacking Dom34, 
Hbs1, Hcr1 or limited in Rli1 abundance. Specifically, the 2A reaction occurred with similar 
efficiency and the growth rate of these cells was unaffected by the expression of a 2A-
containing mRNA, when compared to the wild type control. One exception has been detected 
here, which is Ski7. The absence of this factor led to an increase in both steps of the 2A reaction, 
which may suggest a role of this factor in promoting ribosomes to read through the 2A site, 
removing ribosomes, and/or degrading the mRNA when they are stalled at the C-terminus of 
the 2A peptide. Given the known role of Ski7 in NGD and its importance in coupling 
recognition of the defective mRNA to degradation, it is perhaps more likely to be involved in 
suppressing the 2A reaction by removal of ribosomes/mRNA before the first step of the reaction 
or between the first and second steps. Ski7 is proposed to bind an empty A site on the ribosome, 
which may occur more frequently than during normal translation when ribosomes arrive at the 
2A site since prolyl-tRNAPro does not have a productive interaction with the ribosome and the 
interaction of eRF1 with the ribosome is non-canonical. Thus, the absence of Ski7 may allow 
ribosomes to be more likely to undergo both steps of the reaction. Furthermore, the growth rate 
for these strains was not altered during 2A overexpression.  
Depletion of Rli1 increases the read-through along stop codons (Khoshnevis et al., 2010). 
Structural models of Rli1 have shown that it binds to the same site as eRF3, interacting with 
the C-terminus of eRF1, and that it promotes the placement of the GGQ motif of eRF1 in the 
PTC (Becker et al., 2012). As Rli1 is crucial for yeast survival, a DAmP-rli1 strain was used. 
Since Rli1 is required for normal translation termination, it would be reasonable to expect that 
a decreased availability of this protein (as in the DAmP allele) would also affect the 2A reaction. 
However, given the unusual nature of the 2A reaction and the likely negative effect of ribosomal 
dissociation, also promoted by Rli1, it may be that this factor is not involved or indeed could 
promote ribosomes dissociating at 2A rather than continuing to translate the downstream 
product. A further experiment that sheds light on this was overexpression of RLI1 and testing 
the outcome of translation through 2A. This revealed a significant improvement of the 2A 
reaction in the DAmP-sup45 strain, which underlines this factor as a contributor in the 2A 
reaction, although the limited availability of this factor did not affect such step of the 2A 
reaction.    
Dom34 and Hbs1 promote ribosomal subunit dissociation during NGD and/or NSD, and this 
activity is directed by Rli1. Given that ribosomes pause temporarily at 2A (Doronina et al., 
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2008), it is possible that these factors could be recruited to and either interfere with the normal 
reaction or be part of the mechanism of the 2A reaction. In the current model of the 2A reaction, 
where there is no need for the subunits to dissociate from each other, after upstream peptide 
release, the intact ribosome continues to translate the remaining open reading frame. However, 
the reaction could proceed via other pathways. The main function of Ski7 is to target mRNAs 
in the NSD pathway for decay via interactions between the Ski complex and the exosome, 
However, its similarity to eRF3 and Hbs1 (Kowalinski et al., 2015), and ability to bind stalled 
ribosomes, suggest it as a candidate protein that could be recruited to the 2A reaction. Hcr1 
(eIF3j) has been proposed to promote eRF3 release and binding of Rli1 to the termination 
complex (Beznoskova et al., 2013). Despite the role of this protein in termination, the protein 
appears not to be involved in the 2A reaction.  
 
3.8.2 eRFs are required to drive the 2A reaction 
Initial experiments using strains with reduced levels of eRF1 and 3 activity confirmed the 
indicated involvement of translational termination factors in the 2A reaction. Although our 
initial observations about eRF1 confirm that they participate in the 2A reaction, it remains 
unclear how these factors are recruited to drive the 2A reaction and trigger the release of the 
nascent peptide chain from the ribosome, in the absence of a stop codon in the ribosomal A site. 
A wider analysis of the role of eRF1 in 2A reaction is described in the next chapter, in order to 
address this point and to generate information on features of eRFs required for their productive 
interaction with the ribosome in this case. 
As we have shown in sections 3.4 and 3.5, reduced availability/activity of eRF1 and eRF3 
reduces the 2A activity. Three strains of eRF1 have been used to investigate this aspect: 
BSC483-sal4-42 which expresses reduced eRF1 activity due to a mutation in the SUP45 gene, 
sup45-2 which encodes an isoleucine residue in place of serine, and finally DAmP-sup45, as 
the SUP45 gene is essential for yeast survival. Whereas strains that were used to analyse the 
effects of eRF3 on 2A reaction were [PSI+], H438Q and R419G, with relevant wild types as 
controls.  It has previously been found that reduced availability of eRF1 in eukaryotic ribosomes 
leads the ribosome to read-through the stop codon, generating different products from that 
encoded in the ORF on the mRNA, whereas mutations or reduced activity of eRF3 impose 
pauses on the ribosome (Merritt et al., 2010; Eyler et al., 2013). These outcomes might be 
different with ribosomes translating active 2A peptides. The observations of pulse labelling and 
immunoprecipitation of 2A reporters in the current study have revealed that deficient strains, in 
such release factors, promote the ribosome to read-through the 2A peptide, generating a higher 
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ratio of the full-length protein. This was observed through quantifying both upstream and 
downstream products and calculating their ratios to the relevant whole products. The decrease 
in the ratio of both upstream and downstream proteins suggests that the ribosome skips the 
release of the nascent chain at the Pro 19 codon, including 2A fragment, and carries on 
translation to the end of the reporter ORF, as a result of the limited availability of eRF1/3, which 
are specified to terminate the canonical translation on a stop codon, contained in the ribosomal 
A site. Unexpectedly, in contrary to other strains tested in this context, the sup45-42 strain has 
shown a decrease in the upstream product of the reaction, but not the downstream. This may 
raise a question: does the truncated sup45-42 protein retain any activity/ability to bind 
ribosomes? Given that this is the case, it could bind, but does not activate termination however, 
the ribosome could not be able to proceed which may lead the ribosome to ‘dropoff’ and thus a 
greater effect on downstream than upstream. 
The 2A reaction was investigated in two strains expressing Sup35 with reduced GTPase 
activity. These strains were previously found to display increased release of the upstream 
product of the 2A reaction (Doronina et al., 2008). In the current study, these strains have shown 
no effects on the 2A reaction, and the growth rate of these strains was unaffected by 
overexpression of the 2A-encoding mRNA. However, limited availability of eRF3, in [PSI+] 
cells, led to the same effect on 2A reaction that has been detected with sup45 alleles. This 
confirms our results, as both eRF1 and eRF3 trigger termination as a counterpart of the PTC, 
in addition to GTP. The eRF3 is essential for eRF1 (Dever and Green, 2012; Eyler et al., 2013). 
eRF3 is important for the proper positioning of eRF1 in the ribosome and triggering GTP 
hydrolysis therefore, both release factors are recruited to the ribosome in the 2A reaction 
however, the way to hydrolyse GTP might be different.  
 
Normally, the eRF1 within the PTC decodes the stop codon in the ribosomal A site, but in the 
case of 2A, no stop codon in the mRNA is encountered by the ribosome. This suggests that 
eRF1 binds the ribosome with different conformational changes, and contacts the PTC to trigger 
the peptide release from the exit tunnel. However, more investigations, in terms of the eRFs 
residues and biochemical analysis, are required to propose a model for the 2A mechanism, 
according to the current outcomes.   
Consistent with the results of pulse labelling and immunoprecipitation, strains with limited 
availability of eRF1/3 have shown inhibition in the growth profiles, while expressing functional 
2A peptide from a strong promoter. The reason behind the growth inhibition is not clear, 
however, it is consistent with the results of Doronina et al., (2008). The inhibition of growth 
rate detected in limited pool of eRFs suggests a toxic effect exerted by the overexpression of 
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2A peptide, which might be attributed to depletion of eRFs from the ribosome through arresting 
them, and impairing the recycling process, which maintains the normal level of release factors. 
This will also be further investigated in the next chapter.     
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4 CHAPTER 4: DISSECTING REQUIREMENTS FOR eRF1 
AND eRF3 IN THE 2A REACTION THROUGH ANALYSIS OF 
POINT MUTANTS. 
4.1 Introduction 
Work presented in Chapter 3 established that both eRF1 and eRF3 are essential factors to 
maintain the normal 2A reaction and the data obtained support the conclusion that they drive 
the reaction by triggering peptide release from the ribosome, which then resumes translation of 
the remaining ORF. As outlined in Chapter 1, eRF1 and 3 bind the ribosome as a complex 
together with GTP. Under normal circumstances, a key initial step in binding of eRFs to the 
ribosome is stop codon recognition, mediated by specific motifs in the eRF1. The presence of 
a Pro codon in the A site during the 2A reaction makes it unclear at this point if eRF1 binds the 
ribosome using the same motifs used to bind stop codons. At the least, it could be expected that 
there is a slight alteration of the N domain conformation to properly accommodate into the 
ribosomal A site, and then enable the M domain to contact the peptidyl transferase centre (PTC). 
In this chapter a collection of mutations, mainly in eRF1, but also eRF3, were analysed to 
identify similarities and differences in the interaction of/requirements for eRFs with the 
ribosome at 2A peptide. The same strategies, including pulse labelling and 
immunoprecipitation, of 2A-containing proteins as used in Chapter 3 were used to carry out 
these experiments.  
 
4.2 Biochemical analysis of eRF1 mutants for effects on the 2A reaction. 
4.2.1 Laboratory materials 
A strain of S. cerevisiae was used in the experiments presented in this chapter; YTH91 
(see table 2.1). The SUP45 gene is deleted in this strain, and viability maintained by a 
centromeric plasmid (pTH400 CEN/URA3 (Merritt et al., 2010), expressing wild type SUP45 
from a GAL1 promoter. Alongside this strain, a collection of sup45 alleles (Merritt et al., 2010) 
was used. This collection was assembled in the laboratory of Dr. Tobias von der Haar and 
includes alleles described in previous studies and all alleles are placed into the same context, 
the CEN/LEU2 plasmid pRS315 (Sikorski and Hieter, 1989), under control of the SUP45 
promoter. Importantly, this collection includes alterations to amino acids in and close to key 
conserved motifs of eRF1, and all have been characterised for their effects on growth and 
defects in termination (table 4.1).  
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Protein Mutation Domain Protein 
abundance (%) 
(Merritt et al., 
2010) 
Stop codon 
read- 
through 
(Merritt et 
al., 2010) 
eRF1 S30P N 101 ↑ 
I32F N 30 ↑↑ 
P38L N 96 ↑↑ 
L49A N Nd ↑ 
E52A N Nd ↑ 
T55A N 86 ↑ 
N58A N 140 ↑↑↑ 
S61A N Nd ↑ 
R62A N 87 ↑ 
V68A N 85 ↑↑ 
V107D N 29 ↑↑ 
P174Q M 82 ↑ 
I222S M 85 ↑ 
T295A C Nd ↑ 
T388A C Nd ↑ 
F401Y C Nd ↑ 
Y410F C 74 ↑ 
eRF3 R320I G   
G357D G  
S416F GTPase  
 
Table 4.1: The mutations in eRF1 and eRF3 used in the study and their locations in the 
protein. 
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4.2.2 The effect of mutations to residues in the N domain of eRF1 on the 2A reaction 
To analyse different sup45 alleles, strains were transformed with plasmids containing 
the desired sup45 variant and the LEU2 selectable marker. Transformed cells were plated on 
media lacking leucine and then onto 5-FOA-containing plates, to select for cells that had lost 
the URA3-marked plasmid containing the wild type gene (Materials and Methods). These cells 
were then maintained on glucose plates/media. Both strains and plasmids (Merritt et al., 2010), 
used in this section, were obtained from Dr. Tobias von der Haar, University of Kent. Strains 
expressing sup45 mutations were transformed with plasmids from which the HA-F-2A/2A*-
GFP polyprotein reporters were expressed, and cells cultured, pulse labelled, proteins extracted, 
and immunoprecipitation and quantification performed as described in Chapter 3. An example 
of immunoprecipitations from a variety of the strains analysed here is presented in figure 4.1. 
Each strain was analysed at least 3 times and graphed data in figures 4.2-4.6 is averages +/- the 
standard error.   
The TASNIKS motif, and specifically the NIKS sequence, imposes a strict requirement for U 
at the first position of the stop codon (Bulygin et al., 2010). Yeast cells expressing the HA-F-
2A-GFP reporter protein and Sup45 containing mutations mapping to residues upstream, within 
and just downstream of this motif (L49A, N58A, T55A, S61A, R62A, V68A) were pulse-
labelled and the effect of the Sup45 mutations on the 2A reaction examined by 
immunoprecipitation and quantification of 2A reaction products. When compared to the 
reaction in cells expressing wild type Sup45, cells expressing two of the mutations, L49A and 
R62A, revealed a significant (p<0.01) decrease in the production of both the upstream and 
downstream products of the 2A reaction (figure 4.2). This indicates that in the presence of these 
mutations to Sup45, more ribosomes read through 2A and into the downstream sequence. 
Neither of these mutations lead to increase in stop codon read-through (Merritt et al., 2010). In 
contrast, the T55A mutant led only to a significant decrease in downstream product but a similar 
amount of upstream product to the wild type cells. This is consistent with a similar fraction of 
ribosomes undergoing the first (i.e. termination) part of the 2A reaction, but fewer proceeding 
to re-start translation to generate the downstream product. The remaining 3 mutations to this 
region of Sup45 did not affect the 2A reaction significantly.  Of these 2, N58A and S61A, are 
within the core of the TASNIKS motif. The N58A mutation leads to strongly increased read-
through of all 3 stop codons, consistent with the role of the TASNIKS motif in stop codon 
recognition. 
Overall, these results are consistent with the interactions of the TASNIKS motif necessary for 
the 2A reaction, where no stop codon is present in the ribosomal A site, being different to those 
required for efficient termination at stop codons. 
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Figure 4.1 Immunoprecipitation of proteins derived from strains expressing mutations in 
various regions of eRF1. 
 
 Strains expressing the variant of Sup45 indicated were transformed with empty vector (EV) or a plasmid 
expressing the 2A reporter or non-functional (2A*) variant, pulse labelled with [35S] methionine/cysteine and 
translation products were detected by imunoprecipitation with anti-HA (A) or -GFP (B) antibodies. 
Immunoprecipitated proteins were resolved on an SDS-PAGE gel which was subsequently fixed and dried and 
exposed to a phosphorimager screen. Screens were scanned using Typhoon phosphoimager. 
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Figure 4.2: Mutations in TASNIKS but not the NIKS core motif inhibit the 2A reaction. 
 
Pulse-labelled proteins extracted from strains containing the indicated Sup45 variants as the only version of the 
protein, and expressing the HA-F-2A/2A*-GFP reporter, were isolated by immunoprecipitation with anti-HA 
(A) or anti-GFP (B) and the immunoprecipitated proteins resolved on SDS-PAGE gels. Gels were fixed and dried, 
and then exposed to phosphor screens. Screens were scanned using Typhoon phosphoimager, and bands quantified 
using ImageQuant to find the ratios of smaller products to the full-length. Values presented are from 3-5 
independent experiments. * refers to significance p≤0.01. 
 
 
4.2.3 Mutations affecting recognition of the second and third bases of the stop codon 
The YxCxxxF motif and E52 (E55 in mammalian eRF1) interact with the purines at 
positions 2 and 3 of the stop codon (Seit-Nebi et al., 2002) and along with the GTS motif to 
provide the key region of eRF1 that allows specificity of recognition of the bases at these 
positions  (Blanchet et al., 2015). No mutations were available directly affecting the YxCxxxF 
motif, but the nearby amino acid V107 is supposed to perform a function related to it.  Yeast 
strains expressing Sup45, and containing the V107D mutation, changes within and close to the 
GTS (S30P, I32F, P38L) or the E52A as the only version of the protein were tested for effects 
on the 2A reaction.  
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Figure 4.3: Mutations to residues specified for recognition of the second and third bases of the 
stop codon affect the 2A reaction. 
  
Pulse-labelled proteins extracted from strains containing the indicated Sup45 variants as the only version of the 
protein, and expressing the HA-F-2A/2A*-GFP reporter, were isolated by immunoprecipitation with anti-HA 
(A) or anti-GFP (B) and the immunoprecipitated proteins resolved on SDS-PAGE gels. Gels were fixed and dried, 
and then exposed to phosphor screens. Screens were scanned using Typhoon phosphoimager, and bands quantified 
using ImageQuant to find the ratios of smaller products to the full-length. Values presented are from 3-5 
independent experiments. * refers to significance p≤0.01. 
 
As seen in figure 4.3, all mutations that have been examined here affect the 2A reaction either 
by elevating or inhibiting the products of the reaction. Expression of HA-F-2A-GFP in strains 
expressing the S30P mutation to the core GTS motif, in addition to mutations beyond this motif 
(I32F and P38L), led to reduced levels of both upstream and downstream products of the 
reaction when compared to the wild type strain, indicating that a greater fraction of ribosomes 
read through the 2A sequence. In contrast, the E52A mutation significantly reduced the 
upstream product and increased the downstream. In this case, the ribosome seems to pause at 
the Pro 19 codon, releasing the nascent chain then, a high ratio of these ribosomes may re-start 
again to generate the downstream product. The V107 residue is located close to the YxCxxxF 
motif, and assumes a function in stop codon decoding. Here, the V107D increased both products 
of the 2A reporter, indicating an increase in the efficiency of both steps of the 2A reaction over 
the level of the strain expressing wild type eRF1. 
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4.2.4 Mutations affecting the M domain inhibit the 2A reaction 
The M domain contains the key GGQ motif that extends to the PTC and drives release 
of the nascent chain. Mutations within the GGQ motif itself are inviable and/or unstable in S. 
cerevisiae (Merritt et al., 2010) and thus 2 other mutations were tested here, P174Q (Pillay et 
al., 2016) and I222S, which is the analog of the sup45-2 strain (see Chapter 3 for details). These 
are important in the peptide chain release, together with the GGQ motif (residues 180-182). 
The P174 residue is located 6 residues prior to the GGQ motif, which contacts the PTC and 
triggers the peptide release from the ribosome. 
 
 
Figure 4.4: Mutations in the M domain of eRF1 inhibit the 2A reaction.  
Pulse-labelled proteins extracted from strains containing the indicated Sup45 variants as the only version of the 
protein, and expressing the HA-F-2A/2A*-GFP reporter, were isolated by immunoprecipitation with anti-HA 
(A) or anti-GFP (B) and the immunoprecipitated proteins resolved on SDS-PAGE gels. Gels were fixed and dried, 
and then exposed to phosphor screens. Screens were scanned using Typhoon phosphoimager, and bands quantified 
using ImageQuant to find the ratios of smaller products to the full-length. Values presented are from 3-5 
independent experiments. * refers to significance p≤0.01. 
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Expression of the 2A reporter in strains expressing the P174Q or I222S mutation in Sup45 as 
the only version of the protein reduced the ratio of upstream and downstream products of the 
2A peptide-containing polyprotein (figure 4.4). A 40% reduction in the first step of the reaction 
was detected for both P174Q and I222S mutations (figure 4.4: A), whereas the second step was 
reduced about 45% in the strain expressing P174Q, and about 66% in the strain expressing 
I222S, when compared to the wild type strain (figure 4.4: B).  
 
4.2.5 Effect of mutating residues in the C domain of eRF1 on the 2A reaction 
eRF1 interacts with eRF3 via their C domains. Thus, mutating residues in eRF1 which 
are responsible for interaction with eRF3 may affect the 2A reaction. In this section, yeast cells 
expressing the HA-αF-2A-GFP 2A reporter protein and Sup45 with mutations in the eRF1 
interface with eRF3, as the only copy of the protein, were tested for effects on the 2A reaction. 
Four mutations were tested, T295A, T388A, F401Y and Y410F. As before, cells were pulse-
labelled, proteins generated from the reporter immunoprecipitated with anti-GFP or anti-HA 
antibodies and quantified.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
95 
 
 
Figure 4.5: Effect of mutations in the C domain of eRF1 on the efficiency of the 2A reaction. 
Pulse-labelled proteins extracted from strains containing the indicated Sup45 variants as the only version of the 
protein, and expressing the HA-F-2A/2A*-GFP reporter, were isolated by immunoprecipitation with anti-HA 
(A) or anti-GFP (B) and the immunoprecipitated proteins resolved on SDS-PAGE gels. Gels were fixed and dried, 
and then exposed to phosphor screens. Screens were scanned using Typhoon phosphoimager, and bands quantified 
using ImageQuant to find the ratios of smaller products to the full-length. Values presented are from 3-5 
independent experiments. * refers to significance p≤0.01. 
 
 
Immunoprecipitation data revealed that T295A and F401Y reduce the overall efficiency of the 
2A reaction. Both steps of the reaction were significantly (p≤0.01) reduced, by ~ 40 and 50% 
in strains expressing the T295A and F401Y mutations respectively (figure 4.5). The T388A 
mutation also reduced the efficiency of the reaction, though not to the same level of 
significance. Although Y410 is stated as a key residue for eRF1 binding to eRF3 (Song et al., 
2006), the Y410F mutation in the current study has shown no significant effect on both 
upstream and downstream products. It increased the production of the downstream fragment, 
but below the significance level used in our study. 
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4.3 Biochemical analysis of eRF3 mutants for effects on the 2A reaction. 
The data in the preceeding section significantly add to the understanding of the 
contribution of several different regions of eRF1 to the 2A reaction. The effect of mutations 
within the protein on the 2A reaction differs from the effect on canonical termination in many 
instances. The determinant here is the absence of a stop codon in the ribosomal A site.  
We found in Chapter 3 of this study that cells limited in eRF3 activity ([PSI+]) significantly 
inhibit the 2A activity, in terms of reducing ratios of both upstream and downstream products. 
On the other hand, mutating residues in the GTPase domain of eRF3 did not affect the reaction 
activity (see Chapter 3). Based on the structure of eRF1-eRF3 interaction in the ribosome, we 
identified mutations in eRF1’s C domain, in residues which serve as binding points between 
eRF1 and eRF3, that inhibit the 2A reaction by reducing both upstream and downstream ratios. 
To further address the effect of eRF3 on 2A reaction, we have investigated, in this section, the 
effect of some mutations in eRF3 C domain. 
 
4.3.1 Laboratory materials  
A strain of S. cerevisiae (JDY879) was used to investigate the effects of eRF3 on the 
2A peptide. In this strain SUP35 transcription is driven by the repressible kanMX4-tet07 
promoter. The strain was transformed with plasmids containing sup35 alleles (provided by Dr. 
Tobias von der Haar) or the wild type under control of the SUP35 promoter maintained on 
media containing doxycycline 15 µg/ ml to repress the genomic SUP35, leaving cells reliant on 
expression from the plasmid-borne copy of the gene.    
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4.3.2 The S416F mutation in Sup35/eRF3 inhibits the 2A reaction 
 
                 Figure 4.6: Analysis of sup35 mutations for effects on the 2A reaction. 
Strains expressing the variant of Sup35 indicated were transformed with empty vector (EV) or a plasmid 
expressing the 2A reporter or non-functional (2A*) variant, pulse labelled with [35S] methionine/cysteine and 
translation products detected by imunoprecipitation with anti-HA (A) or -GFP (B) antibodies. Immunoprecipitated 
proteins were resolved on an SDS-PAGE gel which was subsequently fixed and dried and exposed to a 
phosphorimager screen. (C) Quantification of the upstream products. (D) Quantification of the downstream 
products. Data presented are the average of 3-4 independent experiments. * refers to significance p≤0.01. 
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Three mutations to Sup35 were tested: G357D, R320I and S416F, all located in domain 1 of 
the C terminus of eRF3. This is the G-nucleotide binding domain of the protein, which assumes 
its function in GTP hydrolysis during canonical termination (Fabret et al., 2008). Only the 
S416F mutation revealed a significant inhibition of the 2A reaction (figure 4.6), diminishing 
the amount of both upstream and downstream products by 50 and 70% respectively. Whereas 
the G357D and R320I mutations had no effect on either step of the reaction. These outcomes 
confirm the role of eRF3 in the 2A reaction, together with eRF1, the process which needs GTP 
hydrolysis to ensure the efficiency of the reaction. 
 
4.4 Measurement of growth rates of cells with mutant release factors, 
expressing a 2A-containing reporter 
To add to data from immunoprecipitation experiments, we evaluated the effect of over-
expressing the 2A reporter in cells expressing mutant forms of eRF1 and eRF3. The 
experimental approach was similar to that adopted in chapter 3 (section 3.5) and was 
accomplished by measuring optical densities of cultures at 600 nm. Strains expressing the same 
variants of Sup45 (or Sup35) as the only form of the protein as used in chapter 3 were 
transformed with plasmids from which either HA-F-2A-GFP or the inactive HA-F-2A*-
GFP were expressed from the GAL1 promoter. Growth of cultures of cells containing these 
plasmids were compared. Data presented here is in the same order used in the 
immunoprecipitation section. 
 
4.4.1 Mutations in the TASNIKS motif 
Analysis of mutations in or close to the TASNIKS motif indicated that only L49A and 
R62A affected the overall 2A reaction while the T55A mutation led to a specific reduction in 
generation of the downstream product indicating a defect in the second (re-initiation) step  in 
the 2A reaction (section 4.2.2.1). L49A and R62A mutations do not affect the ability of Sup45 
to terminate translation at stop codons, while T55A has only a very minor defect, specifically 
at UAA stop codons (Merritt et al., 2010). The same set of mutations that was examined for 
effects on the 2A reaction (L49A, T55A, N58A, S61A, R62A and V68A) were assessed in the 
same manner explained above for growth rate when the 2A- or 2A*-containing reporter was 
expressed. 
As seen in figure 4.7, the presence of 2A-coding sequence peptide in cells expressing any of 
the TASNIKS-motif associated mutations does not alter the growth rate/doubling time. They 
grew equally well in the presence of 2A or 2A*. The measurement and comparison of growth 
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in strains expressing active 2A peptides has shown no effect compared to strains with inactive 
2A (2A*).   
 
 
 
 
Figure 4.7: Growth doubling time is not affected in strains with mutations in the TASNIKS 
motif while expressing 2A peptide. 
          
Strains with mutations in TASNIKS motif of Sup45 (YTH91 transformed with pTH438, 355, 371, 373 and 374), 
along with the wild type (YTH91 transformed with pTH353), were transformed with 2A and 2A*-containing 
reporters (pJNY279 and 278) and grown overnight at 30 ºC in selective media. Cultures were diluted on the next 
day with the same media plus 2% w/v galactose to induce the GAL1 promoter of the 2A reporter. OD600 was 
recorded every one hour for eight hours, and data were processed to find the doubling time for each strain 
expressing active 2A, and normalised to the doubling time of the strain expressing 2A*. (A) Table of doubling 
time values. (B) Chart of values corresponding to A.  
                       
4.4.2 Growth doubling time with mutations affecting the recognition of the second and 
third bases in the stop codon sequence 
The same strains tested in section 4.2.3 for their tendency to inhibit the 2A reaction are 
tested here to address the inhibitory effect of 2A overexpression on the growth of these cells. 
These strains include the core GTS mutation, S30P as well as two other mutations located close 
to this motif, I32F and P38L. Furthermore, strains expressing E52A and V107D have been 
included to this range of mutations.  
 
 
 
 
 
 
 
Strain 
Expressing 
2A 
Growth 
Doubling Time 
(%) (mean±SE) 
WT 103.505± 4.73 
L49A 123.981± 5.66 
T55A 112.067± 5.12 
N58A 112.798± 5.15 
S61A 120.610± 5.51 
R62A 132.509± 6.06 
V68A 111.626± 5.10 
A                                                 B 
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Figure 4.8: Growth doubling time of strains with mutations to residues which recognise the 2nd and 3d 
bases of  the stop codon. 
 
Strains expressing S30P, I32F, P38L, E52A and V107D in Sup45 (YTH91 transformed with pTH399, 313, 314, 
439 and 316), along with the wild type (YTH91 transformed with pTH353), were transformed with 2A and 2A*- 
containing reporters (pJNY278 and 279) and grown overnight at 30 ºC in selective media. Cultures were diluted 
on the next day with the same media plus 2% w/v galactose to induce the GAL1 promoter of the 2A reporter. OD600 
was recorded every one hour for eight hours, and data were processed to find the doubling time for each strain 
expressing active 2A, and normalised to the doubling time of the strain expressing 2A*. Averages of 3-4 
independent experiments are presented above± standard error. (A) Table of doubling time values. (B) Chart of 
values corresponding to A. * refers to significance p≤0.01. 
 
Mutations tested in the GTS motif (S30P) significantly increased the doubling time of cells 
expressing 2A compared to the wild type cells, whereas the increase in the doubling time 
detected in the I32F mutation, which is located beyond the GTS motif, was insignificant at p 
level 0.01.  However, the P38L did not affect the growth pattern of cells expressing 2A peptide. 
(figure 4.8) It has already been detected in this study that all the three mutations affected the 
2A reaction, by reducing the production of both upstream and downstream reaction products in 
relation to read-through product (section 4.2.3). In contrast, cells expressing the Sup45-P38L, 
E52A or V107D mutation grew equally well with no detectable difference in doubling time 
compared to the wild type (figure 4.8). 
 
4.4.3 Mutations affecting the M domain inhibit the growth in strains expressing 2A 
peptide 
As presented above in regard to other functional parts of the eRF1, mutations before 
and beyond the universally conserved GGQ motif were examined here, whether they affect the 
growth of yeast cells, while expressing 2A peptide. Two mutations were tested in this context, 
P174Q and I222S. 
Strain 
Expressing 
2A 
Growth 
Doubling Time 
(%) (mean±SE) 
WT 103.505± 4.73 
S30P 230.211± 10.52* 
I32F 130.814± 5.97 
P38L 112.513± 5.14 
E52A 100.889± 9.54 
V107D 111.922± 5.11 
 
A                                                           B 
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Figure 4.9: Growth doubling time in strains expressing mutations to residues close to 
the GGQ motif. 
 
Strains expressing P174Q and I222S in Sup45 (YTH91 transformed with pTH443 and 445), along with the wild 
type (YTH91 transformed with pTH353), were transformed with 2A and 2A*-containing reporters (pJNY278 and 
279) and grown overnight at 30 ºC in selective media. Cultures were diluted on the next day with the same media 
plus 2% w/v galactose to induce the GAL1 promoter of the 2A reporter. OD600 was recorded every one hour for 
eight hours, and data were processed to find the doubling time for each strain expressing active 2A, and normalised 
to the doubling time of the strain expressing 2A*. Averages of 3-4 independent experiments are presented above 
± standard error. (A) Table of doubling time values. (B) Chart of values corresponding to A. * refers to significance 
p≤0.01. 
 
Of the 2 Sup45 variants tested, only I222S, which is the same change to the protein as that in 
the sup45-2 allele (see Chapter 3 for details), has revealed an inhibition in the growth, detected 
by increased doubling time, while expressing active 2A, compared to the same strain expressing 
inactive 2A peptide. The doubling time in this strain was approximately double of that observed 
in the wild type. The strain expressing Sup45-P174Q revealed no effect in this context as a 
result of expressing the construct encoding active 2A (figure 4.9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strain 
Expressing 
2A 
Growth 
Doubling Time 
(%) (mean±SE) 
WT 103.505± 4.73 
P174Q 124.074± 5.67 
I222S 215.813± 9.86* 
 
  A                                                           B 
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4.4.4 Growth of cells with mutations in the C domain of eRF1 
 
 
 
 
 
 
 
 
 
 
 
 
        
 
Figure 4.10: Growth doubling time is increased in some strains expressing mutations in the C 
domain of Sup45. 
Strains expressing mutations in Sup45 C domain which includes, T295A, T388A, F401Y and Y410F (YTH91 
transformed with pTH363, 365, 366 and 357), along with the wild type (YTH91 transformed with pTH353), were 
transformed with 2A and 2A*-containing reporters (pJNY278 and 279) and grown overnight at 30 ºC in selective 
media. Cultures were diluted on the next day with the same media plus 2% w/v galactose to induce the GAL1 
promoter of the 2A reporter. OD600 was recorded every one hour for eight hours, and data were processed to find 
the doubling time for each strain expressing active 2A, and normalised to the doubling time of the strain expressing 
2A*. Averages of 3-4 independent experiments are presented above ± standard error. (A) Table of doubling time 
values. (B) Chart of values corresponding to A. * refers to significance p≤0.01. 
 
As with mutations in other regions of Sup45, the 4 variants in the C domain of the protein 
yielded different growth patterns and thereby different doubling time, when the 2A-containing 
reporter was expressed. Thus the growth of cells expressing the T295A and Y410F variants was 
inhibited and showed a significant increase in the doubling time compared to the wild type 
strain, whereas those expressing T388A and F401Y were growing normally. The strain with 
F401Y-sup45 has revealed a significant inhibition of the 2A reaction, when biochemically 
assessed by immunoprecipitation (section 4.2.5). Surprisingly, the growth of this strain here is 
normal while expressing 2A peptide, compared to the control expressing 2A* (figure 4.10). 
Conversely, the presence of active 2A in the Y410F strain has inhibited the growth, relative to 
the overexpression of 2A* in the same strain background, although no effect was detected with 
this strain in terms of immunoprecipitation (figure 4.5). Worth noting however, 4-5 repeats of 
growth measurement have been performed to confirm these results. 
 
 
 
Strain 
Expressing 
2A 
Growth 
Doubling Time 
(%) (mean±SE) 
WT 103.505± 4.73 
T295A 178.932± 8.17* 
T388A 119.679± 5.64 
F401Y 109.313± 4.99 
Y410F 290.667± 13.28* 
 
A                                                           B 
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4.5  Measurement of growth of strains with mutant eRF3 
The same selection of mutations within the GTP binding domain of Sup35 were tested 
as in the immunoprecipitation experiments (section 4.2).  
 
 
             
Figure 4.11: Growth doubling time of strains with mutations in the GTP-binding 
domain of Sup35 while expressing 2A peptide. 
 
Strains expressing mutations in Sup35 GTP-binding domain which includes, R320I, G357D and S416F (JDY879 
transformed with pTH770, 773 and 774), along with the wild type (895 transformed with pTH769), were 
transformed with 2A and 2A*-containing reporters (pJNY278 and 279) and grown overnight at 30 ºC in selective 
media. Cultures were diluted on the next day with the same media plus 2% w/v galactose to induce the GAL1 
promoter of the 2A reporter. OD600 was recorded every one hour for eight hours, and data were processed to find 
the doubling time for each strain expressing active 2A, and normalised to the doubling time of the strain expressing 
2A*. Averages of 3-4 independent experiments are presented above ± standard error. (A) Table of doubling time 
values. (B) Chart of values corresponding to A. * refers to significance p≤0.01. 
  
The R320I strain grew slower when the active 2A-coding construct was expressed, but other 
strains were not affected. S416F is not different in terms of doubling time compared to the wild 
type, while expressing 2A, although it showed a significant reduction in the 2A reaction 
outcomes, when assessed using immunoprecipitation (figure 4.6). This strain revealed a 
significant high doubling time, referring to the slow growth induced by expression of 2A 
peptide relative to the strain expressing 2A*, and compared to the wild type. Worth noting, the 
strain expressing the G357D mutation did not reveal changes in the growth compared to the 
wild type (figure 4.11).  
 
4.6 Overexpression of 2A-containing protein inhibits termination 
Overexpression of mRNA encoding 2A may lead to increase in stop codon read-through 
in trans, indicating a titration effect on eRF activity. The experiments carried out by Doronina 
et al (2008) used a β-galactosidase-STOP-luciferase construct, to examine stop codon read-
through. Extending from that work, here a similar dual luciferase reporter system (Grentzmann 
et al., 1998) was used to test whether expression of the 2A-encoding mRNA leads to increased 
Strain 
Expressing 
2A 
Growth 
Doubling Time 
(%) (mean±SE) 
WT 115.178± 5.26 
R320I 205.047± 9.37* 
G357D 105.916± 4.84 
S416F 109.145± 4.98 
 
 A                                                          B 
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read-through of stop codons in cells expressing the range of Sup45 and Sup35 variants used in 
the experiments above. 
4.6.1 The dual luciferase reporters 
Dual luciferase reporters for analysing translational recoding were first developed by 
Atkins and colleagues (Grentzmann et al., 1998), and subsequently adapted for use in yeast 
(Keeling et al., 2004; Salas-Marco and Bedwell, 2004). These comprise sequences encoding 
Renilla luciferase followed by the stop codon, and then Firefly luciferase and are available with 
each stop codon with every one of the 4 possible nucleotides after them. Here, two stop codons 
(UAG and UAA), with different 3’ nucleotides, have been investigated for the possibility of 
being suppressed by expression of 2A-coding mRNA (see section 2.4.3 for details). An empty 
vector was used to provide a background measurement for the luciferase assays, and a version 
of the dual luciferase reporter with a sense codon provided a positive (100% ‘read-through’) 
control. 
 
4.6.2 Strains  
The same collection of strains used in the immunoprecipitation and growth experiments 
above were used here. This collection expresses a variety of mutations in eRF1. Controls are 
used with each sample (mutation) including vectors (no luciferase reporter), 2A* (inactive 2A 
peptide), in addition to the active 2A, each tested with both sense and stop codon-containing 
luciferase reporters. Strains expressing different variants of Sup45 were transformed with either 
2A or 2A*-encoding plasmids and then each of these was transformed with a plasmid 
containing the dual luciferase reporter, the positive (sense) control plasmid or the empty vector 
negative control. Cells were then grown under conditions that induce expression of the 2A/2A* 
encoding mRNA, and luciferase measured in extracts of the cells. Readings were processed, 
and normalised to values obtained with the construct containing the sense codon (100%), and 
empty vector (0%). For each strain, data are presented as a comparison of read-through in 
strains expressing active 2A-and the inactive 2A*-containing mRNA and an empty vector. 
Statistical analysis was performed by comparing the value of stop codon read-through of strains 
to the value of isogenic wild type eRF1. Example of data is shown below in figure 4.12. Of 
note, with these strains, the one expressing the wild type eRF1 has shown an increased stop 
codon read-through in all experiments undergone with the dual-luciferase reporter. 
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Figure 4.12: Stop codon read-through in wild type S. cerevisiae with sense and stop codon-
containing dual luciferase plasmids. 
Yeast strains transformed with the HA-αF-2A/2A*-GFP plasmids and also containing either the sense or stop 
codon UAG/UAA/UGA (pJNY250-255), and containing a version of the dual luciferase plasmid were grown, 
lysates made and luciferase activities measured as described in section 2.4.4 (Materials and methods). The ratio of 
firefly values to the Renilla was calculated from the average of each sample readings, setting the value obtained 
with the sense codon version of the dual luciferase plasmid to 100%. 
 
4.6.3 Mutations in the TASNIKS motif increase stop codons read-through in cells 
expressing 2A peptide 
Dual-luciferase activity was measured in yeast cells expressing mutations to the 
TASNIKS motif and adjacent amino acids as used in previous experiments (L49A, N58A, 
T55A, S61A, R62A, V68A) and HA-F-2A/2A*-GFP reporters. A comparison of read-through 
of UAA and UAG stop codons is presented in figure 4.13. Two different contexts of the UAG 
stop codon (UAGA and UAGC) were used, as the 4th position has a significant effect on the 
recognition of the stop codon, with C being the 3’ base that yields the highest basal levels of 
read-through (Salas-Marco and Bedwell, 2004). As seen in figure 4.13, compared to the effect 
on wild type cells, expression of HA-F-2A-GFP led to significant increase in read-through in 
strains expressing L49A, T55A and R62A variants of Sup45 with all 3 tested stop 
codons/contexts. The V68A mutation caused a significant increase in read-through with the 
UAGC context sequence, compared to the wild type, whereas the elevation in this strain was 
insignificant with other tested stop codons (figure 4.13).   
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 Figure 4.13: Expression of 2A leads to increased stop codon suppression in trans in strains expressing mutations close to the TASNIKS motif. 
 
Cultures of the indicated strains, expressing dual luciferase reporter with sense, UAG or UAA stop codons followed by cytosine or adenine as a context sequence with plasmids 
encoding empty vector, 2A* or 2A, were grown overnight in selective media. Proteins were extracted and 10-20 µg were used for luciferase measurement of each sample. Data 
obtained were processed to find averages, values of sense codons were normalised to 100%, and samples were calculated accordingly. Values of the active 2A in each strain 
with a stop codon were statistically compared to the relevant value of the isogenic wild type. * refers to significance p≤0.01. 
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Figure 4.14:  Stop codon read-through in trans in strains expressing 2A peptide, and maintaining termination with eRF1 expressing mutations to 
residues in necessary for stop codon recognition.   
Cultures of the indicated strains, expressing dual luciferase reporter with sense, UAG or UAA stop codons followed by cytosine or adenine as a context sequence with plasmids 
encoding empty vector, 2A* or 2A, were grown overnight in selective media. Proteins were extracted and 10-20 µg was used for luciferase measurement of each sample. Data 
obtained were processed to find averages, values of sense codons were normalised to 100%, and samples were calculated accordingly. Values of the active 2A in each strain 
with a stop codon were statistically compared to the relevant value of the isogenic wild type. * refers to significance p≤0.01. 
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4.6.4 Mutations in the stop codon recognition residues increase stop codon read- 
through when cells express 2A-encoding mRNA 
As seen in figure 4.14, yeast strains expressing eRF1 with mutations beyond the GTS 
motif, I32F and P38L, have increased the read-through level over the wild type strain. The level 
of read-through approaches 100% with the UAG C reporter for both strains, whereas with the 
UAG A, read-through increase was apparently greater than that seen with the sense-codon 
containing construct (160%) in the strain expressing I32F and 100% in the strain expressing 
P38L. Strains expressing either of these eRF1 variants have reduced 2A activity. A third eRF1 
variant that reduces 2A activity, S30P (see section 4.2.3 for details), did not significantly affect 
stop codon read-through in trans.
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 Figure 4.15:  Stop codon read-through in trans in strains with mutations to residues close to the GGQ motif of eRF1 while expressing 2A 
peptide.   
Cultures of the indicated strains, expressing dual luciferase reporter with sense, UAG or UAA stop codons followed by cytosine or adenine as a context sequence with plasmids 
encoding empty vector, 2A* or 2A, were grown overnight in selective media. Proteins were extracted and 10-20 µg was used for luciferase measurement of each sample. Data 
obtained were processed to find averages, values of sense codons were normalised to 100%, and samples were calculated accordingly. Values of the active 2A in each strain 
with a stop codon were statistically compared to the relevant value of the isogenic wild type. * refers to significance p≤0.01. 
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4.6.5 Mutations in the M domain of eRF1 show elevated read-through of stop codons 
when 2A-containing mRNA is expressed 
The two eRF1 variants in the M domain that affect the 2A reaction (P174Q and I222S) 
were tested using the dual-luciferase reporters. It was observed (figure 4.15) that expression of 
2A-containing mRNA in a strain expressing the I222S variant of eRF1 led to a significant 
increase in stop codon read-through with all codons tested here. This result is in accordance 
with our previous observation with immunoprecipitation, where we found that this mutation 
caused a significant inhibition in the 2A reaction. On the other hand, the P174Q mutation, which 
is located 6 amino acids before the universally conserved GGQ motif (180-182 S. cerevisiae 
numbering), caused a significant elevation of read-through only of the UAGC codon. However, 
these results confirm the role of eRF1 in the 2A reaction, which depletes/deactivates eRF1, 
leaving the ribosome undergoing defective termination.    
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Figure 4.16:  Stop codon read-through in strains expressing 2A peptide, with mutant eRF1 in the C domain as the only version of the protein.  
 
Cultures of the indicated strains, expressing dual luciferase reporter with sense, UAG or UAA stop codons followed by cytosine or adenine as a context sequence with plasmids 
encoding empty vector, 2A* or 2A, were grown overnight in selective media. Proteins were extracted and 10-20 µg was used for luciferase measurement of each sample. Data 
obtained were processed to find averages, values of sense codons were normalised to 100%, and samples were calculated accordingly. Values of the active 2A in each strain 
with a stop codon were statistically compared to the relevant value of the isogenic wild type. * refers to significance p≤0.01. 
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4.6.6 The effect of 2A overexpression on stop codon read-through in strains expressing 
eRF1 with mutations in the C domain  
Here, the same mutations examined for the effect on the 2A reaction were tested for 
their effect on stop codon inhibition. The overexpression of 2A-encoding mRNA in these strains 
revealed an increased read-through in cells expressing the T295A mutation only (figure 4.16), 
whereas the other mutations analysed in this domain have no effect on read-through. Given that 
the T295 is one of the key residues in eRF1 for its interaction with eRF3 in the ternary complex. 
The variation in the importance of eRF1 residues between canonical termination and 2A 
confirms that the conformation of eRF1 in the ribosome translating 2A sequence is different 
from that known in canonical translation/termination. 
 
4.6.7 Expression of 2A-encoding mRNA leads to increased stop codon read-through in 
strains with reduced eRF3 activity  
Strains which were analysed for the effect of alterations to Sup35 activity on the 2A 
reaction (section 4.3.2) were examined to determine whether the expression of the 2A-
containing mRNA affected read-through of stop codons in trans. As with strains containing 
alterations to Sup45, dual-luciferase reporters were used with the same stop codons/contexts.  
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Figure 4.17:  Stop codon read-through in trans in strains with  mutant eRF3 while expressing 2A peptide.   
 
Cultures of the indicated strains, expressing dual luciferase reporter with sense, UAG or UAA stop codons followed by cytosine or adenine as a context sequence with plasmids 
encoding empty vector, 2A* or 2A, were grown overnight in selective media. Proteins were extracted and 10-20 µg was used for luciferase measurement of each sample. Data 
obtained were processed to find averages, values of sense codons were normalised to 100%, and samples were calculated accordingly. Values of the active 2A in each strain 
with a stop codon were statistically compared to the relevant value of the isogenic wild type. * refers to significance p≤0.01. 
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As seen in figure 4.17, a range of mutations in eRF3, particularly in the GTP-binding domain, 
along with the [PSI+] and [psi-], were tested here for the tendency to read-through stop codons, 
while overexpressing 2A-encoding mRNA. The results of the dual luciferase assay are in 
accordance with what we have found in regards to the effect of these mutations of eRF3 on the 
2A reaction (see section 4.3.2). In all stop codons tested, the strain expressing S416F mutation 
in eRF3 showed a significant increase in read-through, over that seen in the wild type strain, 
whereas, values of other mutations were statistically similar to the wild type strain. The [PSI+] 
strain, in which the available eRF3 is significantly reduced through formation of aggregates of 
the protein, also revealed a significant increase in read-through of stop codons, compared to the 
equivalent [psi-] strain (figure 4.17).  
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4.7 In vitro analysis of effects of some mutations in eRF1 on 2A reaction 
To complement the in vivo biochemical analysis of the 2A reaction, another biochemical 
analysis was applied through an in vitro translation experiments, which were carried out using 
translation-competent extract from yeast. Strains chosen were ones that had revealed defects in 
the 2A reaction in vivo (I32F, P38L, L49A, T55A, R62A, P174Q and [PSI+]). These were 
assembled into in vitro translation reactions (Materials and Methods) with [35S]-labelled 
methionine and capped mRNA transcripts encoding αF, followed by 2A/2A*, and GFP.  
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Figure 4.18: In vitro analysis of the 2A reaction. 
In vitro translation reactions were assembled using extracts from wild type yeast cells expressing the indicated 
Sup45 variant or [PSI+] cells with mRNA transcripts encoding 2A/2A* reporters. Reactions were resolved onto 
SDS-PAGE, gels were fixed and dried, and exposed to exchange screen. Gels from 3 independent experiments 
were quantified, values normalised according to the number of methionine residues in the proteins and the amount 
of upstream and downstream fragments of the 2A reaction was calculated and expressed as a fraction of the amount 
in the reaction assembled with the wild type extract set to 100%. * Significance at 0.01. 
 
Data obtained from the in vitro translation experiments confirmed those obtained from in vivo 
analysis. Thus, in vitro translation of the 2A-containing reporter revealed a significant decrease 
in upstream/downstream products in extracts from all the mutants tested here. I32F, P38L, 
(located beyond the GTS motif) and R62A (just downstream to the NIKS motif), had the most  
impact on the 2A reaction representing 25, 18 and 15% respectively of the WT value of the 
upstream product, and 22, 23 and 34% respectively in the downstream products. Two 
observations are inconsistent here with the in vivo experiments undergone by 
immunoprecipitation; first, the T55A mutation caused a significant decrease here in the 
upstream product whereas it did not change the ratio of this product in the immunoprecipitation 
experiments (see figure 4.2). In addition, the L49A mutation caused insignificant decrease in 
the downstream product here, whereas it was significant in the immunoprecipitation. It is 
unclear as to why these differences were seen, though the difference in conditions between the 
in vivo and in vitro experiments may impact on the outcome of the reaction. The experiments 
do though confirm that the mutations in eRF1 and the [PSI+] state impact on the 2A reaction. 
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4.8 Discussion  
Much research has been carried out using 2A peptides and the 2A reaction. However, 
relatively few studies have investigated the 2A reaction mechanism. The main focus of this 
chapter is to investigate the involvement of a broad range of residues in the eRF proteins in the 
2A reaction. In Chapter 3, it was demonstrated that limited activity of eRF1 and eRF3 in cells 
inhibits the 2A activity below the wild type strains. This led to the conclusion that the initial 
step in the 2A reaction is a non-canonical termination.  According to data presented in this 
chapter, a variety of residues, in different motifs/domains, of eRF1 are essential for cells of S. 
cerevisiae to maintain a normal 2A reaction. Further, alteration to S416 in eRF3 also impaired 
the 2A reaction. Data obtained in this chapter are summarised in Table 4.2. 
Mutation Location Biochemical Effect 
2A Reaction Products Stop Codon Read-through in trans Growth 
Doubling 
Time 
Upstream Downstream 
UAGC UAGA UAAA 
S30P N (GTS)       ↓ ↓      NS    NS     NS       ↓ 
I32F N       ↓ ↓        ↑      ↑      ↑     NS 
P38L N       ↓ ↓        ↑      ↑      ↑     NS 
L49A N       ↓ ↓        ↑      ↑      ↑     NS 
E52A N       ↓ ↑       NS     NS     NS      NS 
T55A N 
(TASNIKS) 
     NS ↓        ↑      ↑       ↑      NS 
N58A N 
(TASNIKS) 
     NS        NS      NS NS NS      NS 
S61A N 
(TASNIKS) 
    NS       NS      NS NS NS      NS 
R62A N       ↓        ↓       ↑       ↑       ↑      NS 
V68A N      NS      NS       ↑ NS NS      NS 
V107D N       ↑ ↑      NS NS NS      NS 
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Table 4.2: Mutations in Sup45 and Sup35 used in this study and their effects on the 2A 
reaction. 
The point mutation analysis undertaken in this study is summarised in the table above. The table shows mutations 
in each Sup45 and Sup35 with their locations in the protein structure in addition to the functional motif/loop. The 
different effects of such mutation are presented either by ↑, stands for elevation, ↓, stands for reduction or NS, 
stands for No Significance. It is also presented in the table the observed effects in terms of stop codon inhibition 
in addition, the different effects of such mutation studied on the level of growth of strains expressing such 
sup45/sup35 variants. 
 
eRF1 triggers peptidyl-tRNA hydrolysis, thereby releasing the nascent peptide chain from the 
ribosome. A wealth of biochemical and genetic studies have led to recognition of the 
importance of three highly conserved motifs in the N domain, GTS, NIKS and YxCxxxF, for 
stop codon recognition. A universally conserved tripeptide, GGQ is located in the M domain of 
eRF1, and is critical for peptidyl-tRNA hydrolysis in the PTC (Zhuravleva et al., 2007). It has 
been suggested that in termination complexes, uridine in the first position of the stop codon 
contacts the NIKS motif (Chavatte et al., 2002). On the other hand, purines in the second and 
third positions contact the GTS and YxCxxxF motifs (Bulygin et al., 2011). Studies also 
referred to different conformational changes adopted by the N domain to recognize signals in 
the ribosomal A site (Wong et al., 2012). Recent cryo-electron microscopy studies have 
confirmed the direct role of the three implicated motifs in the N domain in deciphering the stop 
codon (Muhs et al., 2015). Structurally, differences in positioning of the GGQ motif have been 
found relative to the PTC, GGQ in the pre-termination complex is divergent from the PTC, 
P174Q N       ↓ ↓       ↑ NS NS     NS 
I222S M       ↓ ↓       ↑      ↑      ↑      ↓ 
T295A C       ↓ ↓       ↑      ↑      ↑      ↓ 
T388A C      NS NS      NS NS NS     NS 
F401Y C       ↓ ↓      NS NS NS     NS 
Y410F C      NS NS      NS NS NS      ↓ 
R320I G      NS NS      NS NS NS      ↓ 
G357D G      NS NS      NS NS NS     NS 
S416F G        ↓ ↓       ↑       ↑      ↑     NS 
[PSI+]         ↓ ↓       ↑       ↑      ↑       ↓ 
[psi-]        NS NS      NS NS NS      NS 
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which indicates inactivity of eRF1 in this stage (Matheisl et al., 2015). Conversely, complexes 
in the post-termination stage impose shifting of the M domain, positioning the GGQ tripeptide 
directly in the PTC, with vicinity to the 3’-terminus of the P site tRNA (Preis et al., 2014). 
 
4.8.1 eRF1 is recruited to the 2A reaction  
The analysis of a wide range of eRF1 mutants described in this chapter confirms the role 
of this protein in the 2A reaction, and provides information about residues involved in 
maintaining the normal 2A reaction in S. cerevisiae cells. Specific residues located around both 
GTS and TASNIKS motifs of eRF1 are important in this context. The S30P mutation, which is 
located in the core of the GTS motif, as well as the I32F and P38L mutations all adversely affect 
the 2A reaction, as assessed using the HA-αF-2A-GFP reporter. Experiments revealed a 
significant reduction of the 2A activity, characterized by reducing amounts of both upstream 
and downstream products, indicating that in cells expressing these variants of Sup45, a higher 
ratio of ribosomes read-through the 2A peptide to generate the full-length protein of the 2A 
reporter. GTS motif/loop (28-30 of  S. cerevisiae numbering) has an essential role in stop codon 
recognition, in cases of canonical translation, through decoding purines in the second and third 
positions, and probably the first context base just after the stop codon (Conard et al., 2012). 
This is carried out through a specific conformation of eRF1 in the ribosomal A site, where the 
GTS motif aids the YxCxxxF motif, in addition to the E55 residue (Brown et al., 2015). Despite 
the different situation in the case of the 2A reaction, where no stop codon is occupying the 
ribosomal A site, it seems that the same residues specified to decode stop codons are involved 
in maintaining the 2A reaction. Using NMR techniques, studies have revealed different 
conformations undergone by the GTS loop, which impacts specificity to bind stop codons 
(Wong et al., 2012). Noticeably, GTS loop in termination lies in vicinity of guanine residues in 
the second or third position of the stop codon, moreover, mutagenesis of human eRF1 identified 
some essential residues for termination (Kryuchkova et al., 2013). This study highlighted S33 
(equivalent to S30 in yeast) as the main residue involved in guanine decoding. It has been 
reported through NMR analysis of several mutations in the N domain of eRF1 that mutations 
of the S30 residue may change the local conformation in the eRF1 N domain, which confirms 
the importance of the shape of a serine residue at this position. Mutagenesis of the S30 residue 
causes shifting in other residues across different motifs, one of the affected residues is I32, 
which is located in the secondary sequence of the eRF1 protein (Blanchet et al., 2015). Thus, 
this effect may also include the P38 residue, which inhibited the 2A reaction as a result of 
mutating it to leucine.  
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The next residues which have been examined locate in the TASNIKS motif, these include L49, 
T55, N58, S61, R62 and V68. Only N58 and S61 lie in the core NIKS motif, and notably do 
not influence the 2A activity. As described by Ito and his collaborators, the NIKS loop normally 
functions to interact with the first uracil of the stop codon through the anti-codon mimicry (Ito 
et al., 2002). On the other hand, our data reveal that residues just before or after the NIKS loop 
have shown a significant inhibition of the 2A reaction, these include T55 and R62, which may 
indicate a slightly different conformation of the protein, undergone in the ribosome in the 
absence of a stop codon in the ribosomal A site. R62 is located at the edge of the pocket 1 cavity 
in the N domain of the eRF1 tertiary structure, and it is presumed to perform a role in terms of 
the protein structure and activity. Furthermore, arginine is a positively charged amino acid, thus 
there is a possibility to interact mainly with mRNA via the negatively charged phosphate group, 
but probably interaction occurs with the rRNA as well (Blanchet et al., 2015). It has been 
demonstrated that threonine 55, together with alanine 56 and serine 57, which imply to the first 
three residues in TASNIKS motif, may function as an anticodon peptide. Furthermore, TAS, 
along with the NIKS region, forms a flexible sequence, which can adopt a tight or loose 
conformation to decode the stop codon, specifically, the second nucleotide of the UGA stop 
codon, whereas the asparagine 58 has been found to assume the recognition of the third 
nucleotide (Nakamura et al., 2000; Muramatsu et al., 2001).  Finally, a study found that 
TASNIKS loop undergoes a function to promote the right conformation of eRF3 in the TC, in 
addition, this loop may also trigger the GTP hydrolysis (Fan-Minogue et al., 2008). It has been 
found that the valine in position 68 of S. cerevisiae eRF1 functions in the recognition of the 
adenine residues in stop codons structure (Fan-Minogue et al., 2008; Blanchet et al., 2015). 
Furthermore, structural studies have revealed that the distance between the Y-C-F and the GGQ 
motif is ~80 Å, which is similar to the distance between the anticodon and the CCA end of the 
tRNA, thus it can easily be located in vicinity with the stop codon when the GGQ is placed at 
the PTC close to the CCA end of the peptidyl-tRNA (Inagaki et al., 2002). Mutations in the Y-
C-F motif abolish the recognition of the three known stop codons (Seit-Nebi et al., 2002). 
However, we were not able to carry out assessment for such mutation in this motif during the 
course of this study, as none could maintain cell viability (Merritt et al., 2010).  
The eRF1 structure resembles the letter ‘Y’, which in part mimics the ‘L’- shaped of the tRNA 
moiety, where the M domain of eRF1 simulates the tRNA acceptor stem (Nissen et al., 2000). 
Thus, it is suggested that the GGQ function is equivalent to the 3’-CCA end of tRNA (Ivanova 
et al., 2007). The amino acid sequence between leucine 173 and alanine 207 in S. cerevisiae 
eRF1 is strictly conserved and contains the invariant GGQ motif. Apart from this motif, some 
nearby residues are also conserved among species, these residues include proline 174 and serine 
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183, which are both located in the loop region. The conserved residues in the M domain may 
suggest a functional role through forming a surface for the eRF1 to bind mRNA (Ivanova et al., 
2007). The particular geometry of residues 177-184 region corresponds to a loop that connects 
secondary structures (Song et al., 2000). The molecular mechanism of the peptide release in the 
PTC has not been fully uncovered. However, it has been found that there would be a process of 
water coordination to the GGQ. The glutamine 182 side chain acts as a coordinator for the water 
molecule, which performs nucleophilic attack on the peptidyl-tRNA bond. The neighbouring 
residues, including the conserved glycines 180 and 181, enhance the contact with the phosphate 
group of both rRNA and the acceptor stem of the ribosomal P site tRNA (Song et al., 2000). 
Moreover, it has been reported that mutating isoleucine 222 of the eRF1 to serine yields a 
significant inactivation of the functional protein. This particular mutation namely, sup45-2 in 
S. cerevisiae, reduces the proteins ability to bind the ribosome as well as the ability to trigger 
the peptide chain release (Stansfield et al., 1997). 
As stated above, eRF1 binds to eRF3 to form a complex which binds the ribosome to trigger 
termination. The binding of both eRFs is carried out through their C domains thus changing 
residues in eRF1’s C domain may alter the termination efficiency, and concomitantly the 2A 
reaction activity. In this context, we tested several mutations in the eRF1’s C domain: these 
include: T295A, T388A, F401Y and Y410F, using immunoprecipitation of both upstream and 
downstream products of the 2A reporter. We found that both T295A and F401Y have reduced 
the smaller products (upstream or downstream), indicating more ribosomes undertaking read- 
through across the C terminus of the 2A peptide. Studies have demonstrated that deletion of 6- 
19 amino acids from the eRF1’s C domain in S. cerevisiae, and 17 amino acids of S. pombe, 
results in a complete loss of binding capacity to eRF3 (Ito et al., 1998; Eurwilaichitr et al., 
1999). It has been identified that two regions in each eRF1 and 3 are the key regions for mutual 
binding, these include residues 281-305 and 411-415 (GILRY) in eRF1, whereas residues 478- 
530 and 628-637 represent the binding interface in eRF3 (Merkulova et al., 1999b). A computer 
modelling study suggested that two residues threonine 295 and tyrosine 410 are exposed to be 
the surface of the Sup45 protein molecule. Furthermore, among amino acids in this region, 
tyrosine residue can interact with residues on the Sup35 surface since it contains hydroxyl group 
(Akhmaloka et al., 2008). A motif has been distinguished, termed AMLRY, which lies at positions 
406-410 of yeast eRF1. In general, mutations at the C terminus of eRF1 do not significantly 
affect the overall function as these residues are stabilized by water solvent. However, 
substitution of Y410 alters the secondary structure of residues 343-349, despite the relative long 
distance between these two regions. This might be attributed to the capability of the proton in 
the tyrosine molecule to be readily ionized, in addition to the functional group and electrons 
122 
 
contained in the tyrosine molecule. An exception, substitution of tyrosine to phenylalanine does 
not disturb the amino acids structure in the stated region (Akhmaloka et al., 2008).  
 
4.8.2 Effect of eRF3 on the 2A reaction 
The effect of three mutations of the eRF3 protein, R320I, G357D and S416F, on the 2A 
reaction was tested. All lie in the functional G domain region of eRF3, however only S416F 
revealed a significant inhibition of the 2A reaction, reducing the amount of both upstream and 
downstream fragments generated. S416 is located in the hydrophobic pocket (residues 385- 
429), which holds the guanine base of G-nucleotides (Andersen et al., 2001). Thus, mutating 
serine 416 to phenylalanine clearly impairs the GTPase function of this domain, and hence the 
termination efficiency while translating 2A peptide. However, mutation of glycine 357 and 
arginine 320, which assume a role in the GTPase activity of eRF3 (Salas-Marco and Bedwell, 
2004), did not significantly alter the reaction outcomes. The change in the eRF1 conformation 
in the ribosome, caused by the presence of the Pro 19 codon rather than a stop codon in the 
ribosomal A site, may result in a change in the normal conformation of eRF3, seen in the 
canonical termination, for better binding to eRF1, thus, change in specific residues for eRF3  
binding are expected in the case of 2A. This conclusion is based on the reduction of the 2A 
activity caused by mutating threonine 295 (section 4.3.2), one of the key residues in the eRF1 
binding site to the eRF3. eRF3 contributes in peptide release by increasing the rate ~5 times 
over the basal rate (Eyler et al., 2013). This effect is possibly due to the role of eRF3-GTP in 
mediating the proper conformation of eRF1 in the TC. This confirms that eRF3 is also recruited 
to the ribosome in the presence of 2A peptide. 
 
4.8.3 Overexpression of 2A inhibits the growth of cells expressing some eRF1/3 
variants 
The growth doubling time of strains with some mutations in eRF1/3 was inhibited by 
expression of a 2A (but not 2A*) -encoding mRNA. These data are in accordance with what 
was obtained from the same strains when we exposed them to the pulse labelling. These data 
are also consistent with the results of Doronina et al., (2008). However, the former work was 
carried out only on strains with reduced eRF1/3 activity (sup45-42), or [PSI+] respectively, but 
they confirmed that 2A peptides from other viruses such as Thosea asigna virus and Theiler's 
murine encephalitis virus are also able to inhibit the growth. Strains expressing some Sup45 
variants showed a significant reduction of the 2A reaction, detected by immunoprecipitation, 
but no effect on the growth, for example, P38L, P174Q and L49A strains. On the other hand, 
the strain expressing the Y410F mutation of eRF1 has shown a significant increase in the 
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doubling time while expressing both active and inactive 2A peptides, which might be attributed 
to a toxicity in the strain background, although this curve was repeated several times to confirm 
the current result. This is inconsistent with Doronina et al (2008), who suggested that the growth 
inhibition is not “sup45 allele specific”. On the other hand, the same study found that the 
expression of 2A-containing polyprotein from a “moderate strength promoter” such as PHO5 
does not alter the growth of strains with reduced eRF activity. Those findings, and data from 
the current study, suggest that the expression of 2A is toxic for cells, especially in presence of 
certain mutations in the ribosomal termination factors.  
 
4.8.4 Stop codon read-through in cells expressing 2A and undergoing termination with 
eRF1/3  variants 
To investigate the effect of 2A expression on termination efficiency in S. cerevisiae cells 
with mutant eRF1, plasmids encoding dual-luciferase reporters with different stop codons and/ 
or context sequences were used. These effects have been investigated on UAA and UAG stop 
codons, with adenine as a context sequence for the former and adenine or cytosine for the last 
stop codon. It has been reported that there is an increase in stop codon read-through in cells 
expressing 2A (Doronina et al., 2008), however the former study did not consider mutations in 
the eRFs. In the current study, we observed a highly significant stop codon suppression, 
expressed by the ratio of ribosomes undergoing read-through over different stop codons. 
Excluding the S30P-sup45, our results are quite consistent with what we observed from the 
immunoprecipitation experiments; all strains have shown different levels of read-through 
compared to the strain expressing isogenic wild type SUP45. It has already been demonstrated 
that mutations in eRF1 induce stop codon read-through. To confirm that the stop codon read-
through results from the 2A peptide expressed in yeast cells, we used different controls for each 
sample, which is the 2A*, this an inactive version of 2A carries P17A mutation, which 
inactivates the peptide. Therefore, we can attribute the increase in the read-through ratio to the 
effect of 2A expression in cells. Our analysis has revealed a high base line read-through being 
promoted by UAG C, which is consistent with other studies (Rakwalska and Rospert, 2004). 
Thus, this stop codon is an efficient and sensitive indicator of termination defects, with almost 
no effect of the context sequence in terms of measuring the read-through ratio in the strain 
expressing isogenic wild type eRF1. The stop codon read-through was lower with the UAA A 
stop codon, compared to the other stop codons. This was revealed by the wild type basal read-
through however, it is still above the normal value, such an effect might be attributed to the 
presence of a large pool of 2A peptides. The same results, in terms of increased stop codon 
read-through, have been detected in strains expressing sup35 alleles, with the most significant 
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elevation undergone by the [PSI+] strain. The increased basal level of stop codon inhibition is 
unlikely to be eRF-specific, but instead, 2A-induced effect, given that the wild type eRFs are 
also increasing the stop codon inhibition while expressing active 2A peptide compared to the 
inactive 2A. The increased stop codon read-through, in trans, in the presence of multiple copies 
of 2A, suggests that 2A may deplete termination factors in the cytosol, and these factors may 
remain bound to the ribosome at 2A, which reduces the availability of these factors for 
canonical termination. We have confirmed that 2A reaction is mainly a termination event, 
driven by eRF1/3, which are recruited, somehow, to the ribosome. Although mutations in 
eRF1/3 produce a significant ratio of full-length product of the 2A reporter, Ribosome could be 
stalled at the 3’ end of mRNA, and ribosomal subunits might stay bound to each other, with no 
proper release of eRFs from the ribosome. Our findings, when reduced Rli1 abundance (DAmP-
rli1)  did not affect the reaction, support this theory. Thus, a high ratio of eRF1 will not be 
recycled and hence it is functionally inactive to drive successful termination and decode stop 
codons. It has been found that 2A peptide has no effect on cellular eRFs levels (Doronina et al., 
2008). Furthermore, it has been found that the reduction in Sup45 level in S. cerevisiae is the 
main reason for increased stop codon read-through (Salas-Marco and Bedwell, 2004).  
 
SUMMARY 
Data presented in this chapter confirm results presented in Chapter 3, that both eRF1 and 
eRF3 are essential to drive the 2A reaction. The analysis of a broad range of mutations in eRF1, 
which covers the most key regions for the protein activity, revealed a clear involvement of some 
residues of the protein in the 2A reaction. However, this involvement is likely to be different 
from that undergone in canonical termination, in the presence of a stop codon in the ribosomal 
A site. A modification/shifting in the normal conformation of eRF1 is proposed here for proper 
accommodation of eRF1 in the ribosome, and thereby successful releasing of the nascent 
peptide chain from the PTC. Given that eRF3 assumes an essential role for eRF1 function, in 
terms of driving translation, eRF3 seems to be an important counterpart of the 2A reaction, 
through its GTPase activity. These main results have been confirmed by 1) measuring growth 
doubling time of strains expressing 2A and driving termination using sup45 alleles, and 2) 
assessing the propensity of the former strains to suppress stop codons, and thereby promoting 
read-through. Although the outcomes of growth rates are not fully consistent with the results of 
the main biochemical experiments, the observations regarding to the read-through assay are 
found to be in accordance with the biochemical analysis, undergone by cell pulse labelling and 
immunoprecipitation. To sum up, changing the availability, activity, or even replacing 
particular key residues of eRF1/3 results in a significant inhibition of the 2A reaction, 
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promoting the ribosome to read-through the 2A peptide coding sequence, and pauses at the 3’ 
end of the ORF.                      
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5 CHAPTER 5: DEVELOPING NOVEL REPORTERS FOR 
STUDYING 2A ACTIVITY 
5.1 Introduction 
Polyprotein reporters that have been used thus far to study the activity of the 2A peptide 
lie in two categories: 1) reporters such as αF-2A-GFP, which has previously been described in 
Chapters 2, 3 and 4. Analysis of translation products of this reporter requires at a minimum 
western blotting and for accurate determination of activity pulse-labelling, 
immunoprecipitation and quantification are required. 2) Reporters such as Ub-R-2A-ADE2 
(Sharma et al., 2012). In this reporter, the 2A reaction releases Ade2 protein from degradation 
imposed by an N-terminal arginine (exposed after proteolytic cleavage of the translation 
product). Activity is then scored on the basis of yeast colony pigmentation: in a genetically 
ade2 background, which yields red cells on media containing limited adenine, this produces 
cells of decreasing colouration as 2A activity increases. Although the adenine reporter is easy 
and quick to implement, it relies on several cellular metabolic pathways and enzymes, both to 
generate the red pigment and to process the Ub-R-2A-Ade2 protein. Indeed, attempts to use this 
reporter in screens for cellular mutations that affect the 2A reaction have thus far only identified 
false-positives (Sharma et al., 2012). In this chapter, alternative strategies were considered, 
aiming to generate reporters which are less reliant on cellular pathways for function. Two 
reporters are described, based on the use of DHFR or GFP. 
 
5.2 Dihydrofolate reductase (DHFR) reporter 
A dihydrofolate reductase  (DHFR)-based reporter of the 2A reaction was generated by 
placing sequences coding for 2A within DHFR at the position used to split the protein into the 
2 fragments (termed F1,2 and F3), used in the protein fragment complementation assay (PCA) 
(Tarassov et al., 2008). With the knowledge that the DHFR protein split at this position is 
unable to form a functional enzyme, and that fusion of sequences to the protein at this point 
does not leave the fragments unable to form a functional enzyme when they are brought 
together, made this a strong candidate for a suitable position to place 2A. Activity of 2A should 
separate the enzyme into 2 inactive fragments (F1,2 and F3), whereas any full-length protein 
produced, e.g. through the effect of either a mutation within 2A that inactivates it or a trans-
acting mutation that leads to the 2A reaction being inefficient, would hopefully be active. 
DHFR activity can be scored using Methotrexate (Mtx). Mtx is a competitive inhibitor of 
DHFR, a key enzyme in folate metabolism that catalyses synthesis of tetrahydrofolate, which 
is required for de novo synthesis of thymidine (Miran et al., 2017). The mouse DHFR used to 
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generate the new reporter exhibits increased resistance to Mtx (10,000 times less sensitive to 
Mtx than the endogenous yeast enzyme), due to specific mutations within its sequence. At the 
levels of methotrexate used to test constructs containing this DHFR sequence, the yeast enzyme 
is completely inhibited. 
The F1,2 and F3 fragments of the DHFR gene were amplified by PCR from yeast strains 
containing plasmids which included sequences encoding these (kind gift of Dr P. Banks, 
Newcastle University).  These were cloned with the two parts of DHFR separated by 
appropriate restriction sites to allow subsequent cloning of the 2A-coding sequences (figure 
5.1). Two induced mutations in the DHFR coding sequence were obtained; L23Y and F32S, 
these were confirmed via sequencing the constructs which have been cloned. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1: The sequence of the DHFR used to develop the 2A reporter. 
The sequence of pDHFR obtained after cloning. The mutations that confer increased resistance to methotrexate 
(L23Y and F32S) and restriction sites into which 2A/2A* were subsequently cloned are indicated. 
 
Three plasmids were generated, one containing the full-length DHFR coding sequence (termed 
pDHFR), and two with FMDV 2A sequences inserted between the F1,2 and F3 fragments. Of 
these, one contained the P17A mutation that inactivates 2A, termed 2A*. Wild type yeast strains 
(JDY2, 4 and 895) were transformed with plasmids pDHFR, pDHFR-2A, and pDHFR-2A* and 
then screened for resistance to Mtx by spotting serial dilutions onto plates containing different 
concentrations, 50, 100 and 200 µg/ml of Mtx (data not shown). It was found that the highest 
concentration (200 µg/ml) is the optimal concentration for testing growth of yeast in the PCA 
using Mtx selection (Tarassov et al., 2008).  
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Figure 5.2: Scheme of the DHFR reporter cloning strategies. 
The PCR-5’ and 3’ fragments of the DHFR open reading frame (coding for the F1,2 and F3 fragments  of the 
protein) were cloned into a pRS314 vector using the restriction enzymes indicated. The whole construct was 
basically cloned using single digestion strategy into a SmaI site. This generated pDHFR, containing a linker of 
NcoI, AgeI and XbaI restriction sites. Subsequently, 2A or 2A* fragments were cloned between the NcoI and AgeI 
sites. 
 Testing of the constructs in wild type strains of S. cerevisiae revealed no significant differences 
in the growth rates of cells containing the four plasmids (2A and 2A* cloned between F1,2 and 
F3 of DHFR) on Mtx plates compared to the controls (empty vector and wild type DHFR) in 
wild type strains used (Data not shown).  Additionally, growth of cells transformed with these 
plasmids in liquid media was monitored and it was found that they all grew similarly in the 
presence of Mtx, with no growth inhibition observed due to the presence of active 2A peptide 
in the middle of DHFR (data not shown). 
 
The most concerning aspect to this experiment is that the negative control yeast strains, which 
does not express mouse DHFR, grew similarly to those expressing DHFR on Mtx plates. 
Several tests were carried out to determine the reason for this. It was possible that there may be 
an interaction between Mtx and one or more components in the media, thus preventing it from 
being available for uptake into the yeast cells. Several experiments were undertaken to try to 
determine if media components were to blame, and specifically the agar used since it was 
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highlighted by Professor D. Lydall (Newcastle University) that some agars may inhibit the 
activity of Mtx, whereas noble agar does not. However, cell growth on plates containing noble 
agar was similar to that on plates containing the agar that was typically used (Formedium) (data 
not shown). A second possibility was that the Mtx used had low activity/was inactive. To 
investigate the activity of the Mtx, and also to see whether the strain background used in the 
experiments above could be more resistant to Mtx than the strain used by the Lydall laboratory, 
control yeast strains were obtained (Lydall laboratory), expressing the F1,2 (Nourseothricin, 
NAT resistant strain) and F3 (Hygromycine B, HYG resistant strain) fragments of DHFR fused 
to Sod1, which has a strong interaction due to the dimerization of Sod1 (Shibasaki et al., 2008). 
These were mated and the resulting diploid tested alongside the haploid strains on Mtx plates. 
The two strains, expressing either F1,2 or F3 fragments, were used as controls along with a 
diploid one, all were tested on plates containing appropriate antibiotics (100 µg/ml w/v NAT 
and 200 µg/ml w/v HYG). The haploid strains did not grow on Mtx screens; in contrast, the 
diploid grew due to the expression of intact DHFR (figure 5.3).  
 
Figure 5.3: Testing the activity of Mtx using control strains. 
Haploid strains expressing F1,2 fragment (NAT resistant) and F3 fragment (HYG resistant) of DHFR from 
centromeric plasmids (JDY1299 and 1300 respectively) were mated to generate a diploid strain (NAT and HYG 
resistant), which expresses the intact DHFR gene. Serial dilutions from each strain were prepared and spotted on 
plates containing Mtx (200 µg/ml) against control plates (-Mtx), and incubated at 30 ºC. Rows are duplicated for 
each strain.  
 
The growth rate of the diploid strain was not very fast on Mtx-containing plates, but the same 
growth rate was observed on the control plate for the same strain, whereas the other two strains, 
which do not express an intact DHFR showed an inhibition in terms of their growth on Mtx. 
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This suggests that replacing the Mtx with another one, supplied by Sigma, was successful to 
resolve the problem.  
 
Figure 5.4: Testing the efficiency of the DHFR reporter on Mtx screen. 
Plasmids (pRS314) encoding wild type DHFR, 2A or 2A* inserted between F1,2 and F3 fragments of DHFR were 
transformed in a wild type yeast strain (JDY895) (rows 4,5,6 and 7) to obtain strains expressing DHFR gene, 
interrupted by 2A sequence, as well as a control, which expresses a wild type DHFR (not interrupted by 2A 
sequence). These strains, along with the once which carry F1,2, F3 and the diploid mentioned above (rows 1.2 and 
3) (see legend to figure 5.3 for details), were grown, and serial dilutions were prepared from each and spotted on 
Mtx plates. Plates were incubated at 30 ºC. 
Although the issue with Mtx is likely resolved, we did not find what is expected from expressing 
active 2A peptide within the DHFR sequence. Theoretically, it is supposed that the strain which 
is transformed with a plasmid encoding 2A sequence between F1,2 and F3 fragments of DHFR 
gene, to reduce the growth on Mtx plates, compared to strains transformed with a plasmid 
encoding 2A* between F1,2 and F3 fragments or a plasmid encoding the intact DHFR gene. 
The reason for this, is the expression of DHFR, which enables the strain to grow on Mtx plates. 
Here, we found that the growth of the tested strains is not affected by the DHFR expression i.e. 
the control strains lacking the intact DHFR grew similarly on media containing or lacking Mtx. 
Furthermore, no difference on the growth is detected between the strain expressing the active 
or inactive version of the FMDV 2A peptide (figure 5.4). Given that the two haploid and the 
diploid strains respond to the Mtx-containing plates, we can confirm that there is no issue with 
the activity of the drug. These outcomes may indicate another interference/s with the 2A 
 
F1,2 
 
F3 
 
Diploid 
 
Vector 
 
DHFR 
 
DHFR-2A 
 
DHFR-2A* 
Control                                                     Mtx (200 µg/ml)    
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activity, and suggest that the DHFR reporter does not compromise the 2A reaction, and cannot 
be implemented at moment as a tool to investigate the 2A activity. 
 
5.3  Green fluorescent protein (GFP) reporter 
The second reporter that was developed used GFP, and the same principle was followed 
as with DHFR i.e. separation of the protein into 2 fragments by the 2A reaction, the fragments 
then not being able to re-associate. It has been reported that insertion of sequences between 
residues 157 and 158 of GFP, located in an extended loop in its structure, does not influence 
expression, folding, and fluorescence of the protein. On the other hand, expressing GFP as 2 
fragments separated between residues 157 and 158 yields no reassembled fluorescent protein 
(Gosh et al., 2000) (figure 5.5).  
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Figure 5.5: Scheme of the GFP reporter. 
 GFP fragments (sequence encoding residues 1-157 and 158-end) were generated by PCR using appropriate 
oligonucleotides. Also, sequences of 2A were generated using the specific forward oligonucleotide encoding the 
2A sequence and a T3 oligonucleotide. This generates fragments of DNA encoding 2A sequence at the 5’ in 
addition to the second fragment of GFP (sequence of residues 158-end) in addition to the T3 terminator. Initial 
cloning for GFP sequence was performed using SmaI restriction site to clone the basic construct (GFP 1-157-2A- 
GFP 158-end). Different 2A sequences were then cloned to the vector by replacing the first sequence of 2A using 
BglII site at the 5’ and EcoRI at the 3’ of T3 terminator. Cloning was done into pRS316, URA3 yeast vector. 
Plasmids encoding GFP reporters were transformed into a wild type strain (JDY895) of S. cerevisiae, and assessed 
using different strategies. In general, when 2A is inactive, it is expected the GFP to show normal fluorescent 
activity. Whereas inserting active 2A in GFP decreases the fluorescence depending on the 2A activity. 
 
 2A coding sequences were cloned between codons 157 and 158, flanked with linkers to give 
structural flexibility and hopefully promote proper folding of the protein. Cloning was 
performed into the URA3-marked low copy (centromeric) pRS316 plasmid (Sikorski and 
Hieter, 1989), and the gene initially expressed from SRP14 promoter. A variety of 2A sequences 
were used including, FMDV, IFV, DCV, TaV, PTV, PrV, amplified by PCR using T3 as a 
reverse primer, and such cloning was achieved using BglII and EcoRI sites which flank 2A- 
second part of GFP (158-end)-T3. Controls were provided by the 2A* and an uninterrupted 
wild type GFP. 
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Preliminary experiments were carried out using fluorescence microscopy and western blotting 
(data not shown) to examine the efficiency of the reporter. These experiments revealed that 
cells expressing active 2A within the GFP structure showed decreased fluorescence compared 
with cells expressing the inactive 2A*.  
 
5.3.1 Fluorescent microscopy of the GFP reporter 
The initial constructs of the GFP reporters included cloning of 2A/A* sequences from 
Thosea asigna virus (TaV) 2A encoding for 19 amino acids. The efficiency of these constructs 
has been initially examined under the fluorescent microscope (figure 5.6). 
 
 
 
 
 
 
 
 
 
134 
 
 
 
 
Microscopic test revealed strong fluorescence from some, but not all, cells containing TaV 2A* 
(figure 5.6 C and D). In contrast, cells expressing GFP with active TaV 2A showed less 
fluorescent activity which was expected in the presence of active 2A (figure 5.6 E & F). Of 
note, all constructs expressing GFP showed higher fluorescent activity compared to the empty 
vector which does not express GFP ( figure 5.6 , A & B), suggesting that the TaV 2A peptide 
was not fully active, leading to some intact GFP being expressed. However, these data cannot 
be confirmed unless compared to a wild type GFP. 
 
5.3.2 Measurement of GFP fluorescence in yeast using flow cytometry 
To this point, the GFP reporter provides a qualitative assessment for 2A activity, where 
we can roughly estimate the reaction efficiency. GFP fluorescence can be quantified on a single 
cell level using flow cytometry, allowing the expression profile across a population of cells to 
be examined. This was of particular interest since the initial fluorescence microscopy 
experiments (e.g. figure 5.6 D) had revealed differences in fluorescence in cells and some that 
appeared not to fluoresce. Cultures of each strain were incubated overnight in selective media 
Figure 5.6: Fluorescence activity 
of yeast cells expressing TaV GFP 
reporter. 
Reporters were constructed with active 
2A and inactive (P17A, 2A*) and cloned 
into the coding sequence for GFP between 
the codons for amino acids 157 and 158 of 
the protein. Versions of 2A used in this 
experiment were TaV-2A (19 amino 
acids), TaV-2A* (19 amino acids), and an 
empty vector. These constructs were 
transformed into a wild type yeast strain, 
BY4741 (Cubillos et al., 2009) and grown 
overnight at 30 ºC. Cultures were diluted 
in the morning and following regrowth for 
2-4 hours, cells fixed in low melting point 
agarose on slides. Cells were visualised 
and images captured using an Axiovert 
200 microscope (Zeiss) with a 100X lens. 
(A & B) Phase contrast and GFP 
fluorescence of the empty vector. (C & D) 
Phase contrast and fluorescence of the 
TaV-2A*/ respectively. (E & F) Phase 
contrast and fluorescence of TaV 2A 
respectively. All fluorescence and all 
phase contrast images were captured with 
the same settings using Zeiss Axiovision 
software, exported as TIF files, and 
processed in the same way using 
Photoshop (Adobe). 
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at 30 ºC, diluted on the next day, and allowed to grow 2-3 hours. The OD600 was measured and 
five ODs were harvested by centrifugation, washed with sterile dH2O and then PBS, and re-
suspended in 1 ml PBS. Suspensions were sonicated (0.5 mA) for 10 seconds. Fluorescence 
was measured using FORTESSA X20 in the Medical School Flow Cytometry Core Facility 
(FCCF), using appropriate settings for GFP fluorescence (figure 5.7). 
 
                                                     
                                                                 
5.3.3 The length of the 2A peptide is directly related to the activity 
Next, we compared the activity of short amino acid sequences (19 residues) with longer 
sequences (31 residues) of the 2A peptide (figure 5.8). Results of fluorescent microscopy (data 
not shown) and/or western blotting revealed that longer 2A peptides derived from TaV have 
higher activity, compared to the shorter peptides. The protein expression in yeast, observed by 
western blotting is higher with the 19 amino acids length of the TaV 2A peptide. This is 
confirmed by measuring the GFP fluorescence using flow cytometry, which reflects lower 2A 
activity, thus the ribosome is promoted to assume continuous translation through the proline 
19, with no release of the upstream fragment. Consequently, the higher fraction of intact protein 
produced in cases of lower 2A activity shows higher GFP fluorescence in cells under the 
microscope. 
 
Figure 5.7: Measurement of GFP 
fluorescence using flow cytometry. 
Cultures of the yeast strain JDY895 already 
transformed with plasmids encoding GFP reporter 
including: wild type GFP, where no 2A was 
inserted, 2A*, 2A and empty vector to subtract the 
background, were incubated at 30 ºC in the 
afternoon. Cultures were diluted in the morning 
and allowed to re-grow again for 2-3 hours. 5 
OD600 were harvested from each strain, washed 
twice with water and PBS, and re-suspended in 1 
ml PBS each. Sonication at low power was 
performed for 10 seconds to reduce cells 
aggregation. Fluorescence measurement was 
achieved on FORTESSA X20 using specific GFP 
settings (488 710/50-A against 488 530/30-A. A 
propagate was set around the population of the 
empty vector sample (A). This is to estimate the 
noise/background in the strain expressing the 
empty vector, where no GFP is expressed, and to 
clarify the GFP-positive events in other tested 
strains, which are shown outside the gate in B, C 
and D in  such measurement. (A) Empty vector. 
(B) Wild type GFP. (C) 2A* and (D) 2A     
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Figure 5.8: Comparative activity of different lengths of 2A peptides derived from TaV 
2A peptide. 
The effect of peptide length has been investigated, and results are presented regarding to both western blotting 
(left) and flow cytometry (right). Western blotting for proteins extracted from cells expressing 19 and 31 amino 
acids was undergone according to the standard method described in the Materials and Methods, and proteins on 
the membrane were treated with primary anti-GFP antibody (1:1000 mouse monoclonal antibody supplied by 
Abcam).   The same laboratory procedures presented in the above figures have also been followed here. Data 
analysis of the flow cytometry measurement. Values presented represent the ratio of GFP positive cells in such 
strain. The ratios of GFP-positive cells were obtained from the oparating software (BD FACSDiva™ software) 
which is used with the FORTESSA X20 operation. This is performed by relating the GFP-positive cells to the 
parent cells. 
 
 
From data presented in figure 5.8, longer TaV 2A peptide showed higher activity, observed by 
fluorescent microscopy, western blotting and flow cytometry. The longer peptide sequence of 
2A shows more activity, obtained by decreased GFP fluorescence, it represents less than 25% 
of the activity shown by the wild type GFP, whereas it is ~30% in the shorter peptide sequence 
of 2A (19 amino acids). Both shorter and longer inactive 2A peptides have shown similar 
fluorescence activity, which is less than that in the strain expressing wild type GFP, where no 
2A is inserted. This suggests a direct relationship between the length of the 2A peptide and the 
activity. Of note, it has clearly been observed that the insertion of 2A peptide reduces the ability 
of GFP to show a normal fluorescence activity. Noticeably, data from both longer and shorter 
2A* indicate that although 2A is inactive, the presence of this sequence in the middle of GFP 
protein may influence the florescence, which is found to be in these strains ~65% of that seen 
in the strain expressing wild type GFP. Furthermore, data observed from both fluorescent 
microscopy and/or flow cytometry show that not all cells express the GFP in the same manner, 
in other words, GFP reporter is being expressed in a fraction of cells rather than the total cell in 
the culture (figures 5.6 & 5.7). This may reduce the efficiency of the reporter and interfere with 
the accuracy. Efforts for further optimisation of the GFP reporter will be carried out for 
optimum results.    
137 
 
 
5.3.4 Investigating the effect of codon usage bias in yeast on the 2A activity using the 
GFP reporter 
Codon usage bias (CUB) is species-specific differences in the prevalence of 
synonymous codons, reflecting the abundance of the tRNAs that bind to them (Pop et al., 2014). 
It has been proposed that CUB helps to maintain fast translation with high degree of accuracy. 
Given that yeast cells are not the natural host of viruses encoding 2A peptide, 2A reaction might 
not be optimised in yeast, at least partly due to differences in codon usage. Depending on CUB, 
we proposed that changing particular nucleotides in the 2A-coding sequence with others 
preferred by S. cerevisiae translation machinery may have positive or negative effects on 2A 
activity. Here, we used 31 amino acid FMDV sequences encoding 2A and 12 upstream amino 
acids to undergo the current expriments.  Two versions were constructed, ‘optimised’ and ‘de-
optimised’ with respect to synonymous codon usage in yeast, specifically across the conserved 
GDVESN motif just prior to the end of the 2A peptide sequence (figure 5.9). In the optimised 
sequence, we used the most preferred codons in S. cerevisiae, whereas a standard 2A sequence 
of the FMDV was used as a de-optimised sequence. The expected outcome of these differences 
in codons would be that ribosomes translating the de-optimised sequence would be slower as 
they approached the critical glycine-proline codons.   
 
 
 
 
 
 
 
 
 
Figure 5.9: Comparative sequence of optimised and de-optimised 2A peptides derived from 
FMDV. 
Nucleotide and consequent amino acid sequences of optimised vs de-optimised (a wild type sequence) 2A peptides 
of the FMDV are presented for comparison. Different nucleotides between the two sequences are underlined. The 
standards of S. cerevisiae codon usage bias were taken into account when primers were designed. 
 
 
 
Optimised: 5’- 
CCAAGATCTAGACATAAACAAAAAATTGTTGCTCCAGTTAAACAAACTTTGAATTTTGAT 
 P  R  S  R  H  K  Q  K  I  V  A  P  V  K  Q  T  L  N  F  D  
TTGTTGAAATTGGCTGGTGATGTTGAATCTAATCCAGGTCCATCCGGA-3’ 
 L  L  K  L  A  G  D  V  E  S  N  P  G  P  S  G     
 
De-optimised: 5’- 
 CCAAGATCTAGACATAAACAAAAAATTGTTGCTCCAGTTAAACAAACTTTGAATTTTGAT 
  P  R  S  R  H  K  Q  K  I  V  A  P  V  K  Q  T  L  N  F  D  
TTGTTGAAATTGGCTGGGGACGTGGAGTCGAACCCAGGTCCATCCGGA-3’ 
 L  L  K  L  A  G  D  V  E  S  N  P  G  P  S  G     
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Figure 5.10: Comparative data of optimised versus de-optimised 2A peptides from FMDV. 
 
Fluorescence microscopy of a wild type yeast strain (JDY895) transformed with plasmids encoding GFP reporters 
with optimised/de-optimised FMDV 2A peptide. (A& B) Phase contrast and GFP fluorescence of the wild type 
GFP. (C& D) Phase contrast and GFP fluorescence of the 2A*. (E& F) Phase contrast and GFP fluorescence of 
the optimised FMDV 2A peptide. (G& H) Phase contrast and GFP fluorescence of the de-optimised 2A. The chart 
underneath represents the flow cytometry data observed from same strains when exposed to cell sorting. Cells for 
both techniques were treated as described earlier in the Materials and Methods. The ratios of GFP-positive cells 
were obtained from the operating software (BD FACSDiva™ software) which is used with the FORTESSA X20 
operation. This is performed by relating the GFP-positive cells to the parent cells. 
 
The optimisation of the third nucleotide in codons of the C-terminus conserved motif of the 2A 
peptide increased the activity of the reaction, observed by decreased GFP fluorescent activity 
shown by both fluorescent microscopy and flow cytometry. The 40% decreased 2A activity 
observed in the strain expressing the optimised 2A, compared to the de-optimised 2A, and the 
75% decrease compared to the inactive 2A peptide, confirms the concept of more efficient 
 
 
 
 
 
 
 
 
 
 
 
D 
A B 
E F 
C D 
G H 
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translation when considering the optimum codons depending on the codon usage bias. On the 
other hand, de-optimising the DVESN conserved motif showed more GFP activity than the 
optimised one, but still less than the inactive 2A with about 40% (figure 5.10). 
 
5.3.5 Testing the efficiency of the GFP reporter with mutations in the conserved motif 
of FMDV 2A peptide 
In this section, we investigate the effects of three mutations in the conserved motif, 
located at the C-terminus of the FMDV 2A peptide. These mutations include: E14Q, S15I and 
N16H. These mutations were created in a longer sequence of FMDV 2A peptide in order to 
observe higher activity, given that we already approved above that longer sequences of 2A 
peptides are more active than the standard sequence (19 amino acids) (figure 5.8). 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11: Flow cytometry analysis of GFP fluorescence with mutations in the conserved 
motif of FMDV 2A peptide. 
Three point mutations in the C-terminus conserved motif of 2A peptide including, E14Q, S15I and N16H, were 
induced using PCR. Appropriate oligonucleotides encoding a single mutation in each were used to amplify PCR 
DNA fragments. DNA fragments were cloned into pRS316, URA3 vector, and plasmids were transformed into a 
wild type strain of S. cerevisiae. Transformed strains were grown in selective media at 30 ∘C, and overnight cultures 
were diluted on the next day using the same media, and allowed to grow again until reaching OD600~0.5. Five ODs 
were harvested in Falcon tubes using bench-top centrifuge at 3000 rpm for 5 minutes and washed with sterile PBS. 
Pellets were re-suspended in 1 ml PBS and sonicated for 30 seconds. Samples were exposed to flow cytometry as 
described in Materials and Methods.  
 
Mutating S15 or N16 residues does not affect the GFP fluorescence detected by flow cytometry 
whereas, the E14Q mutation caused a sharp reduction (~50%) in the fluorescence compared 
with the wild type FMDV 2A activity (figure 5.11). This suggests an improvement in the 2A 
activity with this mutation over the value of the wild type FMDV 2A peptide, where the normal 
codons for the whole sequence is not changed. However, the value of the wild type FMDV 2A 
represents ~30% of that of the 2A*. 
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5.3.6 Comparative analysis of 2A activity from different viruses 
To this point, we successfully developed an efficient tool to study the 2A activity. From 
experiments carried out and presented above, the GFP reporter responds properly and reflects 
accurate results where we can assess the 2A activity during different conditions. Further work 
has been undertaken here to optimise the reporter efficiency. In this section, we have utilised 
the GFP reporter to investigate the activity of 2A peptides from different viruses, and to find 
out if the activity is different when 2A sequence is expressed in S. cerevisiae cells. Thus far, 
longer sequences of both FMDV and TaV 2A peptides were used in the previous experiments. 
Here, it seems logical to investigate activities of different 2A peptides in S. cerevisiae cells as 
a comparative analysis. DNA sequences of 2A peptides presented in table 5.1 were cloned into 
the same vector encoding the GFP, the resulting plasmids were transformed into a wild type 
yeast strain (JDY895). Experiments were carried out as described in above sections. 
 
Infectious flacherie virus 
(IFV) (AB000906) 
 
P S I G N V A R T L T R A E I E D E L I R A G I E S N P G 
P 
Perina nuda picorna-like 
virus (PrV2A1) 
(AF548354) 
 
L E M K E S N S G Y V V G D R G S L L T C G D V E S N 
P G P 
Drosophila C virus  
(DCV) 
Q G I G K K N P K Q E A A R Q M L L L L S G D V E T N 
P G P 
Porcine tescho virus-1 
(PTV) 
A M T V M T F Q G P G A T N F S L L K Q A G D V E E 
N P G P 
Infectious myonecrosis 
virus (IMNV) 
W D P T Y I E I S D C M L P P P D L T S C G D V E S N P 
G P 
Thosea asigna virus  
(TaV) 
G R S R G P R P Q N G S G E G R G S L L T C G D V E N 
P G P 
Foot and Mouth Disease 
Virus (FMDV) 
P R S R H K G S G V K Q T L N F D L L K L A G D V E S 
N P G P 
 
Table 5.1: Different 2A peptides used for comparison with their amino acid sequences. 
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The comparative activity of these different sequences was assessed via western blotting and 
flow cytometry. Different amino acid sequences showed different activities when expressed in 
S. cerevisiae cells. It has been shown in figure 5.12 that different 2A peptides have different 
fluorescence, thereby different reaction activity. Here, we have chosen the most active 2A 
peptides amongst the collection which has been examined. 
 
 
Figure 5.12: Different 2A peptides from several viruses illustrate different activities in S. 
cerevisiae cells. 
 Different sequences of 2A peptides encoded in several viruses are compared here in terms of their activities. 
Different DNA sequences of 2A peptides encoded in several viruses were amplified using PCR, and resulting 
fragments were cloned into pRS316, URA3 vectors. Plasmids were transformed into a wild type S. cerevisiae 
strain, and grown in selective media at 30 ºC. Cultures were diluted on the next day and allowed to grow again to 
the OD600~0.5. Five ODs were harvested from each culture and treated as decribed previously for flow cytometry. 
Proteins were extracted from the same cultures for western blotting (see Materials and Methods for details). 20 µg 
of each protein were resolved into SDS-PAGE and trans blotted onto hemicellulose membrane. Protein bands were 
detected on the transblotted membranes using anti GFP monoclonal antibody. Panel (A) Flow cytometry analysis 
of strains expressing a variety of 2A-coding sequences, placed in the middle of GFP as a reporter, compared to the 
wild type GFP and/or 2A*. Panel (B) Western blotting of proteins extracted from yeast strains expressing the same 
GFP reporters with different 2A peptides, presented in panel A. Protein bands observed in this panel demonstrates 
slight differences in term of their sizes, due to differences in their amino acid sequences, and hence, molecular 
mass. 
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From data presented above (figure 5.12), different amino acid sequences of 2A peptides have 
shown different activities, assessed by both western blots and flow cytometry, and confirmed 
by fluorescent microscopy (data not shown). Noticeably, the amino acid sequence in different 
2A peptides is implicated in its activity when expressed in S. cerevisiae cells. The most active 
2A peptide amongst the range that has been tested is the peptide taken from PTV 2A. In this 
peptide, the fluorescence of GFP is at its minimum level, representing ~10% of the controls, 
which include both wild type GFP and 2A*. The high efficiency of PTV permitted no intact 
GFP to be produced by the ribosome, concomitantly, no fluorescence has been detected. 
Furthermore, DCV and IMNV have also shown higher activity (30% of the controls) obtained 
by flow cytometry and/or western blotting outcomes. However, it is still below the level that 
has been shown by the PTV 2A peptide. The PrV 2A results are slightly contradictory, the 
fluorescent activity of this peptide, observed by flow cytometry, is ~50% of that in the wild 
type GFP, whereas, it reflects a high activity by western blot. Furthermore, these results show 
that the least active 2A peptide among the selection examined was the TaV 2A peptide, this is 
demonstrated in the flow cytometry outcomes, and confirmed by western blotting. The control 
used in this experiment consists of the wild type GFP, where the sequence of the protein was 
not interrupted by the 2A peptide, as well as the TaV 2Amut (2A*). Both controls approached 
the same levels of fluorescence although the western blotting screen demonstrates a higher 
intensity of the protein band corresponding to the 2A* (figure 5.12 A& B). 
 
5.3.7 Optimisation of the GFP reporter efficiency 
As we have previously mentioned, the GFP reporter is currently efficient in measuring 
the 2A activity in different conditions, and indicating increased/decreased activity when 
reaction circumstances are changed accordingly. However, the cells in fluorescent microscopy 
and/or flow cytometry do not show equality in their fluorescence, in other words, yeast cells in 
the same culture have different levels of fluorescence although they express the same reporter- 
encoding sequence from the same promoter. To address the reason for the variable fluorescence 
among cells in culture, we proposed that the plasmid copy number during cells replication may 
be the reason for this unequal fluorescence, accordingly a few steps were taken to improve the 
reporter efficiency. 
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 Integration of the GFP reporter into S. cerevisiae genome  
To investigate whether the plasmid copy number of pRS316, the basic vector of the GFP 
reporter, is the issue in regard to the different fluorescent activity among cells, integration of 
the same GFP construct, with 2A peptide inserted at the 157 residue has been carried out into 
the cells genome. If the plasmid copy number was to blame, the integration ensures higher 
expression of the construct encoding the GFP reporter, regardless of the plasmid copy number 
in cytoplasm.  
To achieve this integration, we made use of the his3-Δ1 mutation in the wild type strain 
(JDY895) that we have used. This mutation includes an internal deletion of 187 base pairs from 
an area flanked with two HindIII sites (nt 305-492). Thus, we excised the GFP reporter from 
its basic vector (pRS316), and cloned it into a HIS3 vector (pRS303). GFP reporter/s were 
amplified using specific oligonucleotides flanked with SmaI restriction sites on both 5’ and 3’ 
ends using PCR. The resulting DNA was cloned into a pRS303 vector using SmaI sites, and the 
cloned plasmids were linearized by HindIII restriction enzyme and integrated into the JDY895 
strain, using standard yeast transformation protocol described in the Materials and Methods 
chapter.  
 
 
Figure 5.13: GFP fluorescence of TaV 2A peptide sequence integrated into the cell genome. 
 
Plasmids (pRS303) encoding WT GFP, 2A* and active FMDV 2A peptides were linearized, and extracted from 
the digests. 10 µg of each linearized plasmid was integrated into a WT S. cerevisiae strain genome (JDY895) using 
standard yeast transformation protocol (see Materials and Methods). Transformed cells were plated on plates 
lacking histidine thus, integrated cells were able to grow, as histidine gene is expressed from the integrated 
plasmid. Growth conditions and flow cytometry procedures are similar to previous experiments shown above.   
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Increasing the expression of the GFP reporter via integration into the genome did not increase 
the ratio of cells which are positive to GFP. The number of yeast cells properly expressing the 
protein in the strain integrated with the wild type GFP is ~30% of the parent cells sorted by the 
flow cytometer. This number is about the same in the strain integrated with the inactive 2A 
construct however, the number of cells expressing GFP is decreased in the strain integrated 
with the active 2A construct (figure 5.13). Given that only 30% of cells express the entire GFP 
in controls, where no 2A activity is supposed to be detected, the integration did not resolve the 
problem, and another solution is going to be suggested below.  
 
 Overexpression of the GFP reporter   
Here, we presumed using an inducible promoter would increase the expression of the 
reporter in all cells, leading to an increase in the efficiency of the reporter in terms of assessing 
2A activity. The GAL1 promoter has been used for this purpose, and sequences encoding wild 
type GFP, GFP-2A*, GFP-TaV-2A and GFP-PTV-2A were cloned into a vector, already cloned 
with a GAL1 promoter. The GAL1 sequence from pJNY11 vector (the basic vector of the 2A 
reporter used in the immunoprecipitation) was used here by excising the GAL1 gene sequence 
and clone it upstream to the GFP-2A sequence into the pRS316 vector. Then, to change the 
selection marker from URA3 to HIS3, the HIS3 gene was taken from pRS313 vector and cloned 
into appropriate sites within the URA3 gene sequence of the newly developed vector, to end up 
with a plasmid expressing the GFP reporter from a GAL1 promoter, and carrying a HIS3 
selection marker. This time, the GFP reporter was utilised to examine the efficiency of the 2A 
peptide in the presence of different mutations of eRF1/3. The newly cloned GFP reporter into 
the GAL1 vector was transformed into the strains, which maintain termination via mutant 
eRF1/3 (same strains used in experiments presented in Chapter 4). As previously mentioned in 
this thesis, strains of S. cerevisiae with attenuated SUP45 gene with kanmix (YTH91, table 2.1) 
were used. Therefore, they undertake termination by a plasmid-born (centromeric plasmid 
URA3) copy of wild type SUP45. These strains were transformed with plasmids with LEU2 
selection marker. These plasmids encode  point mutations in SUP45 (pTH313-774, table 2.2). 
Cells were selected on 5-FOA plates, to select colonies with only the LEU2 plasmid copy of 
sup45 being expressed. Cultures of these strains were incubated overnight in selective media at 
30 ºC with 2% w/v raffinose, diluted on the next day with the same media plus 2% w/v 
galactose, and allowed to grow for ~4 hours. Cells were harvested and diluted as described 
above for the flow cytometry measurements. The highest efficiency detected amongst the tested 
selection was with the PTV 2A peptide (section 5.3.6), thus we started assessing the effect of 
Sup45 mutations using the GFP reporter containing PTV coding sequence. Despite the 
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overexpression of the GFP reporter used in this experiment, the high activity of the PTV 2A 
peptide overrides the prospective effects of mutant eRF1, when the high efficiency of the 
reaction diminished to a great extent, the fraction of ribosomes undergoing read-through over 
the proline 19 of the 2A peptide (figure 5.14).  
 
 
       
 
 
     
 
 
 
 
 
 
Figure 5.14: GFP fluorescence in cells expressing mutant eRF1. 
GFP reporter with PTV 2A-coding sequence was used to examine the effects of mutations in different domains of 
eRF1. The GFP reporter was under a GAL1 promoter, and plasmids encoding wild type GFP, PTV-2A* and PTV-
2A were transformed in yeast strains expressing sup45 as the only copy of eRF1 for termination (YTH91 strain 
transformed with plasmids, pTH313-774, table 2.2 see text in section 5.3.7.2 for details). Strains were inoculated 
into selective media with 2% w/v raffinose and incubated at 30 ºC overnight, diluted in the morning with the same 
media plus 2% w/v galactose. Further incubation was applied for 4-5 hours, and 5 ODs600 were harvested, washed 
twice with dH2O and PBS respectively, and re-suspended in 1 ml PBS. Suspensions were sonicated for 10 seconds 
each, and exposed to the flow cytometry analyser. Data were automaticslly processed, by the analyser operating 
system (BD FACSDiva™ software) to obtain the ratio of cells expressing GFP (GFP-positive cells) from each 
strain, detected by FORTESSA X20 analyser. Data presented as means±SE. Values are from 4 independent 
experiments. 
 
 
To avoid the interfering effect of the high activity of 2A peptide, expressed by the PTV-2A, we 
replaced the PTV with a less active 2A peptide from TaV (figure 5.15). This was performed 
using the same cloning strategy mentioned for the GFP cloning which includes, the 
amplification of the TaV 2A sequence with the second part of GFP (sequence of residues 158-
end) using the specific forward oligonucleotides for TaV and T3 oligonucleotide as the reverse 
primer. The PCR fragment was cloned into the modified pRS316 vector (with a HIS3 selection 
marker and GAL1 promoter, see text in 5.3.7.2 for details) using BglII site which flanks the 5’ 
end of the fragment and EcoRI at the 3’. This plasmid was transformed into strains maintaining 
termination through a range of Sup45 mutations (YTH91 transformed with pTH313-774). The 
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former experiment was repeated to investigate whether the usage of the GFP reporter gives the 
same results observed by the immunoprecipitation experiments, presented in Chapters 3 & 4. 
 
Figure 5.15: GFP reporter is sensitive to changes in the 2A activity produced by mutations in 
eRF1. 
GFP fluorescence of strains with a variety of sup45 alleles, expressed by flow cytometry is presented above. 
Plasmids encoding a GFP reporter with TaV 2A were transformed in yeast strains expressing sup45 alleles as the 
only copy of eRF1 for termination. The GFP reporter encodes TaV 2A peptide, and expressed from GAL1 promoter 
in presence of 2% w/v galactose in the growth media. All procedures are similar to the experiments explained 
above. Values of GFP fluorescence here were normalised according to the value of the strain expressing the 
reporter with 2A* where the 2A is inactive (shows the maximum read-through/fluorescence). The fluorescence 
value of this strain was set to 100. Then, other samples were normalised using the formula: Z=Y*100/X, where Z: 
the value of the sample/mutation presented in the chart. Y: the original value of the sample observed by the flow 
cytometer. X: the original value of the strain expressing 2A* observed by the flow cytometer (the value before 
being set to 100).  Data were plotted to present differences in the read-through triggered by each mutation/strain, 
compared to the wild type. Values were taken from three independent experiments and expressed as mean±SE. 
 
The utilisation of TaV-2A peptide within the GFP reporter resolved, to a great extent, the former 
problem obtained when the PTV-2A peptide was used. It has been clearly shown in figure 5.15 
that the expression of the GFP reporter from a GAL1 promoter results in about 7 fold increase 
in the ratio of GFP-positive cells in such sample, retaining the variation in the GFP fluorescence 
among strains expressing different mutations of eRF1. The analysis presented in figure 5.15 
reveals massive differences in 2A activity, in strains maintaining termination with mutant eRF1, 
observed by GFP fluorescence. The differences in the GFP fluorescence imply changes in ratios 
of ribosomes translating the reporter, which is caused by the inhibitory effect of eRF1 mutations 
on the 2A activity. The majority of mutations tested here reveal consistent results with those 
observed from immunoprecipitation. Most mutations such as, I32F, L49A, T55A, R62A, 
P174Q, I222S and T295A, show an increased GFP fluorescence, which approaches the value 
observed in the inactive 2A, suggesting more fractions of ribosomes undergoing translation of 
the entire GFP. These data are in accordance with the pulse labelling and immunoprecipitation 
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data. The test of most mutations of eRF1 revealed a status of read-through across proline 19 of 
2A peptide in the polyprotein reporter, observed by reducing the ratio of each upstream and 
downstream product (table 4.2). Of note, data regarding the strains expressing S30P and F401Y 
are not consistent with that obtained by immunoprecipitation. However, this experiment proves 
that the GFP reporter is sufficiently accurate to be used to investigate the 2A activity
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5.4 Discussion 
The structure of GFP, shown in figure 5.16, illustrates a barrel-like formation with a 
diameter of about 24 Å and a height of about 42 Å. The chromophore is located in the centre of 
the barrel, and mutational analysis revealed that almost the entire structure is required for 
chromophore formation. Residues 2-232 or 7-229 are essential for the GFP fluorescence. GFP 
folds into an 11-strand barrel, which is likely to be essential for the chromophore formation. 
Intramolecular cyclization of Ser65-Tyr66-Gly67 is responsible for the chromophore 
formation, which is an autocatalytic event (Heim et al., 1994). Therefore, the amino acid 
sequence and the consequent three dimensional structure of the protein is responsible for the 
intramolecular cyclization of residues 65-67. The barrel structure of the protein provides 
protection for the chromophores and, in addition, it aids to stabilize the GFP structure (figure 
5.12) (Ward and Bokman, 1982). Although the GFP protein folds quickly, the chromophore 
formation, and the consequent oxidation are likely to be a slower processes (Reid and Flynn, 
1997).        
 
Figure 5.16: The structure of GFP barrel and folding direction. Adapted from 
http://www.cryst.bbk.ac.uk/PPS2/projects/jonda/structur.htm 
The diagram shows the topology and pattern of GFP folding. On the right, ribbon structure of the GFP β-barrel 
with the loop, on the top, corresponding to the site of possible separation (residues 157-158). The diagram on the 
left represents the pattern and the direction of protein folding to produce the normal fluorescent activity.      
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It has been previously shown that the dissection of GFP at the loop located between residues 
157 and 158 can accommodate an insertion of 20 amino acids residues (Abedi et al., 1998). The 
ultimately chromophore-forming residues, Ser65, Tyr66 and Gly67, will be contained in the N 
terminus of the protein, and will configure properly in terms of fluorescence (Tsien, 1998). Two 
sites in the GFP protein structure have been defined for insertion of short peptides; one of these 
sites is within a smaller loop (Ala154-Gly160), this site possesses more mobility than other 
loops, as it is not integral to the structure of the protein. Although several sites in GFP have 
been defined to be the best accommodation locations for peptide insertion, the protein does not 
produce fluorescence levels as high as the wild type GFP (Abedi et al., 1998). 
In this chapter, we used the properties of GFP to accept insertions at particular locations to 
develop a novel reporter to study the 2A reaction. This has been tested according to the GFP 
fluorescence and/or protein expression, therefore cells with less 2A activity would be sorted as 
having higher fluorescence, whereas, cells with higher 2A activity give less/undetectable 
fluorescence. Initial experiments indicated promising results, assessed by fluorescent 
microscopy, where strains expressing functional 2A peptide have shown low level of 
fluorescence vs strains expressing 2A*.      
Using the newly-developed GFP reporter, we found that the longer sequence of 2A peptides, 
the more efficient. We used TaV 2A peptide to achieve this part. Two versions of TaV 2A 
encoding sequences were used, 19 and 31 amino acids. The differences between the two lengths 
of 2A peptides, on the level of protein expression, are not clear, in addition, the images of 
fluorescent microscopy show a massive difference between wild type GFP, 2A* on one side, 
and active 2A on the other side, but it is unclear between the 19 and 31 amino acids (data not 
shown). Cell sorting techniques provided a good analysis of strains expressing different lengths 
of 2A peptides, when fluorescence of such is measured. Values obtained from flow cytometry 
suggest that the longer sequence of 2A peptide is the stronger in activity, given that the 
fluorescence of the strain expressing the 31 amino acid length 2A peptide is less than that of 
the strain expressing the 19 amino acid 2A (figure 5.8). 
Despite the efficiency of the 31 amino acids TaV 2A peptide over the 19 amino acids 2A, TaV-
derived 2A seems to be the less efficient 2A amongst the range of 2A peptides that have been 
tested. PTV 2A shows the maximum activity detected by the lowest fluorescence measurement 
by flow cytometry (~10% of the wild type), which is in accordance with the results of (Kim et 
al., 2011). Furthermore, both DCV and PrV 2A peptides show higher activity than others, 
fluorescence: 25% and 46% respectively of the wild type. However, the western blotting shows 
lower protein expression in the lane corresponding to the PrV 2A (figure 5.12 A&B).  
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Donnelly and colleagues demonstrated that the TaV 2A peptide shows a high activity (~100%), 
followed by both PTV and FMDV 2A peptides (Donnelly et al., 2001a). In contrast to these 
results, Szymczak and colleagues reported that the highest activity of 2A peptides has been 
observed in both FMDV and TaV 2A peptides (Szymczak et al., 2004). The results of this study 
seem more consistent with Donnelly’s group results. Since previous studies were based on an 
in vitro translation of transcripts encoding these 2A sequences, a question remains unclear about 
how 2A reaction may act in in vivo experiments. It has been found that the PTV 2A peptide is 
the highest, in terms of activity, among a range of 2A sequences that have been tested in human 
cell lines, zebrafish embryos and mice liver (Szymczak et al., 2004). The mechanism by which 
PTV 2A peptide exhibits a high activity is still unclear, however it has been proposed that 2A 
activity can be promoted (de Felipe et al., 2006) by inclusion of a GSG linker at the N-terminus 
of a 2A sequence (Szymczak et al., 2004; Holst et al., 2006). In addition, insertion of C-
terminus residues of the 1D fragment in the N-terminus of the 2A peptide can also elevate the 
efficiency of the reaction, this means that the addition of the C-terminus five amino acids, 
APVKQ, to the N-terminus of the 2A increases the activity in the FMDV up to 13% in an in 
vitro study (Donnelly et al., 1997). Furthermore, it has been demonstrated that the insertion of 
C-terminal seven residues, APVKQLL, of the FMDV 1D peptide to the N-terminus of its 2A 
raises the activity up to 15% in baby hamster kidney and porcine alveolar macrophages cells 
(Groot Bramel-Verheije et al., 2000). These data are in agreement with our findings, in terms 
of the high 2A efficiency associated with the increased length of the 2A peptide. Although 
previous studies provided knowledge about activities of some 2A peptides, they did not account 
for the differences in the activity among 2A peptides from different viruses, as they assessed 
the activity of 2A peptide derived from the same virus, but in presence or absence of extra 
residues. Noteworthy, it was found that the 19 amino acids length of 2A is more efficient than 
the 22 amino acids in human cell lines. However, the three extra amino acids may not induce a 
detectable effect (Szymczak et al., 2004) which is inconsistent with our data. Given that the 
current study is carried out on yeast cells, variations, in terms of 2A activity, are expected due 
to the ability of cells to replicate plasmids as well as the nature of vectors/promoters encoding 
the 2A sequence. There might be other factors governing the differences in cleavage efficiency 
among different 2A peptides. 
2A peptides have been confirmed to function in eukaryotic cells such as, yeast (de Felipe et al., 
2003), plants (Park et al., 2009), mammalian cells (Hu et al., 2009) and transgenic animals 
(Trichas et al., 2008). Thus, the expression of 2A-containing ORFs occurs independently of 
cell type, since the 2A reaction is only dependent on the presence of eukaryotic translating 
machinery, which is universally conserved in terms of structure.    
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The 2A/2B of FMDV 2A reaction is a translational modification applied in the ribosome by the 
2A peptide, allowing the release of upstream protein, associated with 2A from the translation 
machinery, while the downstream protein synthesis is permitted (Donnelly et al., 2001a). 
Meanwhile, the efficiency of the 2A cleavage is not 100% i.e the translation through an ORF 
with 2A coding sequence may also yield a proportion of ribosomes generating a full-length 
product (Wang et al., 2007). The specific site of cleavage of the 2A reaction, G18/P19, 
participates a main role in the recoding event (Sharma et al., 2012). Therefore, mutations at this 
site abrogate or at least reduce the 2A activity (Doronina et al., 2008; Sharma et al., 2012). 
Mutational analysis of the 2A peptide mainly concentrates on the conserved C-terminus motif 
(Minskaia et al., 2013), however some studies also performed single amino acid mutational 
analysis for the N-terminus extension. It has been found that the 2A activity is completely 
abrogated when G18 is mutated (Sharma et al., 2012).  
Synonymous yeast codon usage bias plays an important role in this context (Kramer et al., 
2009; Tuller et al., 2010). Gene expression can be affected with even a single nucleotide 
mutation (Kimchi-Sarfaty et al., 2007). Additional information might be contained in the 
mRNA, which can fine-adjust protein folding, therefore ribosomal pausing at a rare codon may 
also impact protein folding (Komar, 2009). 2A-induced cleavage is an instant event following 
the synthesis of the polypeptide chain in the PTC, when the ester bond is hydrolysed and the 
nascent peptide chain is concomitantly released from the tRNA. In this point, the G18 seems to 
be the key amino acid to maintain the 2A activity, along with the conserved motif, due to its 
location right upstream to the 2A peptide cleavage site. The importance of G18 comes from its 
specific location which contributes to the assumption that mutating this particular residue may 
influence the 2A activity (Gao et al., 2014).  
In general, it has been found that the amino acid sequence in GFP structure plays a role in the 
protein function/and expression. Codon usage is a major determinant that may alter dynamics 
and/or speed of translation (Novoa et al., 2012; Novoa and Ribas de Pouplana, 2012). It is well 
defined that ribosomes synthesise proteins on a linear substrate, and no uniform speed has been 
recognized for this process. Therefore, some co-translational effects can be a result of transient 
pausing of ribosomes, these effects may include protein folding (Li et al., 2012). Sharma and 
colleagues (Sharma et al., 2012) confirmed that there is an interaction between the nascent 
peptide chain, in case of 2A reaction, and the exit tunnel, which may dictate a status of co- 
translational recoding (stop carry on). It has been found, through a comprehensive analysis of 
the mRNA sequence and its role in the protein synthesis, the corresponding nucleotide sequence 
may influence the structure of newly formed protein, even when the protein retains its amino 
acid sequence (Kimchi-Sarfaty et al., 2007). Modelling of the 2A function has proposed that 
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the G18-P19 may take a shape of tight-turn straight away beyond α-helix (Donnelly et al., 
2001a). Gao and colleagues investigated the 2A sequence to test the codon usage bias, 
particularly G18. They replaced the GGT codon of G18 with GGG and found that the GGG is 
the most frequent codon used by CHO cells (Gao et al., 2014). However this codon needs more 
energy than cognate codons to break the codon-anti codon bond between guanine and cytosine, 
compared to the required energy used by adenine and thymine. Codons with high pairing energy 
possess a strong tendency to bind the anti-codon on the tRNA while the ribosome is translating 
2A peptide. This may reduce the translation efficiency (Cannarozzi et al., 2010). It has been 
suggested, based on the above findings, codon usage bias could slightly alter the speed of 
translation, resulting in differences in the 2A activity. In the context of our results, the finding 
stated above lie in accordance with our current results regarding to the codon usage bias. The 
optimised 2A peptide showed ~20% fluorescence compared to the strain expressing the wild 
type GFP, whereas the GFP fluorescence (read-through level) of the strain expressing the de-
optimised 2A  has slightly elevated (~30% of the wild type GFP) (figure 5.10). However, we 
did not subject the G18 to the codon analysis, but instead concentrated on the conserved C-
terminus motif of the 2A peptide.  
The newly developed GFP reporter has been utilised to confirm the results mainly presented in 
Chapter 4, regarding to the mutational analysis undertaken on eRF1. The differences in the GFP 
fluorescence, detected by flow cytometry, are consistent to what was observed by 
immunoprecipitation. However, two mutations which were found to promote the read-through 
propensity in Chapter 4 showed no effect when assessed by the GFP reporter. The S30P 
mutation has been found to reduce the 2A activity through quantifying the outcomes of 
immunoprecipitation, and also caused a reduction in the strain growth rate, however its effect 
on the stop codon read-through was mild. In this case, the expression of the GFP reporter might 
be blamed. The degree of expression could be an important factor to obtain clear results, we 
found that the differences in fluorescence among the range of mutations in eRF1 were not 
significant when the construct was expressed from SRP1 promoter (data not shown), although 
they depict a clear feature about the effect of such mutation on the 2A activity. Whereas the 
differences in the fluorescence were clearer when the GFP reporter was expressed from an 
inducible (GAL1) promoter (figure 5.15). However the fluorescence of the strain expressing 
S30P mutation was not altered.  
Regarding to the DHFR reporter, it seems that the growth inhibition due to methotrexate 
treatment is not related to the change in DHFR expression induced by the 2A peptide. However, 
control strains expressing F1,2 and F3 showed what is expected, in terms of growth, on 
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methotrexate screen. Changing strain background also did not resolve the problem, which 
suggests that the expression/folding of DHFR is defective when 2A is inserted in between.  
 
SUMMARY 
The GFP reporter is a sensitive tool, which can be successfully used to examine the 2A 
activity. This reporter is independent of metabolic pathways in yeast, and fast to generate data. 
The results presented in this chapter suggest that using this reporter to be expressed from a 
plasmid in yeast is sufficient to obtain satisfactory results with consequent significance. 
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6 CHAPTER 6. SUMMARY AND DISCUSSION 
 
6.1 Background 
The 2A reaction comprises 2 unusual translational events; an ‘early’ nascent peptide 
release from the ribosome at the end of 2A sequence, with no requirement for a stop codon to 
occupy the ribosomal A site, which is instead occupied by the Pro 19 codon, and a re-start to 
translation using the same Pro 19 codon (Ryan and Flint, 1997). The mechanism of re-starting 
translation is still unknown, though it is coupled to the first step of the reaction. It has been 
proposed that amino acids of the 2A peptide have specific interactions with one or more 
components of the ribosome, modifying the activity of the PTC such that it cannot carry out its 
normal function (Donnelly et al., 2001a; de Felipe et al., 2010). Thus, its capability to generate 
a peptide bond between the Gly 18 and Pro 19 is hindered. Despite the N-terminal region of the 
2A amino acid sequence being highly variable, it has been found that the whole amino acid 
sequence of 2A peptides are essential for activity: many changes to the N-terminal of the 
peptide reduce its activity (Sharma et al., 2012). Unlike other cases of recoding, 2A activity is 
derived from peptide, rather than RNA sequence (Doronina et al., 2008; Sharma et al., 2012). 
Many 2A sequences, including the FMDV peptide, have a high alpha helical propensity. This 
has been suggested to be important for the peptide’s activity (Donnelly et al., 2001b). However, 
recent data indicate that 2A peptides from a variety of viruses, including FMDV, are extended 
in the ribosomal exit tunnel. Thus, specific contacts, and possibly the conformation, of a few 
key amino acids of 2A are likely to drive the changes to PTC activity.  
 
6.2 Methodology 
 Limited set of mutations to eRF1 and 3, plus strains in which the proteins were depleted, 
were used in this study. A strain, DAmP-sup45, was used to investigate the effects of depleting 
eRF1. This was complemented with an extensive set of strains expressing a variety of 
mutations, located in different domains of eRF1 and also eRF3, and which have different effects 
on canonical termination. The approach taken was to use methods that had previously been 
informative in analysing the 2A reaction (pulse-labelling and immunoprecipitation, 
measurement of growth and stop codon read-through in cells expressing a 2A-containing 
mRNA to high levels, and in vitro translation), alongside a newly developed GFP-based 
reporter of the 2A reaction.  
The novel GFP reporter, developed in this study, allows efficient assessment of the 2A activity 
via measurement of the GFP fluorescence, using flow cytometry. This reporter has several 
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advantages including positive selection of the GFP positive cells, and no interference with 
cellular metabolic pathways. In addition, it provides a quick and accurate tool for studying the 
2A activity. Data observed in this study through immunoprecipitation were confirmed using the 
GFP reporter, and results from the 2 methods were almost entirely consistent. 
  
6.3 Key findings 
The work in this thesis proved that both eRF1 and eRF3 are involved in the 2A reaction, 
and extend this to reveal that alteration to some residues affect the reaction more than others. 
Of particular note, some residues which are highly important for efficient canonical termination 
are not essential in the case of 2A, whereas changes to other amino acids that do not strongly 
affect canonical termination have much larger effects on the 2A reaction.  
Further to this, the first inroads into understanding key features of the second step in the 2A 
reaction emerged from the work. Specifically, reduction in levels of eEF1 activity reduces the 
generation of the downstream product. This strongly supports the suggestion that the generation 
of the first peptide bond of the downstream peptide is less favourable than other peptide bond 
formation events in the ribosome. 
 
6.4 Expanding discussion of the findings 
Sup45: Data presented in Chapter 3 clearly show that decreased abundance of eRF1 
(SUP45) results in significant inhibition of the 2A reaction. This was detected in the DAmP- 
sup45 strain (figures 3.2 & 3.3). The inhibition of the 2A reaction was demonstrated as a 
reduction of both upstream and downstream products of the 2A reaction, revealing that a larger 
fraction of ribosomes in this case translated Pro 19 as per canonical decoding, to generate full-
length translation product. Other experiments confirmed the data obtained with strains carrying 
the sup45-2 and sup45-42 alleles: these both reduce 2A activity. Expression of the 2A peptide 
in the sup45-42 strain, results in a significant reduction (at p≤0.01) only in the upstream product. 
This is perhaps attributable to variation among experiment repeats, and the relatively high 
standard error (about 12): here, only the high significant difference (p≤0.01) was considered.  
A key confirmatory experiment demonstrating the involvement of eRF1 in the 2A reaction was 
to overexpress SUP45 in the strains with defective eRF1 (see section 3.7.1). The overexpression 
of SUP45 in the DAmP-sup45 strain restored the fractions of both upstream and downstream 
products of the 2A reaction (figure 3.12). Intriguingly, overexpression of RLI1, in the DAmP-
sup45 strain, also brought the products ratios to the level seen in the wild type. This suggests 
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that the increased abundance of Rli1 could enhance the efficiency of eRF1 in catalysing the 2A 
reaction, which is consistent with the established roles of Rli1 in termination (Muhs et al., 2015; 
Mancera-Martinez et al., 2017).  
As presented in Chapter 4, a broad range of mutations located in different domains of eRF1 was 
analysed for effects on 2A reaction. A number of these revealed reduction of the 2A reaction, 
with both products of the reaction being reduced. The conclusion obtained from this work is 
that these mutations result in more ribosome passing through the 2A site without undergoing 
the reaction. Exceptions to this are E52A, which showed a decrease in the ratio of the upstream, 
whereas the downstream was significantly increased, compared to the wild type eRF1 (figure 
4.3). By reviewing the absolute values of both upstream and downstream products, obtained 
after quantification and correction according to Met/Cys in each product, it is clear that this 
particular mutation (E52A) exhibits this effect. Absolute ratios of 2A reaction products (before 
normalising the values), corresponding to this mutation revealed 34% vs 36% in the wild type 
for the upstream product, and 32% vs 14% for the downstream. This confirms the accuracy of 
this part of the results, in which the downstream product is almost doubled. An additional 
mutation V107D, located in the N domain close to the Y-C-F motif, revealed a significant 
increase in both products of the 2A reaction (figure 4.3). In the case of V107D mutation, it 
seems that this alteration to eRF1 promotes increased efficiency of the 2A reaction over the 
strain expressing the wild type eRF1. Presumably this specific amino acid change alters the 
conformation/interaction of eRF1 such that it improves its ability to interact with the ribosome-
nascent 2A peptide complex. Interestingly, this effect is diametrically opposite to the effect of 
this mutation on termination at stop codons, which is reduced for all three (Merritt et al., 2010). 
Differences between the effects of a mutation in eRF1 on canonical termination and the 2A 
reaction were also seen with a number of other eRF1 variants. The point mutations analysed in 
this study in yeast eRF1 revealed specific eRF1-associated phenotypes in the case of the 2A 
reaction. This indicates that there may be specific eRF1 functional epitopes that are key for the 
2A reaction.  
Aberrant termination at a sense codon is rare in eukaryotes (~10-4) (Arava et al., 2005). Given 
that eRFs are the main factors to drive the 2A reaction, how eRFs are prompted to efficiently 
bind the ribosome in the absence of a stop codon is unclear. Depending on the fact that 
ribosomes undergo different conformational changes during the cycle of peptide bond 
formation and termination, Doronina et al. (2008) suggested that 2A may overcome the 
necessity for a stop codon through imposing a similar conformation on the ribosome to that 
undergone in the case of stop codons. This, to some extent, is inconsistent with our results. Data 
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in the current study suggest that eRFs, particularly eRF1, undergo a modified conformation in 
the functional domains to structurally, and functionally accommodate in the A site and trigger 
an early termination. Moreover, 2A imposes a different conformation on the 
ribosome/interactions of the ribosome with factors, this is supported by the observation that if 
the Pro 19 codon is replaced by a stop codon then ribosomes are unable to pass 2A and instead 
stall (Sharma et al., 2012). The conformation is sufficiently unusual that a stop codon cannot 
be recognised and termination is effected normally. However, it is not very far from the normal 
conformation of the ribosome during translation as replacement of Pro 19 with other sense 
codons leads to efficient: it read-through is only disturbed enough to alter the ability of prolyl-
tRNAPro and eRF1 to interact differently to normal. 
The ribosome translating a 2A peptide may pause, for a longer time than that seen in the 
canonical termination, at the 3’ of the 2A-coding sequence, where eRF1 is supposed to be 
associated, yielding low concentration of effective eRF1 being available for next rounds of the 
reaction, this may influence/delay the recycling efficiency of eRF1 to ensure sufficient pool of 
eRF1 for successful termination.  
Our results confirm the role of eRF1 and 3 in the 2A reaction, as key factors catalysing 
termination as the first step in the reaction. Machida (Machida et al., 2014) argued against this 
scenario, suggesting that termination factors are “likely” not required for the reaction. This team 
proposed an alternative mechanism including interaction of the C-terminus of 2A with the exit 
tunnel, this possibly affects the PTC activity, leading to hydrolysis of the 2A-peptidyl-tRNA 
bond, rather than the reaction being catalysed by eRF1. This model is based on the 
understanding that peptide bonding by proline is slower than other amino acids residues 
(Skabkin et al., 2010). This study also suggested a possible contact between the 2A C-terminus 
and the ribosomal protein L10e to activate the PTC, however, this study provided no evidence 
for this. A second possibility this study raised is that some ribosome-associated proteins could 
not be removed from the translation system they purified, and might be involved. A potentially 
confounding aspect to the Machida study is that the in vitro translation experiments were carried 
out for several hours and no time courses are presented to show how they proceed during that 
time. It is possible that the 2A reaction may proceed at slower (uncatalysed) rate in the absence 
of eRFs, and that this is what was being detected in the experiments in this paper. Furthermore, 
the fact that proline is relatively slower than other amino acids, in terms of peptide bond 
formation, is in support of our proposal, in which a competition may occur between prolyl-
tRNA and eRF1 to occupy the A site of the ribosome. Our study provides clear evidence, mainly 
in vivo, but also in vitro, that eRFs are the key elements that are required to maintain the 2A 
reaction, based on biochemical analysis of mutation effects in both eRF1 and eRF3. 
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A three dimentional structure of eRF1 with residues examined in this study highlighted in 
functional domains/motifs of the protein is presented below in figure 6.1. 
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Figure 6.1: The structure of eRF1 and point mutations analysed in this study. Figures adapted 
from Merritt et al (2010). 
(Top left) mutations to residues in eRF1 are presented in spacefill in a ribbon model of Sup45. Mutations are 
shown in orange/green. (Bottom left) same of the top with 180∘ rotation of the protein and mutations to residues 
highlighted. (Top and bottom right) the conservation of amino acids in different domains/motifs are indicated in 
spacefill.  
 
6.5 Rli1 takes part in the 2A reaction  
Depletion of Rli1 leads to defects in termination and ribosome recycling (Shoemaker and 
Green, 2011). The DAmP-rli1 strain had no detected defect in the 2A reaction. Thus Rli1 is not 
a limiting factor for eRFs activity in promoting termination at 2A. However, Rli1 can enhance 
the reaction through overexpressing of this factor in cells with defective eRF1, to approach the 
value seen in cells expressing a wild type eRF1. This is in accordance with the function of Rli1 
in canonical termination. 
Ski7 perhaps competes with Rli1 (Rli1 promoting recycling of eRF1 from the 2A complex). 
Examination of strains deficient in factors that promote a variety of ribosome rescue/mRNA 
degradation pathways (Chapter 3) revealed an increase in the efficiency of the 2A reaction in a 
ski7 strain (figure 3.7). When a polylysine segment interacts with the ribosomal exit tunnel, a 
halt of translation is expected. This increases the probability for the mRNA to be exposed to 
endonucleases (Tsuboi et al., 2012). This endonucleolytic activity might be provided by the 
exosome, where a nuclease is recruited to the ribosome by the Dom34:Hsb1 complex, however, 
some evidence refers to the effect of the ribosome itself to recruit this unknown nuclease 
(Hoshino, 2012; Inada, 2017). In contrast, no nuclease recruitment, with a continuous 
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translation of the mRNA, was detected in yeast strains with ski7Δ (Hoshino, 2012). It has been 
confirmed that Ski7 plays an essential role in release of polypeptides encoded by stop codon- 
less mRNA (Chiabudini et al., 2014). Given these findings, it is possible that Ski7 is recruited 
to some ribosomes paused at the 2A site, leading to degradation of the mRNA. Thus Ski7 could 
be considered as an inhibitor of the reaction. Further experiments should then test the abundance 
and degradation (half-life) of 2A-encoding mRNA in strains containing or lacking Ski7.  
 
Protein Mutation Domain Effect on 2A Effect on 
termination  
Protein 
abundance Upstream           Downstream 
eRF1 S30P N ↓↓↓ ↓↓↓ ↓ = 
I32F N ↓↓↓ ↓↓↓ ↓↓ ↓↓↓ 
P38L N ↓↓ ↓↓ ↓↓ = 
L49A N ↓↓ ↓↓ ↓ Nd 
E52A N ↓↓ ↑↑ ↓ Nd 
T55A N = ↓↓ ↓ ↓ 
N58A N = = ↓↓↓ ↓↓ 
S61A N = = ↓ ↓ 
R62A N ↓↓ ↓↓↓ ↓ ↓ 
V68A N = = ↓↓ ↓ 
V107D N ↑↑ ↑↑ ↓↓ ↓↓↓ 
P174Q N ↓↓ ↓↓ ↓ ↓ 
I222S M ↓↓ ↓↓ ↓ ↓ 
T295A C ↓↓ ↓↓ ↓ Nd 
T388A C = = ↓ Nd 
F401Y C ↓↓ ↓↓ ↓ Nd 
Y410F C = = ↓ ↓ 
 
Table 6.1: Comparative effects of eRF1 mutations between stop codon and 2A reaction. 
 
Mutations of eRF1 tested in this study, along with locations in the protein structure are summarized in this table. 
Comparison is made between effects of mutations on the 2A reaction and canonical termination at a stop codon. 
In addition, protein abundance of such mutation is shown (Merritt et al., 2010). Nd: not determined, =: no effect, 
↑: increase, ↓: decrease. 
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As seen in table 6.1, although most mutations tested here have a reducing effect on the level of 
protein abundance, their inhibitory effects, when found, on the 2A reaction is at least two times 
of that seen on protein abundance. For example, the S30P mutation inhibited the 2A reaction 
by ~65%, whereas it shows no effect on the protein abundance. Also, P38L inhibited the 2A 
reaction by ~40% with no effect on the protein abundance. On the other hand, both N58A and 
V68A have shown no effect on the 2A reaction but the protein abundance in these mutations is 
reduced (Merritt et al., 2010). The evidence confirms that the inhibitory effect of such eRF1 
mutations on the 2A reaction and the consequent effects on growth rates and stop codon read-
through are not affected by protein availability of such mutations, but instead by the key role 
of each residue to maintain a normal 2A reaction. Data in support of this, the N58A and S61A 
mutations, which did not alter the 2A reaction, show a sharp decrease in protein abundance. 
Furthermore, the V107D increased both upstream and downstream products, but also has a low 
protein abundance. This confirms that effects seen here on 2A reaction are not results of reduced 
protein abundance. 
The alleles tested in this study for their effects on the 2A reaction are corresponding to human 
eRF1 i.e. they affect canonical termination in human ribosomes. They were previously 
examined for their effects on the canonical termination by both in vivo and in vitro analysis, it 
is not surprising that both N58A and S61A, located in the core functional NIKS loop of the 
TASNIKS motif, have inhibitory effect on canonical termination (cause increased read-
through), detected by both in vivo and in vitro assays (Frolova et al., 2002; Merritt et al., 2010). 
In our study, we chose a few mutations for an in vitro analysis, and found that the results mirror 
the corresponding in vivo biochemical analysis of such allele examined by pulse labelling and 
immunoprecipitation. The highest inhibitory effect in both upstream and downstream products 
was seen in S30P and I32F. Whereas R62A revealed the same effect on the downstream product 
but less inhibition on the upstream. P38L, L49A, P174Q, I222S, T295A and F401Y revealed 
less inhibition on both translation products than that observed in both S30P and I32F.   
Models for stop codon decoding involve linear positioning upon physical binding between 
TASNIKS motif and the stop codon (Muramatsu et al., 2001; Chavatte et al., 2002), in addition 
to a cavity model, which propose that several cavities contained in the N domain of eRF1 may 
bind the three nucleotides of the stop codon (Fan-Minogue et al., 2008; Hatin et al., 2009). It 
has been reported that stop codons are physically linked to individual amino acids. This was 
assessed by an in vitro assay used s4U-label cross links the first base of the stop codon to either 
R62, S61 or K60 (yeast numbering) (Chavatte et al., 2002). This concept seems to be acceptable 
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by our outcomes, given that R62A is amongst the mutations which show the highest inhibitory 
effect of the 2A reaction, determined by immunoprecipitation, growth rate measurement and 
consequent doubling time, stop codon read-through and confirmed by the GFP reporter. 
Unfortunately, we were unable to examine the K60 due to its effect on cell viability, but given 
that the S61A mutation has shown no effect on the 2A reaction, we presumed that the R62 
residue assumed a unique role to bind a base in the Pro 19 codon in the A site. The specific 
conformation undergone by eRF1 includes the involvement of the S30, located in the core GTS 
motif, as well as I32 and P38, which are incorporated with in the YxCxxxF motif. 
Unexpectedly, when mutating valine 107, which is also located adjacent to the Y-C-F motif, to 
aspartic acid, it was revealed an increase in the 2A reaction efficiency over the value of the wild 
type, suggesting that the aspartic acid in this conformation plays an essential role to improve 
the translation. However, more investigations are required to utilise this point mutation as a tool 
to improve the 2A reaction.  
Consistent with our observations, regarding the functional role of TASNIKS in stop codon 
recognition, during the canonical termination, the ribosome adopts a particular conformation, 
similar to that seen in stalled ribosomes in the NMD, and the pre-termination complex in 
mammals, containing eRF1 and 3 (Becker et al., 2011; des Georges et al., 2014). eRF1 contacts 
the ribosomal 40S subunit via its N domain, directing the TASNIKS loop in vicinity of the stop 
codon in the ribosomal A site. The core NIKS motif is then localised opposite to the stop codon, 
simulating the model suggested in bacteria (Korostelev et al., 2008). A two-step model has been 
proposed to recognize the first two bases of the stop codon, which is followed by a conformation 
of the N domain of eRF1, facilitating the decoding of the second and third bases (Kryuchkova 
et al., 2013). eRF1 contacts domain III of eRF3 via the C domain. A mini domain has been 
recognized in the eRF1’s C domain (Mantsyzov et al., 2010), which anchors eRF1 in this point, 
to the “beak” of the 40S subunit, while the M domain is packed against the eRF3’s domains, 
providing an interaction surface, where the switch regions of the eRF3’s G domain contact 
eRF1. Both M and C domains of eRF1, together with eRF3, bind to each other in such a position 
that the functionally essential GGQ loop is positioned between the 40S subunit and the G 
domain of eRF3, in a tight conformation that prevents peptide release activity at this stage. To 
activate the release activity, a dramatic conformational change is required to localize the GGQ 
loop in the PTC (Preis et al., 2014).  
We also found a role for eEFs in the 2A reaction, particularly in catalysing the generation of 
the downstream product of the reporter. This confirms that the second step of the 2A reaction 
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is indeed an elongational event. As the main function of eEF1α is to deliver the aminoacyl- 
tRNA to the ribosome, the role of eEF1β is complementary, by triggering guanine exchange. 
Both eEF1α and β altered the second step of the 2A reaction, by reducing the ratio of the 
downstream product.  
To sum up our findings, it seems plausible that NIKS motif is not involved in the 2A reaction. 
Given that the main function of NIKS is to bind the first uridine of the stop codon (Chavatte et 
al., 2002), which is replaced, in the case of 2A with Pro 19 codon (CCA), therefore it is not 
expected that NIKS loop interacts with the cytidine. Moreover, purines in the +1 position of the 
stop codon are likely to be incompatible, in terms of propensity to form hydrogen bond.  On the 
other hand, GTS loop, which normally binds purines in the second and third positions (Bulygin 
et al., 2011), may be involved in the 2A reaction by binding  the adenine in the third position 
of Pro codon. This is perhaps carried out by S30, which, when mutated, significantly inhibited 
the reaction, probably caused by shifting of particular residues across different motifs (Blanchet 
et al., 2015).  
R62 is supposed to play an important role in the 2A reaction. Literatures in support of our results 
demonstrate that arginine in this position interacts with rRNA in the ribosome via its negative 
charge, allowing proper conformation for eRF1 (Blanchet et al., 2015). 
Finally, we have suggested a model for the 2A reaction, according to data obtained from this 
study, which includes the involvement of both termination and elongation factors in the reaction 
(figure 6.2).
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Figure 6.2: A schematic model of 2A reaction. 
 
A model of the 2A reaction is presented according to the data of the current study. (A) The ribosome reaches the 
end of the 2A peptide sequence, where a Pro 19 codon (CCA) is in the A site. A recruitment of the pre-termination 
complex is triggered, then eRF1 binds the Pro codon, with different conformation than that with a stop codon. (B) 
Release of eRF3 and binding of ABCE1 to promote the peptide release. (C) After peptide release, the ribosome 
resumes the translation, with the help of the eEF1 to deliver the prolyl-tRNA to the A site to restart the translation 
of the downstream peptide. (D) Magnification view of A, showing the peptide chain of 2A inside the exit tunnel 
before being released from the ribosome by the action of eRF1, which is associated here to the ribosomal A site 
with the M domain/GGQ motif in the PTC to catalyse the peptide  release.
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Conclusions 
2A reaction is mainly a termination event for the first part of the reaction, which includes release 
of nascent peptide chain from the ribosome. 
eRF1 can be recruited to the ribosome to trigger termination on a sense codon rather than a stop 
codon. 
The conformation of eRF1 undergone on 2A peptide (Pro codon) is different from that seen in 
canonical termination, which includes involvement of residues that are not important for the 
termination at a stop codon, and also, exclude the role of some residues that are essential in 
canonical termination. 
eRF3 and ABCE1 are also involved in 2A reaction to complement the function of eRF1 in the 
ternary complex. 
Elongation factors are also recruited to the ribosome to drive the second step of the 2A reaction, 
which includes the translation of the downstream mRNA sequence. 
GFP reporter is a novel tool for investigating the 2A activity. It provides an independent 
assessment of the reaction with accurate and quick outcomes. 
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